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Abstract
In the United States 100 million people live with pain and must negotiate complicated
clinical decisions that lead to a variety of treatments to control pain, some of which are
effective and some that are not. Social identity theory and attribution theory guided the
development of the interview protocol and analysis plan. A qualitative study was
conducted to explore the complex nature of living with chronic pain through the
narratives of seventeen adults in chronic pain for at least 3 months. Structural and
thematic approaches were used to analyze the data. The structural results revealed three
groups of participants: those who were pain-free at the time of the study, those using nonopioid medications to manage pain (over-the-counter or prescription), and those using
opioid medications. The narratives of chronic pain revealed the shared experience of
managing the unpredictable ebb and flow of pain daily. The results also exposed
confrontational and stigmatizing experiences with doctors on issues including how to
express the severity of pain and request opioid medications. Many participants reported
undertreatment for pain. They also noted that anxiety increased pain. All participants
experienced stigma associated with chronic pain from sources such as employers, family,
and friends. The results suggest that (a) an ecological model is useful for understanding
the barriers to pain relief that patients experience, and (b) chronic pain might be better
treated as a separate disease instead of a symptom associated with an underlying
condition. The results also pointed to opportunities for positive social change including
advocating for greater consensus on the definition and treatment of chronic pain, and the
utility of a biopsychosocial approach to treat all aspects of the chronic pain experience.
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Chapter 1: Introduction to the Study
Pain is the oldest and still the most common reason for seeking medical treatment
(Ljungvall et al., 2020; Meldrum, 2003; Prunuske, 2014; Sinatra, 2010; van den Beuken-van
Everdingen et al., 2016; Vargas-Schaffer, 2010). Research often uses the terms “pain” and
“suffering” interchangeably (Chapman & Gavrin, 1999). The difference between these two
terms is critical to the comprehensive understanding of pain. This study was focused on the
experience of persistent, chronic pain, defined as pain that continues after treatment for
longer than medical providers expect (Gatchel et al., 2014; Siddall & Cousins, 2004; Stones
& Cole, 2014). The evidence for the existence of chronic pain is undeniable (Berry & Dahl;
2000; Swan & Hamilton, 2016; Volkow & McLellan, 2016; Wailoo, 2104). This chapter
summarizes the current knowledge and challenges in pain research, how this study addressed
the gaps in that research, and why addressing these gaps was significant. I then review the
research questions and the theories behind the framework of the study. I then consider how
those theories supported the research questions.
Background
In the United States alone, 100 million people have lived with chronic pain (Ambrose
& Golightly, 2015; Ljungvall et al., 2020; Peppin et al., 2015). The treatment of chronic pain,
unlike other physical symptoms, has been fraught with political, economic, and social
challenges (Clauw et al., 2019; Nagel, 2016; Treede et al., 2019; Wailoo, 2014). Treating
chronic pain exceeded the costs of other common chronic conditions such as hypertension,
heart disease, and diabetes (Clauw et al., 2019; Staton et al., 2007). The research estimated
these costs to be between 560 to 635 billion dollars annually (Clauw et al., 2019; Gaskin &
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Richard, 2012). Yet, despite enormous efforts and expense, medicine needed the research on
the patient's voice to develop a more human understanding of the experience of chronic pain
(Nichols et al., 2020; Rajagopal, 2011).
There were multiple ways to define chronic pain in the research (Bell & Salmon,
2009; Calati et al., 2015; Garschagen et al., 2015; Heit, 2001; Stubbs, 2016; Werner et al.,
2004; Wong et al., 2015). In most studies, chronic pain was considered pain that lasts longer
than 3 months (e.g., Clauw et al., 2019; Rivera et al., 2015). By any definition, chronic pain
was a complicated phenomenon and difficult to measure objectively (Koyama et al., 2005;
Littlejohn et al., 2019; Treede et al., 2019).
There were two main views on treating chronic pain (Nijs et al., 2019; Treede et al.,
2019). The first was that chronic pain is a symptom (Dowell et al., 2016; Henry et al., 2015).
The second was that chronic pain is a disease (Clauw et al., 2019; Engel, 2012). Henry et al.
(2015) stated that treating chronic pain as a primary condition masked the pain and led to
increased dosages in pain medications and long-term problems, including addiction. From
this perspective, opioid medications should be titrated down and eliminated over time,
regardless of whether the underlying, pain-producing conditions had been resolved (Dowell
et al., 2016). Collectively these researchers suggested that treating noncancerous pain as the
primary goal risked iatrogenic addiction. In this view, the problem was primarily due to overprescribed pain medications (Dowell et al., 2016). Such research advised limiting or
eschewing opioid pain medications, even when the patient complained of pain. It also
minimized quality-of-life factors and the possibility of undertreatment (Hoffman, 2016).
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Other researchers felt the basis of pain treatment should focus on quality-of-life
considerations, not just medication types or dosages (Lynch, 2016; Melzack, 1990; Nijs et
al., 2019; Treede et al., 2019). In this perspective, doctors administered pain medications at
an effective dose to manage pain for as long as necessary. This control needed to be achieved
by whatever means necessary, including the use of opioids (Gourlay et al., 2005; Kumar et
al., 2015; Rajagopal, 2011; Treede et al., 2019).
A frequent topic of controversy in the history of pain treatment was the need to
confront quality-of-life factors and eliminate needless pain (Nijs et al., 2019). The latest
iteration started in the medical community with cancer pain (Katz & Rosenbloom, 2015;
Melzack, 1990). Later research supported the idea that pain control should be a primary goal
(Bennett et al., 2019; Gatchel et al., 2014; Katz & Rosenbloom, 2015). However, many
researchers took issue with the need to control pain as the primary goal in noncancerous,
chronic pain (Bhamb et al., 2006; Chaparro et al., 2014; Compton & Volkow, 2006; Henry et
al., 2015; Moseley & Butler, 2015).
The epidemiological trend documenting the rise in opiate addiction has further
complicated clinical decisions on pain control and polarized the debate (Peppin et al., 2015).
The Centers for Disease Control and Prevention (CDC, 2015) reported that, from 1999 to
2014, opioid addiction increased, which caused 160,000 deaths. The CDC report also
estimated that there were 1.9 million people who abused or became dependent on opioids in
2013. One theory was the over-prescription of opioid medications caused the rise in opioid
abuse (Compton & Volkow, 2006).
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Other research suggested prescribers may not be the primary cause of this increased
addiction (Finnerup et al., 2015). Sullivan and Levin (2016) stated that more pain-producing
conditions became evident as the number of baby boomers with chronic pain conditions
increased as the country aged. The authors also noted that this population might have brought
a tendency to be more open to the use of medications for pain control. Also, there was little
evidence that reducing addictive pain medications would lead to better long-term pain
management (Finnerup et al., 2015). Long-term pain management might require a
personalized pain genotype, the identification of which needed more progress in neurological
research (Bruehl et al., 2015).
Staton et al. (2007) stated that doctors consistently underestimated pain levels among
patients who sought treatment and complained of pain. The authors found these differences
in perceptions were more pronounced when the patients were from an ethnic minority. Even
when the patients participated in detailed questions about their pain, the goal appeared to
persuade patients to follow medical advice (de C Williams, 2016; Moseley & Butler, 2015;
Zanini et al., 2016).
Stigmatizing systemic, social, and self-shaming judgments complicated pain
treatments and undermined adequate control (Monsivais, 2013). Feelings of stigma were
present in any disabling, chronic illness, including chronic pain (Jackson, 2005). Pain
research often reported stigmatization feelings of chronic pain sufferers (Breivik et al., 2006;
de C. Williams, 2016; Slade et al., 2009; Wilbers, 2015). This stigmatization sometimes
resulted in self-shaming, perpetuating the problem (Waugh et al., 2014; Werner et al., 2004).
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Research on treating pain as a symptom versus pain as a disease created conflicting
recommendations on medical treatments (Peppin et al., 2015). These research studies noted a
possible increase in systemic stigma from the medical community and society in general
(Bennett et al., 2019; Breivik et al., 2006; de C. Williams, 2016; Slade et al., 2009; Wilbers,
2015). Other researchers suggested that the voice of patients was not appreciated (Rajagopal,
2011; Tsao, 2012). More information regarding a chronic pain patient's experience could
better illuminate ways to understand and treat the condition (Bury, 2001; Thomas, 2010). A
narrative approach might address this research gap (Rajagopal, 2011). Webster and Harden
(2013) thought pain was a qualitative experience. They and other researchers recommended
narrative analysis as a possible means of rehumanizing the understanding of chronic illness
(Bury, 2001; Rajagopal, 2011; Thomas, 2010).
Problem Statement
The persistence of chronic pain changes a person’s life and leads to comorbid events,
including loss of work, depression, lower quality of life, isolation, and higher medical costs.
(Von Korff et al., 2016). There is a lack of consensus on whether these aspects of chronic
pain constitute a separate disease that requires its own course of treatment (e,g., Clauw et al.,
2019), or if the search for pain's underlying mechanisms should be the primary goal (Vardeh
et al., 2016). Further, since pain cannot be objectively measured, the treatment of pain is
based on self-report and the judgement of medical providers (Bourke, 2014). Often pain is
considered a symptom of an underlying problem (Robbins, 2017). Accordingly, treatment is
focused on diagnosing and treating the underlying problem and not concentrating on
complaints of pain (Brodal, 2017). What is missing from the debate on how to treat pain is
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the voice of the patients in chronic pain (Rajagopal, 2011; Tsao, 2012). Some research has
tried to address this gap using surveys and focus groups (e.g., Wong et al., 2015).
Researchers are calling for more in-depth understandings from the patients’ perspectives. In
this study I used narrative research to allow the participants to tell the story of their chronic
pain experience in their own words. These stories explore the barriers to the adequate
treatment of pain and how pain treatment can be improved.
Purpose
The purpose of this study was to explore the complex nature of pain through the
narratives of participants who experienced chronic pain. The goal was to collect the stories of
chronic pain treatment-seeking, pain relief, and stigma in pain patients. The plan was that
these narratives would contribute to a deeper understanding of how pain might be better
managed whenever possible.
Research Questions
This study addressed the following research questions and subquestions to draw
closure on the identified gap in the literature:
RQ1: What were the narratives of managing chronic pain for patients?
SQ1a: How did these participants describe their experience of access to
treatment?
SQ1b: How did these participants describe their experience with the pain
management process?
RQ2: What was the meaning of stigma for these participants who used or believed
they needed opioids?
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SQ2a: How was stigma experienced in the treatment process?
SQ2b: How was stigma experienced with family and other social supports?
Framework
One theoretical framework of this study was social identity theory (Dumont & Louw,
2007). This theory posited social roles could take many forms depending on the perceptions
of the individuals within a group (Trepte, 2006). Monsivais (2013) stated that individuals
with chronic pain formed their identity within a group according to how openly they
expressed their chronic pain feelings. With more severe pain, the author concluded chronic
pain was difficult to hide. The result might be a change in social roles imposed by the pain
condition.
The change in social roles because of chronic pain invoked another theoretical
construct, stigmatization. Some researchers suggested that stigma might result from a
changed social role (Jackson, 2005). Much of the research documented the co-occurrence of
chronic pain and stigma (de C Williams, 2016; Monsivais, 2013; Slade et al., 2009; Waugh et
al., 2014; Werner et al., 2004). Stigma was evident in multiple pain studies, even when
stigma was not the focus of the research questions (Breivik et al., 2006; Slade et al., 2009;
Sturgeon & Zautra, 2016). The emotional impact of stigma lowered the ability to manage
pain (Waugh et al., 2014). There was also evidence of stigma in situations where there was
no observable bias (Monsivais, 2013).
A second theoretical framework came from the attribution theory. Attribution theory
deals with how people create causal explanations in the absence of objective evidence
(Kelley, 1973). Attribution theory helped explain why subjects hid their true feelings and
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gave a more socially acceptable answer to their doctors (Augoustinos et al., 2014). Also,
because there is no objective measure of pain except by self-report, this theory was useful in
understanding why patients and doctors disagree about the severity and causes of chronic
pain (Staton et al., 2007). Attribution theory also helped explain when the substitution of a
causal explanation, imposed without the conscious awareness, created a false memory
(Reyna et al., 2016). Finally, attribution theory helped design questions for the structured
interview so that the inquiries did not bias the outcome (Douglass et al., 2013).
Nature of the Study
For this study I used narrative research to explore the experience of people who live
with chronic pain. Jovchelovitch and Bauer (2000) stated that narrative research was a wellrecognized method for documenting shared cultural experiences, particularly illness and
persistent pain experiences. Both the subject and the experimenter were active participants in
creating a credible account with a beginning, middle, and end (Riessman, 2008). Surveys and
case studies removed data from their original contextual relationships and placed them in
another context, thus changing their meaning (Maxwell, 2013). Putting the data back into its
original contextual relationship is an excellent way to maintain and fully understand the
unique experience of chronic pain (Rajagopal, 2011).
For this qualitative, narrative study I interviewed 17 participants with chronic pain
with one interview per participant. The participants were people who responded positively to
an invitation from a referral source or expressed an interest in participation after hearing
about the study's exitance. Each participant signed a written consent before beginning the
interviews. The research questions encouraged each participant to tell their pain story in their
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own words. The data was recorded, transcribed, and then analyzed for common elements.
Analysis of the themes for either supporting or disconfirming the research questions
followed. These analyses included hand-coding, structural analyses, and computer
assisted/aided qualitative data analysis software (MAXQDA™). Participants experiencing
chronic pain often shared sensitive topics. Attempts to earn the participant's trust, assure
confidentiality, and develop a nonjudgmental, empathic connection were high priorities.
To facilitate trustworthiness, the recommendations of experts in qualitative research
guided the creation of the research questions and subquestions (Noyes et al., 2017; Riessman,
2008; Saldaña, 2016; Shenton, 2004). The thematic analysis approach uses structural
analysis, theme identification, member checking, and computer software coding programs
(Riessman, 2008; Saillard, 2011).
Definitions
The following definitions were terms used in this study:
Abuse of pain medications: This term defines one of the ontologically independent
effects of pain medications in the treatment of chronic pain. This term describes when a
person takes a pain medication that a doctor did not prescribe, is prescribed for another
person, or when a person takes over-the-counter (OTC) drugs beyond the recommended dose
without a doctor’s advice (Vowles et al., 2015).
Adverse drug events: The term applies to all possible unfavorable pain medication
outcomes, including side-effects, tolerance, drug escalation, and addiction. (Chapman et al.,
2010; Gourlay et al., 2005; Heit, 2001; Vowles et al., 2015).
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Addiction: This term is one of three ontologically independent expressions used to
define the adverse effects of pain medications. Here it refers to the continued use of a pain
medication despite a lack of relief, apparent harm, or a craving for the recreational effects.
(Vowles et al., 2015).
Attribution theory: The theory states that a person creates an explanation in the
absence of sufficient objective evidence to confirm the conclusion. This term explains how
doctors come to erroneous conclusions on treating pain based on their experiences (Kelley,
1973).
Confirmation bias: This occurs when a person overestimates the effects of a given
treatment or intervention in complicated situations or treatments. (Stubbs, 2016).
Chronic overlapping pain: With chronic overlapping pain, multiple underlying
conditions contribute to the source of chronic pain, making the diagnosis, treatment, and pain
relief more complicated (Fillingim et al., 2020; Littlejohn & Guymer, 2019).
Drug escalation: This occurs when the dosage of a drug increases more quickly than
recommended by the standard practice to relieve pain (Henry et al., 2015).
Dependence on pain medications: This term is one of three ontologically independent
expressions used to define the adverse effects of pain medications. This term applies when
the titration or lowering of a pain medication increases severe pain or the inability to manage
pain effectively. (Vowles et al., 2015).
Epidemic: The term applied to any medical problem that outstrips existing medical or
other treatment resources (Barth et al., 2017; Dowell et al., 2016; Huffman et al., 2015;
Penders, 2013; Reuben et al., 2015; Volkow & McLellan, 2016; Vowles et al., 2015).
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Face Pain Rating Scale: This scale is the most common method of self-reporting
pain. It is a 0-10, Likert-scale with Rating 0 (no pain) to Rating 10 (the most pain possible).
Over each rating are hand-drawn faces that represent the increasing severity of pain (Swan &
Hamilton, 2016).
Gatekeeper: In medicine, physicians have a dual role of healer and gatekeeper. In
their gatekeeper role, they determine access to treatment and medical needs. (Carlsen &
Nyborg, 2017).
Iatrogenic addiction: This term represents an addiction that results from the overprescription of pain medications (Dowell et al., 2016; Higgins et. al., 2018).
Joint Commission: Formerly called the Joint Commission on Accreditation of Health
Organizations (JCAHO). The Joint Commission is an accreditor of hospitals and other health
care providers. They also are deeply involved in setting standards for pain management
(Berry & Dahl, 2000).
Narrative research: This term refers to qualitative research that uses the participant's
entire story and breaks the data into themes. After that, the analysis identifies the common
themes between participants (Jovchelovitch & Bauer, 2000; Maxwell, 2013; Rajagopal,
2011).
Opioid: Any medication based on morphine or designed to give the same relief to
pain as morphine and has proven to lead to addiction in some people (CDC, 2015).
Pain: There was no commonly accepted definition for this term. A lengthy discussion
of the definitions of pain is in Chapter 2. The most common meaning: Doctors should allow
patients to define their pain (Haylock, 2002; Newton et al., 2013).
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Pain model: In the absence of an objective measure or theory of pain, models can
organize various conceptions of pain and pain treatment modalities (Engel, 2012).
Pain event: Because the definition of pain can vary from study to study, this term was
one way to describe a complaint of pain without accepting any given interpretation of pain
(Bourke, 2014).
Pain relief: The term is used when the patient no longer complains of pain. It can also
mean a 50% reduction in pain as defined by the patient (Finnerup et al., 2015).
Pain treatment: This refers to any intervention used to relieve pain, regardless of its
effectiveness (Wailoo, 2014).
Pain tolerance: This term refers to when a patient self-reports a lower level of pain
than expected given the cause (Irving, 1988).
Person-centered care: The term used when treatment included patient values,
preferences, expectations, and social circumstances (Brummel‐Smith et al., 2016). In areas of
long-term treatment, this term is more widely accepted. (Wade & Halligan, 2017).
Propensity scores: This is a method to explore differences in groups with
observational or nonrandomly selected data. A propensity score creates a probability that a
subject will be in one group or another. This evaluation allows researchers to evaluate
whether differences are a result of treatment effects (Luellen et al., 2005).
Pseudoaddiction: The term is used to identify when addictive behavior disappears
after reported pain is relieved. (Bell & Salmon, 2009).
Publication bias: The term is used when outside influences affect the number and
type of studies done on a topic (Sismondo, 2008).
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Quality of life: This term is used when treatment outcomes should consider overall
well-being and pain relief in addition to medication types and dosages (Lynch, 2016;
Melzack, 1990).
Qualitative trustworthiness: Trustworthiness is a term used by qualitative researchers
instead of validity. This term differentiates qualitative study terms from quantitative terms
(Roulston & Shelton, 2015).
Referral source: This is a strategy that prevents a researcher from purposefully
choosing participants in a qualitative study and potentially introducing biases in the research
study. By putting a referral source between the participants and the researcher, participants
would more likely reflect the actual topic under study (McLeod, 2017).
Saturation: In narrative studies, saturation occurs when the same data repeats in
interviews and no new insights are likely to be discovered. Saturation usually leads to
terminating the search for participants (Boddy, 2016; Francis et al., 2010; Mason, 2010).
Social identity theory: Social identity theorists study how a self-concept evolves and
internalizes. This evolution comes from the need to develop and preserve a positive selfimage when interacting with a social group (Abrams & Hogg, 1988).
Stakeholder: Anyone affected by the pain strategies and treatments of the patient
could be considered part of this group. It includes patients, providers, government officials,
pharmaceutical companies, family members, researchers, and affected professional agencies
(Boswell, & Giordano, 2009).
Stigma: This label describes when repeated experiences of negative bias spoil the
social identity of a person (Major et al., 1998)
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Suffering: The taxonomic category ranks above physical pain and includes all types of
human anguish, not just pain that arises from disease (Nagel, 2016).
Triangulation: This is a qualitative research strategy where a researcher collects data
from different sources. This study did not use this technique (Shenton, 2004).
Undertreatment: This is a label used when a provided treatment results in inadequate
pain relief and allows unnecessary pain (Peppin et al., 2015).
World Health Organization (WHO) Algorithm: The WHO suggests an algorithm for a
step-by-step approach to pain treatment. Sometimes this approach results in prescribing
opioids (Ventafridda et al., 1987; WHO, 2017).
Assumptions
I made the following assumptions with this study:


I assumed a person can better understand the experience of pain by interviewing
people who suffer from chronic pain.



I assumed that despite individual differences, there are some similar situations for
people in chronic pain, the exploration of which may help optimize pain
treatment.



I assumed stigma can be a consequence of bias that people with chronic pain
experience, and that this experience is likely in social and medical settings.



I assumed that narrative medicine research can contribute to improving the
treatment of disease though a deeper understanding of a patient’s lived
experience.
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Scope and Delimitations
The following boundaries were inherent in this study:


While there are similar experiences to chronic pain, the results from this study
may not apply to people in acute pain. The short-term duration of acute pain
sometimes allows for the enduring of pain until relief comes via healing. Acute
pain relief within the period that medical providers expect is not part of the scope
of this study.



The nature of purposeful sampling (where the qualitative goal is to seek
participants who share experiences) does not allow for inference to populations
not included in the study.



Due to the locale where I captured the data, the data might have been shaped, at
least in part, by the lack of available local, specialized treatments. This concern
was addressed in the results.
Limitations

The following were limitations to the study:


This study depended entirely on the reported experience of the participant. There
was no attempt to use information from the participant's medical providers,
friends, or family. The study did not use triangulation in any other form to verify
the reported experience of the participant.



While not as easily observable in situations where pain can be lessened or better
tolerated, any kind of pain might still generate similar experiences. The research

16
conclusions of this study might apply to cases where experienced pain is not as
severe. Identifying those situations, however, was not a goal of this study.


Because pain ebbs and flows, a report of pain at the interview may not be
consistent with another interview taken later from the same participant. In this
study I aimed to find similar experiences between pain participants, not to
understand the longitudinal sequala of future pain experiences.
Significance

Considerable literature has documented the propensity to undertreat chronic pain due
to: (a) fear of addiction or misuse, (b) fear of adverse effects, (c) lack of diagnostic criteria,
and (d) lack of training (Bell & Salmon, 2009; Bhamb et al., 2006; Chapman et al., 2010;
Gourlay et al., 2005; Peppin et al., 2015;). Rajagopal (2011) stated that the patient's voice
was missing from the treatment debate in all cases. The author further noted that little
research examined the patient’s narrative regarding pain relief and the effects of stigma. Such
research could deepen the field’s understanding of (a) the consequences of medical decisions
to restrict access to pain medications, and (b) the social effects of long-term pain on
treatment outcomes (Tsao, 2012).
One goal of this study was to contribute to professional practice by improving
compassionate care for patients in a medically appropriate way. Another goal was that this
study's results would add to the growing body of knowledge that contributes to a deeper
understanding of the suffering of millions of patients who experience chronic pain.
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Summary and Transition
Unlike other physical symptoms, chronic pain treatment is fraught with multiple
challenges, including high costs. Because there is no objective measure of pain, our measures
of pain are usually documented by self-report. Despite centuries of research, there are
competing theories as to the characteristics and treatment of pain. The rise in opiate addiction
has further complicated clinical decisions on pain control and polarized the debate. Stigma
might complicate pain treatments and prolong adequate control.
As a result, more research was necessary for people who suffer from chronic pain.
Such research should deepen our understanding of their pain experiences. Pain research also
suggested this understanding might be essential to provide optimal care and reduce
unnecessary pain.
This study's theoretical frameworks included social identity theory and attribution
theory, with the construct of stigma. For the study I had planned to interview 15 participants
with chronic pain, but in the end I interviewed 17 participants for the study. They came from
people who responded positively to an invitation from a referral source or volunteered after
hearing about the study. All responses were recorded and analyzed using techniques
consistent with narrative analysis.
Chapter 2 begins with a historical context of the perception of pain. It includes how
chronic pain is defined and measured in healthcare. The published literature indicates a lack
of consensus on pain measurement, making prevalence estimates difficult. The next section
focuses on the treatment and undertreatment of pain, the latter fueled by fears of growing
addiction. I also discuss research on bias and stigma towards individuals who suffer from
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chronic pain and have used opiates for pain relief. I present the theoretical frameworks of
social identity theory and attribution theory and describe them in relation to the participants’
experiences and how I used them to create the interview guide and analysis plan.
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Chapter 2: Literature Review
There exists a large body of research on pain and the treatment of pain (Bennett et al.,
2019; Clauw et al., 2019; Littlejohn et al., 2019; Ljungvall et al., 2020; Nichols et al., 2020;
Nijs et al., 2019; O’Keeffe et al., 2016; Singh et al., 2016; Schuchat et al., 2017; Tighe et al.,
2017; Treede et al., 2019; van den Beuken-van Everdingen et al. 2016; Walther-Larsen et al.,
2017). However, there remained a lack of consensus on the definition, diagnosis, and
treatment of chronic pain (Bennett et al., 2019; Finnerup et al., 2015; Gourlay et al., 2005;
Nijs et al., 2019; Wailoo, 2014). An in-depth review of the literature revealed that there was
little research on how individuals with chronic pain struggled with treatment options, got
relief from pain, and dealt with the stigma associated with the use of prescription
medications, particularly opioid medications. It also indicated a possible need to develop
more research on the chronic pain treatment experience to illuminate better ways to
understand and treat the condition.
Literature Search Strategy
I used the following databases to search the literature on pain, pain relief, and its
outcomes: (a) EBSCO, (b) PsycINFO. (c) PubMed, (d) SAGE Collections, and (e) Science
Direct. The major search terms included addiction, pain, pain models, pain treatment, pain
relief, and stigma. I also searched two terms associated with qualitative research: bias and
narrative research.
Due to the complex nature of pain, I used other terms within each major search
category to develop a more complete picture of the nature of pain. For addiction, minor
search terms included abuse, DEA, harm reduction, history of opioids, opioids treatments,
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and the War on Drugs. Pain search terms also included acute pain, breakthrough pain,
cancer pain, chronic pain, costs of pain, depression, neuropathic pain, pain assessment,
persistent pain, suffering, and suicide. Pain model terms included searches for biomedical
model and biopsychosocial model. Pain treatment searches sometimes included alternative
therapies, chronic pain treatments, efficacy, Joint Commission, marijuana, opioids,
treatment satisfaction, palliative care, quality of life, side effects, survival analysis, treatment
compliance, and universal precautions. Pain relief was searched with inadequate pain
management, opioid psychopharmacy, outcome measurement, palliative care,
pseudoaddiction, and undertreatment. Finally, stigma searches also sometimes included
disbelief, discrimination, health care encounters, and patient-centered care.
In searching for research bias, I used terms such as confirmation bias, false memories,
hindsight bias, response bias, prejudice, and publication bias. Narrative research included
other search terms such as client satisfaction, illness narratives, qualitative research, and
qualitative synthesis.
Given the multiple perspectives on pain and the various interests of stakeholders in
the treatment of pain, complex searches for this study were inevitable. Whenever possible,
these searches used the most recent citations. Many qualitative and pain treatment
perspectives, however, tended to collect in the more distant past. As values changed, attitudes
towards chronic pain changed, and this affected the research literature. As I will posit, there
appeared to be no consensus in the field of pain treatment.
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A Short History of Pain
Meldrum (2003), in a capsule history of pain management, stated that the philosophy
of pain dated back at least to the Judeo-Christian religion. The author noted that the story of
Job and the Passion of Christ suggested that chronic pain was almost necessary for moral
behavior. Meldrum added that early utilitarian philosophers used pain and pleasure as
opposing measures to determine good. The author added that doctors in the 17th century
viewed chronic pain as a measure of resilience and potential recovery from illness. Meldrum
stated that these views started to change with the widespread introduction of opium,
beginning in 1680. The author pointed to the later introduction of morphine, an opium
derivative, marketed under Heroin, contributing to this change.
Meldrum (2003) suggested the new use of anesthesia during surgery as another
influence on the medical view of pain. During this period, when the underlying cause of pain
could not be determined, the liberal use of medications to minimize pain was considered
standard practice (Bourke, 2014; Meldrum, 2003; Wailoo, 2014). Meldrum further stated that
the pendulum began to swing in the opposite direction in the early 1900s, when addiction,
psychological treatments of pain, and the development of theories that chronic pain rewired
the nervous system appeared. Meldrum added that, during this period, a wide variety of
alternatives to narcotic medications were developed, with limited success in the case of
chronic pain. After World War II, the suffering of soldiers returning home from the war with
refractory, chronic pain conditions began to change medical opinions back to minimizing
pain as the primary goal (Bourke, 2014; Meldrum, 2003; Wailoo, 2014).
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Wailoo (2014) stated that pain treatment in the next 6 decades was fraught with
political, economic, and social challenges. According to the author, since World War II, the
societal view of pain could be divided between politically conservative and liberal
viewpoints. In the conservative view, pain tolerance was a transformative experience that
helped patients become more vigorous and motivated to overcome any disability. Direct
treatment of pain, in this view, inevitably led to the overuse of medications, increased
government involvement, creeping socialism, and dependency. Wailoo further added, in the
liberal view, chronic pain was a significant obstacle to happiness. The author noted that this
view posited pain relief as essential to developing compassion, a sense of community, and a
quality life. Due to these opposing political views, Wailoo concluded that necessary suffering
and unnecessary pain were often not defined by doctors treating patients. Instead, the author
stated professional agencies, governmental laws, and the courts usually established these
standards.
Bourke (2014), in a book on the history of pain perception, stated that pain
historically was a shared experience based on individual and cultural attitudes of what
Bourke called a “pain event” (p. 20). Other pain research literature also used adverse drug
event terminology when describing pain medication problems (Chapman et al., 2010;
Gourlay et al., 2005; Heit, 2001; Vowles et al., 2015). Bourke went on to say that when a
person was in pain, there was no way of objectively measuring the experience except by what
the person in pain reported and how an observer interpreted that report. The author concluded
that this led to a variety of social and medical perceptions of pain throughout history.
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Since 2000, the need to aggressively assess and treat pain again came into question
(CDC, 2015; Dowell et al., 2016). In an editorial, Robbins (2017) suggested that the
treatment of pain as the fifth vital sign, even when a patient did not complain of pain, led to
the overuse of pain medications. The author suggested that the increase in fatal opioid
addictions coincided with the same period as overzealous pain assessments. Robbins
questioned whether there was undertreatment in more than 10% of people who complain of
postoperative pain. While the author admitted that the increased emphasis on pain
assessments and the increase in opioid addiction might be a coincidence, the use of pain
scales in all medical situations has come into question. The American Medical Association
(Anson, 2016) and the American Academy of Family Physicians (Lowes, 2016) dropped the
advice to use pain scales in routine medical assessments.
The controversy on pain, its costs, and its causes continued to date (Clauw et al.,
2019; Finnerup et al., 2015). The National Pain Strategy, a National Institute of Health study
on pain, concluded that ongoing research on chronic pain could provide (a) insights on
prevention, (b) the best ways to educate patients and physicians, and (c) better interventions
for chronic pain (Deacon, 2013; Von Korff et al., 2016). Yet, the complexity of treating
chronic pain and the continuing lack of consensus on even the definition or assessment of
chronic pain seemed to make that goal elusive (Bruehl et al., 2015).
Defining and Assessing Pain
The dilemmas of understanding pain begin with the challenges of defining and
assessing pain (Bourke, 2014; Wailoo, 2104). Often, pain definitions overlapped,
contributing to research confusion (Vowles et al., 2015). An old description of chronic pain
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was an alarm signaling that a biological system is malfunctioning (Haylock, 2002). Another
was that it is an objectionable sensory experience, with emotional aspects related to tissue
damage or the possibility of tissue damage (Driscoll & Kerns, 2016). Tighe et al. (2015)
compared chronic pain to hunger and nausea, which are medical problems with multiple
causes manifesting with similar symptoms.
Julien et al. (2014), in a book on psychopharmacology, stated that pain has two broad
categories. These categories included: (a) nociceptor pain, where observable tissue damage
was evident; and (b) neuropathic pain, believed to be caused by a nervous system
dysfunction. When pain disappeared within the expected healing time for the observed tissue
damage or diagnosis, doctors defined nociceptor pain as acute pain (Gatchel et al., 2014). On
the other hand, when chronic pain persisted, doctors labeled the pain neuropathic (Julien et
al., 2014). To include pain where there was no observable biological cause, Brodal (2017)
suggested that a reductionist definition of chronic pain focused on specific effects, such as
pain scales, cannot fully comprehend a pain event. Instead, the author proposed a third
general category of pain called homeostatic pain. In this definition, Brodal suggested the
source of chronic pain was a perceived threat to internal hemostasis. The author further
suggested that something triggered the pain alarm system, like an automotive theft alarm
sounding in the dead of night, but the exact cause may be unknown. Further divisions of
these categories into more specific labels often depended on the underlying medical
diagnoses.
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Acute Pain
Doctors labeled pain from a surgical procedure, recent onset of an illness, or a
traumatic injury as acute pain (Sinatra, 2010; Tighe et al., 2015). Qaseem et al. (2017), in an
article on the treatment of back pain, defined acute pain as lasting less than four weeks and
subacute pain as lasting between 4-12 weeks. If it lasted longer, depending on the diagnosis,
it was considered chronic pain.
Johnson (2005) discussed the differences between the two commonly used pain
scales. The author stated that one used a scale without rating numbers (visual analog scale),
and the other used a scale with rating numbers (numeric rating scale). Drawn faces were an
early suggestion for measuring pain in children (Stuppy, 1998) and later added to the
numeric pain scale (Flaherty, 2008). Swan and Hamilton (2016), in an instructional essay on
pain assessment for advanced student nurses, stated that a face pain scale continued to assess
the severity of acute pain. The authors further indicated that it has evolved into the
commonly used pain scale because of its 0-10 ratings and illustrations of facial expressions.
Swan and Hamilton further stated that, in this rating system, the lowest rating represented no
pain, and the highest rating represented the most pain possible. The authors also noted that
hand-drawn faces accompanied these numbers, ranging from a smiling face (Rating 0) to a
frowning hand-drawn face (Rating 10).
In addition to face drawings, a variety of numeric and visual rating scales assessed the
intensity of chronic pain in children (Castarlenas et al., 2017). In addition to numeric pain
scales, there were verbal rating scales where children had to pick out a phrase that best
described their pain (Miró et al., 2016). Hildenbrand et al. (2016) defined the color analog
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scale, a 10-centimeter line colored in increasingly deepened red shades to indicate pain
intensity. The authors added that a child moved a marker over a line to indicate the severity
of pain.
Weissman et al. (2015) found physicians often had to rely on the report of caregivers
when people with disabilities were in chronic pain and were unable to report pain symptoms
reliably. At times the addition of a supplemental checklist facilitated direct observation. The
authors added that doctors depended on this strategy for people with dementia. In older
adults, particularly after a fall or a motor vehicle accident, the tendency to become sedentary,
even when activity was low before the injury, tended to prolong their recovery (Platts-Mills
et al., 2016). Kaufman and Baucom (2014) stated that ignoring these likely comorbid
conditions prolonged recovery and called it diagnostic overshadowing.
Meek (2015), in another clinical review on pain assessment for nurses, stated that a
report of pain needed to be followed by more in-depth questions. The author further noted
that acute pain assessment could use the mnemonic OLDCART: (a) onset of the pain; (b)
location of pain in the body; (c) duration of pain; (d) characteristics of the pain (e.g.,
crushing, burning, stabbing, etc.); (e) aggregating factors of the pain (e.g., triggers, activities,
body positions, events that make the pain worse); (f) relieving factors of the pain (e.g., cold
compresses, heat, avoidance, and relaxation); and (g) temperature (e.g., cold skin, warm
skin). Meek further stated that patient-centered care often required an expanded role for
nurses, and these assessment skills were within their potential competencies. Several newly
developed multimodal pain scales for assessing acute pain also existed but were not yet in
everyday use (Tighe et al., 2015).
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Chronic Noncancerous Pain
Chronic, non-cancerous pain had many definitions, making it very difficult to assess
(Honey et al., 2016). One description was that it was a health disorder that had pervasive
adverse effects on patients and their families (Garschagen et al., 2015; Von Korff et al.,
2016). Others described chronic pain as a disabling physical condition with several
concomitant psychological disorders, including depression, loss of hope, a lack of motivation
(Wong et al., 2015), and suicidal feelings (Calati et al., 2015; Stubbs, 2016). The negative
impacts on employment, leisure, life goals, and other quality of life supports often appeared
in reports of chronic pain (Werner et al., 2004; Von Korff et al., 2016). A fourth definition
was that chronic pain differed from acute pain in that it lasted longer than expected to
provide a protective function for the body to heal (Gatchel et al., 2014). The patient defined
chronic pain by its location and severity as a fifth, older, but still widely accepted definition
(Haylock, 2002; Newton et al., 2013). Finally, as stated above, in many studies, researchers
defined chronic pain as pain that lasted longer than three months (Vallerand et al., 2015; Von
Korff et al., 2016; Vowles et al., 2015).
Chronic Regional Pain Syndrome
Schneider et al. (2015) stated that Chronic Regional Pain Syndrome (CRPS) is a pain
disorder that spreads from an injured site to affect a broader region of the body, often
limiting itself to one area, such as a limb. While usually starting with a traumatic injury
(Type I), the authors stated that the etiology and magnification of its broader pain effect was
unclear, as was its sequela. Schneider added that, even when there was no observable injury
(Type II), the diagnosis was made by observing: (a) abnormal pain processing; (b) changes in

28
skin color and temperature; (c) abnormal burning sensations, sweating, sometimes followed
by chills; (d) edema; and (e) unusual changes in sensory-motor functioning. Carr et al. (2016)
believed that CRPS was very complex to diagnose and treat and often resulted in severe pain.
The authors stated that early diagnosis is essential to treatment, but the accurate diagnosis
often was delayed because it was a diagnosis by exclusion.
Chronic Pain Cancer Related
Parala-Metz and Davis (2013) stated that cancer pain was more difficult to assess
than acute pain. The authors posited its presentation varied according to: (a) multiple onsets;
(b) varying durations; (c) multiple locations; (d) genetics; (e) medical history; (f) patient
mood; (g) patient expectations; and (h) the culture of the patient. Parala-Metz and Davis
further stated that cancer pain was usually classified as chronic pain because it often lasted
longer than three months. Nonetheless, episodes of acute pain frequently flared up within the
course of treatment. These flare-ups were called breakthrough pain (Portenoy et al., 1999;
Winiarczyk & Knetki-Wróblewska, 2016). Other authors stated that doctors did not fully
understand breakthrough cancer pain, making an effective diagnosis and treatment difficult
(Bennett et al., 2019; Mercadante. 2018). Paice et al. (2017) suggested that one way to meet
this challenge was to vary pain diagnoses by types of cancers. However, when the authors
used only three types of cancers, they found that their criteria applied more generally would
cause controversy. This realization led Paice to conclude that their goal of an evidence-based
taxonomy of pain based on cancer type would not occur any time soon.
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Chronic Overlapping Pain
Fillingim et al. (2020) stated that chronic overlapping pain occurred when multiple
sources created chronic pain. The authors noted that chronic overlapping pain was more
likely to develop chronic pain's comorbid psychological effects. Fillingim studied various
combinations of overlapping pain sources and found they all significantly impacted
emotions, which increased overall pain.
Persistent Acute or Chronic Pain
This term became the general term for any pain that continued for longer than a
medical provider expected (Gatchel et al., 2014; Siddall & Cousins, 2004; Stones & Cole,
2014). Based on clinical experience, this expectation was usually classified by diagnosis and
intervention (e.g., Kainu et al., 2016; Proud & Howard, 2016; Rutten et al., 2016). Higgins et
al. (2018), in a meta-analysis, found that persistent acute pain challenged current medical
resource allocations, but the research did not support the widespread incidents of iatrogenic
opioid addiction. In a later chapter, I will discuss the relationship between persistent pain and
addiction.
In summary, pain, acute or chronic, was a condition that most people had
experienced. Yet, the idiosyncratic nature of chronic pain (i.e., origins, time frame, and cooccurring conditions) created challenges for researchers to converge on a single definition or
assessment process. Complex pain symptoms defied precise diagnosis and assessment,
making treatment more difficult.
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Prevalence of Pain
The difficulty of defining and diagnosing pain not only negatively affected the ability
to determine an accurate prevalence of pain, but it also interfered with indirect
epidemiological indicators used to understand the breadth, depth, and severity of a pain
“epidemic” (Barth et al., 2017; Dowell et al., 2016; Higgins et al., 2018; Huffman et al.,
2015; Penders, 2013; Reuben et al., 2015; Volkow & McLellan, 2016; Vowles et al., 2015).
As stated above, treating pain exceeded the costs of other common chronic conditions such
as hypertension, heart disease, and diabetes (Moore et al., 2014; Staton et al., 2007). Chronic
pain cost estimates ranged from $560 to $635 billion annually (Gaskin & Richard, 2012;
Nahin, 2015). Since there was so much variability in the definition and assessment of pain,
physicians used their clinical judgment to assess and treat pain (Bhamb et al., 2006). These
varying clinical judgments affected estimates of pain prevalence (Paydar et al., 2016). To
address these difficulties, pain studies researchers often limited their prevalence studies to
subcategories of pain definitions and diagnoses.
Acute Pain Prevalence
The primary complaint in most emergency rooms was acute pain, encompassing 40%
of the 100 million people who sought emergency care in a hospital each year (Ahmadi et al.,
2016; Sinatra, 2010; Stalnikowicz et al. 2005). Acute pain was also a concern in the 70
million surgeries performed yearly in the United States (Tiege et al., 2015). One study on
postoperative pain indicated: (a) 84% experienced pain five hours after abdominal surgery;
(b) 92% experienced pain two days after surgery; and (c) 96% of post-surgical patients
experienced pain three days after surgery (Singh et al., 2016). Another study stated that 82%
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reported moderate-to-severe pain intensity two weeks after discharge (Sinatra, 2010). Lack of
aggressive treatment of acute pain often sets the stage for preventing a host of later pain
complications--including chronic pain, infection, and morbidity (Nagel, 2016). Tiege et al.
(2015) suggested that, despite enormous research, acute pain was still not well understood.
The resources were variable, and there was a need to go beyond relying solely on
medications.
Chronic Pain Prevalence
By one estimate, in the U.S. alone, more than 100 million people live with chronic
pain. Other estimates ranged from 14%-25% of the general population (Peppin et al., 2015;
Von Korff et al., 2016). The Center for Disease Control estimated that 11.2% of the general
adult population had some form of chronic pain (Dowell et al., 2016). In other countries,
chronic pain estimates range up to 8% of the general population (Gilron et al., 2015). In
patients over 65, chronic pain estimates range up to over 33% of the aging population
(Molton & Terrill, 2014). In a worldwide meta-analysis, chronic pain prevalence increased
steadily according to age group, going from 14.3% in young adults to 62% in adults over 75
years old (Lynch, 2016).
Cancer Pain Prevalence
Patients with cancer experienced chronic pain 30%-45% of the time (Fujii-Lau, et al.,
2015; Vuong et al., 2016). In advanced cancer, the prevalence of pain rose to 75% (Haumann
et al., 2017; Haylock, 2002). In a worldwide meta-analysis, van den Beuken-van Everdingen
et al. (2016) stated that chronic pain in cancer patients was evident in approximately: (a) onethird of cancer patients who survived; (b) more than half of the patients during cancer
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treatments; and (c) two-thirds of the patients with advanced or terminal cancer. Overall, the
authors further stated that more than one-third of cancer patients reported their pain as
moderate to severe. Research showed that numerous factors affected the perception and
sequela of chronic pain management in cancer treatment (Swan & Hamilton, 2016). These
variabilities made developing a consensus on the assessment and treatment of chronic pain
difficult (Von Korff et al., 2016).
Chronic Regional Pain Syndrome Prevalence
Schneider et al. (2015) found 50,000 new chronic regional pain syndrome (CRPS)
cases each year, and a population estimated between 1.5-3.0 million people. Another estimate
was the prevalence of CPRS-I (i.e., with injury) was 0.26 per thousand per year (de Mos et
al., 2007; den Hollander et al., 2016). Ratti et al. (2015) stated the complexity of CRPS
diagnosis made epidemiological estimates unreliable. The authors said that, while CRPS has
had various labels over the past century, the prevalence was considered very rare. Ratti et al.
(2015) concluded that, with better diagnoses, CRPS was secondary to multiple etiologies.
These included: (a) fractures, (b) surgery, and (c) genetic predisposition. Yet, confusion
continued in the literature.
To differentiate chronic regional pain, widespread chronic pain, and fibromyalgia,
Kim et al. (2012) defined chronic regional pain as existing in a particular area of the body
and widespread chronic pain as pain over the entire body. The authors then further
differentiated widespread chronic pain from fibromyalgia by looking for 11 out of 18 tender
points, often seen in fibromyalgia. In a Korean hospital, the authors found chronic regional
pain in 31% of the patients. Kim further found widespread chronic pain in 6.5% of the
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patients and fibromyalgia in 1.7% of the patients. As in chronic pain, CRPS was challenging
to diagnose, treatments lacked consensus, and much more research was necessary to develop
practical prevalence guidelines (Ratti et al., 2015).
Persistent Pain Prevalence
Estimates are that approximately one-third of the American population experienced
pain at any given time (Driscoll & Kerns, 2016). In the most recent study on pain prevalence,
Nahin (2015) extracted data from 2012 medical statistics, taken from 8,781 adults in 17
categories of illnesses likely to produce pain. From that survey, the author estimated that, in
America, 126 million patients (55%) were in some form of pain over the previous three
months. Also, Nahin further estimated that 25.3 million (11.2%) were in daily pain, and 25.3
million (10.3%) were in moderate to severe pain.
In summary, the prevalence of pain was difficult to determine because chronic pain
was difficult to define and assess. Depending on the type of pain, the underlying medical
problem, and the population in question, pain prevalence estimates range from 8% to 45%,
with vulnerable populations and complex pain ranging as high as 75% (Peppin et al., 2015;
Singh et al., 2016; Von Korff et al., 2016). It was the most common complaint when people
seek medical treatment (Meldrum, 2003; Prunuske, 2014; Sinatra, 2010; van den Beuken-van
Everdingen et al., 2016; Vargas-Schaffer, 2010). It was the costliest medical condition to
treat (Moore et al., 2014; Staton et al., 2007). At any given moment, estimates were that onethird of the population experienced various pain (Driscoll & Kerns, 2016). What follows are
descriptions of different conceptualizations of chronic pain and how these models contribute
to the challenge of appropriate and practical approaches to treating pain.
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Conceptual Models of Pain
Biomedical Model
Engel (2012) defined the biomedical model as a factor analytical, reductionist
approach to treatment. In this model, chronic pain was a symptom of an underlying disease.
The author further stated that chronic pain treatments focused on the underlying causes of
chronic pain. This focus tended to ignore any psychological components of the disease.
Engel believed the primary focus on underlying causes was using the biomedical model of
pain treatment. The author further stated that when physicians thought the etiology of chronic
pain was psychological, they often decided that treatment was outside their purview.
In the biomedical view, masking chronic pain by directly treating it led to increased
dosages in pain medications and long-term problems, including addiction (Henry et al.,
2015). Pain medications offered only temporary relief and, ideally, should be titrated down to
zero over time, regardless of whether the underlying, pain-producing conditions were
resolved (Dowell et al., 2016). Brodal (2017) believed that this reductionist approach to pain,
however, often caused problems when it confused the experience of pain with its biological
sources. From a political standpoint, this view was the conservative pain treatment model
(Wailoo, 2014).
Peppin et al. (2015) also stated that the strict biomedical model caused systemic
problems. The authors felt that medical interventions using this paradigm led to
undertreatment and unnecessary pain. The authors posited that with a strict biomedical, the
primary focus was on medications and other pharmaceutical industry solutions. Further
research indicated that this approach also unintentionally led to a treatment that held out the
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hope of a magic bullet, encouraging interventions that were too often futile and ineffective
(Deacon, 2013).
Vardeh et al. (2016), on the other hand, stated that a mechanistic approach to pain
offered the best long-term hope for pain control. The authors admitted that most pain
management treatments were inadequate. Nonetheless, Vardeh stated an effective
intervention might be possible once medicine with an improved understanding of pain
mechanics. The authors also pointed out that an enhanced understanding of mechanisms
helped address such pathologies as diabetes and peptic ulcers.
Biopsychosocial Models
Engel (1980) contrasted the biomedical model with the biopsychosocial model. In this
alternative model, the patient was part of a hierarchy of natural systems with levels ranging
from the biosphere to subatomic particles. According to the author, in the middle of the
biopsychosocial hierarchy were the patients, including their experiences and behaviors. Engel
stated, in place of a reductionist approach, a biopsychosocial model included the feelings of a
patient, the doctor-patient relationship, and any information gleaned from any level of the
hierarchy that might be useful to the resolution or management of pain (see Figure 1). This
model has multiplied into various sub-models regarding chronic pain, with many overlapping
aspects, which often varied according to which aspects were emphasized (Quintner et al.,
2008).
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Figure 1
Biopsychosocial Hierarchy as a Continuum

Note. From “The Clinical Application of the Biopsychosocial Model” by G.L. Engel, 1980,
The American Journal of Psychiatry, 137(5), p. 537. Reprinted with permission, 6/30/2021
Rightslink® by Copyright Clearance Center.
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Biopsychosocial Submodels
Wade and Halligan (2017) stated that the biopsychosocial model's complexity and the
lack of a consensus definition of chronic pain had prevented widespread acceptance, despite
extensive use of the term in research. Yet, the authors felt its influence was growing, and it
appeared to be the basis of what was called person-centered care. In the illness research
literature, the various identifiable sub-models that may guide treatment.
Gate Control Model of Persistent Pain
Melzack (1990) first postulated the gate control model of pain during cancer
treatment. The author theorized the existence of a gate in the spinal dorsal horn that acted as
a switch to turn on and turn off pain before the signal of pain reached the brain. Melzack also
theorized that there many ways to close this gate, including relaxation and cognitive
interventions. The gate was opened, however, by fear of pain. Only after the adequate control
of pain could other interventions work to manage and minimize pain. It put the author in
agreement with researchers who believed that pain control needed to be achieved first by
whatever means necessary, including the use of opioids. This model treated addiction and
adverse side effects as secondary (Bhamb et al., 2006; Chaparro et al., 2014; Compton &
Volkow, 2006; Finnerup et al., 2015; Gatchel et al., 2014; Henry et al., 2015; Hoffman,
2016; Katz & Rosenbloom, 2015; Moseley & Butler, 2015). Since then, the gate control
theory of pain became a widely accepted theory for pain control in cancer treatment (Katz &
Rosenbloom, 2015; Zhang et al., 2018).). Other biopsychosocial models often incorporated
this concept (Driscoll & Kerns, 2016).
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Complexity Model
Peppin et al. (2015) proposed a new paradigm for pain treatment called the
complexity model. The authors stated that the complexity model set goals in all appropriate
areas likely to affect pain management and individualized by circumstances. Peppin
explained that these areas included: (a) education about pain management, (b) establishing
pharmacological goals and medication treatment routines, (c) examining and setting goals
around coping, (d) developing individual and social supports necessary, and (e) developing
an exercise routine that can exist within the limits of any pain-related disability to increase
functioning. The authors stated that these criteria were best accomplished when the related
services were under the same organization, working with the same treatment philosophy.
Peppin concluded that this model worked collaboratively with the pain patient to address
their pain's complex nature, with patient satisfaction as the ultimate goal. In more complex
pain management, the authors added that the use of opioids was necessary for patients in
persistent, chronic pain. Peppin further stated that a complexity approach must deal with
patients for whom medications caused more problems than they solved.
Adjunctive Psychological Model
Jensen and Turk (2014) offered a review of the various psychological treatments used
as adjunctive pain management techniques to address non-biological pain and suffering. The
authors broke these treatments into four categories: strategies to redefine and cognitively
restructure the perception of pain, education on the etiologies and treatments of pain
according to the diagnosis, physical exercises and other activities to help cope with pain, and
other psychological therapies found useful in lowering the perception of pain. In further
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research, while helpful, these techniques were not likely to eliminate pain or even adequately
manage moderate-to-severe pain without medications (Barth et al., 2017; Passik, 2009).
Nonetheless, research shows they have been useful as an adjunct to coping with persistent
pain (Ambrose & Golightly, 2015; Berg & Upchurch, 2007; Galvani et al., 2019; McCracken
& Gutiérrez-Martínez, 2011; McCracken, 1998; Sirois & Wood, 2017; Vlaeyen et al., 2016).
Neurobiological Model
This model held out the hope that it may be possible to directly measure pain by
looking at brain functioning, primarily through brain imaging. It was possible to observe
which parts of the brain were active when a person was in pain using fMRI and PET scans
(Flor, 2014). Brodal (2017) stated, while there appeared to be an observable pain network,
how those areas of the brain interacted, and how it was affected by pain perceptions were not
well understood. The author noted the brain activated in regions of the pain network when
the patient reported no pain. Brodal further stated that, with persistent, chronic pain, other
brain regions, including the cortical gray and white areas, seemed to be affected. The author
felt this created the possibility for many false alarms in pain determination, and brain
imaging seemed to confuse pain remembered but not felt. Brodal concluded that using brain
activation as an objective measure of experienced pain, like blood pressure and heart rate,
was not yet reliable as an objective measure. Other researchers stated that this model might
offer hope in understanding why some patients could tolerate chronic pain and others could
not (Littlejohn & Guymer, 2019; Tracey, 2016).
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Defining Chronic Pain as a Symptom or Disease
Engel (1980) was the first to point out that the differences between the biomedical
model and the biopsychosocial models. These differences focused on whether chronic pain
was a symptom of an underlying problem (biomedical) or a separate disease
(biopsychosocial). If it is a symptom, then the underlying problem would be the primary
focus of treatments (Raffaeli & Arnaudo, 2017). If chronic pain is a separate disease, a more
holistic approach to pain management would be appropriate (Clauw et al., 2019).
As previously stated, Robbins (2017) in an editorial suggested that pain-as-disease
models, particularly when a patient does not complain of pain, have led to the overuse of pain
medications. The author suggested that the increase in fatal opioid addictions coincided with
the same period as overzealous pain assessments. Robbins questioned whether there was
undertreatment in more than 10% of people who complain of postoperative pain.
Stanos et al. (2016) stated that chronic pain's complexity involved biological,
psychological, and social interventions. The authors felt that primary care physicians, who
handle most chronic pain treatment, did not receive adequate training to diagnose and treat
chronic pain at this level. Morlion et al. (2018) suggested that chronic pain was a separate
disease and changed treatment focus to quality-of-life criteria. Other researchers criticized
the biomedical model because it overemphasized medication types and dosages (Melzack,
1990; Rajagopal, 2011). Pain was also sometimes considered the fifth vital sign, like pulse,
respiration, body temperature, and blood pressure (Edlund, 2011; Raffaeli & Arnaudo, 2017;
Yuen & Irwin, 2005). When long-term treatment results in a lifetime of opioid use but a

41
higher quality of life, by this view, it was considered a fair trade (Kumar et al., 2015;
Tompkins et al., 2017).
Treede et al. (2019) described how the International Classifications of Disease (ICD)
might better classify chronic pain as a separate disease. The authors hoped that those changes
would develop better treatment pathways, improve patient access to biopsychosocial
alternatives, and reduce stigma. Treede also stated that opioids might be used long-term
safely with some people. As will be seen, there was little access to biopsychosocial treatment
in participants interviewed for this study. How the medical community could improve patient
access to biopsychosocial treatments under the current classification system will be
addressed in the results.
In summary, given the variety of pain models, no testable pain theory, and no
objective measure of pain, any given pain model's adoption seemed a subjective choice based
on the treating physician's preferences and training. It indicates that treatments that spring
from these models have a subjective, interpretive component in assessing and treating pain.
This subjective component, and its effects, will be further explored in pain treatments. The
next section also discusses the role of pain models in addiction and undertreatment.
Pain Treatments
The ultimate goal in treating pain is to relieve as much pain as possible without
causing more harm than good (Schuchat et al., 2017; Coghill et al., 2003; Kahan et al., 2006;
Penders, 2013; Sehgal et al., 2012). While there has been considerable research to develop
clinical guidelines and best practices, a primary clinician usually makes the risk/benefit
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analysis in pain treatment decisions (e.g., Dowell et al., 2016; Gourlay & Heit, 2009; Jensen
& Turk, 2014).
Two books devoted to educating pain patients provided a fair comparison of opposite
approaches to pain treatments. Nagel (2016) focused on the inability of the medical system to
fully understand and eliminate pain. The author questioned current medical practices and
assumptions. He also encouraged the use of opioids at the outset, if necessary, to successfully
manage pain. Over time, Nagel concluded opioids could be reduced and pain better managed,
but chronic pain control by any means was the best course. Caudill (2016), on the other hand,
while admitting the limitations of current treatments of pain control, seemed to eschew
opioids and encouraged pain patients to use non-opioid pain medications and psychosocial
interventions to control their pain. In the absence of pain relief, the author prescribed
acceptance and continuously challenging the limitations of pain.
In general, the research on pain treatment seemed to chart a middle path, as seen by
the World Health Organization (WHO) recommendations and their guidelines (World Health
Organization, 2017). Initially, the WHO analgesic ladder was a treatment algorithm urging a
step-by-step approach to treating cancer pain that sometimes resulted in using opioids
(Ventafridda et al., 1987). Vargas-Schaffer (2010) stated that this algorithm was modified, by
WHO and others, several times over the past four decades to include all types of pain. The
author said that in every iteration, the fundamental recommendations of WHO remained: (a)
start with oral pain medications, (b) give medications at regular intervals, (c) adjust dosage
by the intensity of pain, individualize pain treatment, and (d) explain the treatment plan to the
patient, the family, and other care providers. Concerns about opioid addiction and how pain
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treatment should vary by diagnosis sometimes caused variations in the WHO analgesic
ladder (Baker, 2017; Morlion et al., 2018).
Acute Pain Treatments
Chronic pain can come directly from the physician's actions when they first
undertreat acute pain (Gatchel et al., 2014; Kehlet et al., 2006; Nagel, 2016). Gordon et al.
(2016) reviewed 32 questions recommended when addressing acute surgical pain. The survey
addressed pain management before, during, and after surgery called perioperative acute pain
management. The authors admitted that the evidence for those questions was sparse and
based mostly on the reported experience of physicians who treat pain. Kent et al. (2017)
postulated that mismanagement of acute pain often results from a poorly defined taxonomy
that depends on the intensity of the acute pain and its duration. Instead, the authors proposed
a multidimensional framework of pain management, similar to the complexity model.
Khidir and Weiner (2016), in a commentary, discussed the dilemma of emergency
room physicians faced when patients complained of severe pain, where they must give
treatment under pressure, without longitudinal medical information, and influenced by an
ever-changing standard of quality care. For instance, Barnett et al. (2017), citing the recent
rise in opioid dependence as justification, did a study on emergency room physicians who
prescribed opioids. The study focused on people with Medicare who came to the emergency
room and had not used an opioid during the previous six months. Barnett then divided the
emergency room physicians into quartiles, with high-intensity, opioid-prescribing emergency
room physicians in one quartile. The other physicians ranked in the other three quartiles, with
low-prescribing physicians in the fourth quartile. The authors found that the patients with the
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high-intensity, opioid-prescribing physicians were more likely to become dependent and
were more likely to experience injuries within the next 12 months. Barnett acknowledged
that their Medicare population studied was predominately older adults and that their findings
were correlations. The authors did not report the effectiveness of pain relief, the quality of
life of the patients, or why most emergency room doctors in the hospital refused to give any
opioid medications. Yet, the subjects in the Barnett study probably knew the hospital was
parsimonious with pain medications. In that case, a person in chronic pain might soon learn
to go to another hospital or request a particular doctor to treat their complaint. As a result, the
patients with the most pain, and the most complex medical problems, might be avoiding lowintensity, opioid-eschewing doctors, leaving them with a healthier population, which could
account for the effects.
Cancer Pain Treatments
As previously mentioned, the assessment and treatment of cancer pain was the first
use of the WHO analgesic ladder (Bao et al., 2016; Haylock, 2002). Treatment outcomes
seemed to be most effective with constant assessment and around-the-clock treatment of
cancer pain with medications (Gatti et al., 2014; Haylock, 2002). As previously mentioned,
cancer pain was where the medical community first understood the need to recognize and
aggressively treat needless pain (Melzack, 1990; Katz & Rosenbloom, 2015). Later research
also supported the idea that adequate control of cancer pain must be a primary treatment
(Gatchel et al., 2014; Kumar et al., 2015; Radbruch et al., 2013; Seymour et al., 2005). Van
den Beuken-van Everdingen et al. (2016), in a meta-analysis on cancer pain, stated that,
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despite some progress in the past decade, pain in cancer patients remained a problem and
needed more research.
Noncancerous Chronic Pain Treatments
The same algorithm as chronic, non-cancer pain guided the treatment of persistent
pain and chronic regional pain. Despite its ubiquity, chronic, noncancerous pain remained the
most complex and complicated treatment (e.g., Honey et al., 2016; Volkow & McLellan,
2016). Dowell et al. (2016), using a strict, evidence-based biomedical model, believed that
opioid medications should be titrated down and eliminated over time, regardless of the
resolution of the underlying, pain-producing conditions. The authors stated that titration
down, either through persuasion or coercion, provides for the patient's overall health. Dowell
allowed exceptions in cancer treatment, palliative care, and end-of-life care. The authors
claimed that it risked an increase in iatrogenic addiction if the primary goal of treating
noncancerous, chronic pain was pain relief. Dowell defined iatrogenic addiction as an
increase in addiction caused by physicians over-prescribing pain medications. The authors
postulated that doctors could avoid this increase by prescribing fewer opioid medications as a
general practice.
Dowell et al. (2016) further recommended that doctors assess the risks and benefits of
opioid use, though they offered no specific recommendations for determining benefits. By
focusing solely on the risks, the authors seemed to support the strict, biomedical point-ofview. However, by giving a palliative care exception, Dowell left room for long-term opioid
medication use. Still, the authors did not define when that decision was an acceptable risk.
Using this model, many doctors continued to limit or even eschew opioid pain medications,
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despite whether pain remained severe, quality-of-life compromised, or undertreatment was
evident (Bhamb et al., 2006; Chaparro et al., 2014; Compton & Volkow, 2006; Finnerup et
al., 2015; Henry et al., 2015; Hoffman, 2016; Moseley & Butler, 2015).
Biopsychosocial pain treatment models viewed opioids and other potentially
addictive medications very differently (e.g., Gourlay & Heit, 2009). In some of these pain
models, drugs were administered immediately at an adequate dose, for as long as necessary,
to manage pain (Kumar et al., 2015; Rajagopal, 2011). Other models followed the WHO
algorithm, slowly increased the type of pain medication, and then gradually reduced the
drugs to their lowest effective dose (Finnerup et al., 2015; Gatchel et al., 2014). They
addressed any secondary problems (e.g., addiction, misuse, tolerance, etc.) through harm
reduction programs (Gourlay et al., 2005). These treatment models collectively advocated
using quality-of-life criteria rather than an enforced reduction of medications (Kumar et al.,
2015; Rajagopal, 2011).
The next section will address addiction and fears of addiction. It will also discuss
when patients in pain reported inadequate treatments or researchers found what they
concluded was undertreatment. Finally, the section discusses how this lack of treatment may
sometimes result from stigma.
Undertreatment of Pain
With no objective measure of pain, factors outside of the doctor/patient relationship
influenced the prevalence of adequately or inadequately treated pain (Wailoo, 2014). Peppin
et al. (2015), in a commentary, addressed how the expanding population of pain patients
often overwhelmed busy primary care physicians and existing pain clinics. The authors
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posited that the complexity of treating chronic pain led to undertreatment due to: (a) lack of
reimbursement for a thorough assessment; (b) lack of physician training, particularly in the
psychological effects of pain; and (c) treatment models that focused on procedures and
symptoms rather than outcomes. Peppin also concluded that these factors led to the
undertreatment of pain.
Gatchel et al. (2014) wrote a commentary on why pain clinics were not addressing the
problem of undertreated chronic pain, which they believed was widespread. The authors
differentiated between a multidisciplinary approach and an interdisciplinary approach.
Gatchel stated that a multidisciplinary approach included different professionals who
intervened in other locations, with limited communication and few shared intervention
philosophies. The authors contrasted this with an interdisciplinary approach, when all
professionals were in the same place, in constant contact, and used the same treatment
philosophy. Gatchel admitted that an interdisciplinary approach's upfront costs were higher,
and insurance companies tended not to approve these more complex interventions. The
authors concluded that this ignored the fact that long-term expenses were much lower in an
interdisciplinary approach, and outcomes were better.
Finnerup et al. (2015), in a literature review of 229 studies on the evidence-based
treatment for chronic pain, found a widespread lack of treatment. The authors reviewed
studies on undertreatment, under-diagnosis, pain treatment effectiveness (50% reduction in
pain), and pain treatment costs. Finnerup focused primarily on randomized controlled studies
from peer-reviewed journals with estimated effect sizes when that data was missing from the
results. The duration of most of the included studies was between 12 to 24 weeks and showed
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no differences in effectiveness in the medications used for pain control. The authors also
found 10% of the research overstated the effects of their pain treatment. Finally, Finnerup
found the research standard for properly managed pain (50% reduction) varied according to
individual response. The authors concluded there was evidence of unmet need in pain
management outcomes.
Breivik et al. (2006), in an international survey of 15 European countries and Israel,
also reported prevalent unmet need in chronic pain treatments. The researchers used
telephone interviews with over 45,000 individuals experiencing chronic pain, some for over
six months. Breivik studied various medication treatments, including NSAIDs, weak opioids,
paracetamol, COX-2 inhibitors, and strong opioids. The authors found about 40% of the
individuals surveyed still reported inadequate pain management. Breivik also found that
moderate-to-severe chronic pain continued to occur in about 40% of adults. The authors
concluded that undertreatment was evident in the chronic pain population.
Bhamb et al. (2006) published a survey of 248 primary care physicians on their
treatment of chronic pain: (a) what medications they used, (b) what diagnoses necessitated
opioid medications, and (c) how they guarded against abuse or other forms of addiction when
prescribing opioids. The authors found that doctors said they felt comfortable prescribing
opioids during cancer treatment and terminal illness. Breivik found that doctors did not feel
comfortable prescribing opioids for non-cancerous pain. The authors found that the primary
concerns of the doctors in those situations were ranked: (a) patients were abusing
prescriptions, (b) possible addiction, (c) side effects of opioids, (d) tolerance to opioids, and
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(e) lack of training on how to choose opioid medications. The authors concluded that there
was evidence of untreated pain after treatment.
Bruehl et al. (2015), in an experiment on the treatment of lower back pain, tested a
screening questionnaire proposed for use by physicians who hoped to supplement their
clinical judgment with objective analysis on the likelihood of later addiction during opioids
use for chronic pain treatment. The goal of the authors was to impact the rising rate of opioid
abuse. Bruehl hypothesized that their screening questionnaire might predict future opioid
abuse because it tapped into individual differences in opioid responses. The authors did find
that one group reportedly liked morphine more than other groups with lower scores on their
questionnaire. Bruehl postulated that these subjects were more likely to become addicted.
However, one limitation of this prediction was that the authors were unable to separate the
influence of pseudoaddiction. It was a label Bruehl gave to subjects who had undertreated
pain before participating in the study. As a result, the authors could not separate addiction
from pain relief in the group that said they liked the medication.
Rajagopal (2011) wrote a commentary on his experience with long-term, refractory
pain. As a patient, he endured severe pain until his condition eventually improved, a painful,
year-long struggle. As a specialist in palliative care, Rajagopal was shocked when his fellow
clinicians ignored treatable pain and seemed not to understand that pain relief was necessary.
The author identified six sources of these misunderstandings: (a) a lack of resources,
particularly in the developing world; (b) a lack of education in palliative care strategies; (c)
government and industry regulations that were too focused on treatment rather than pain
relief; (d) fears of addiction; and (e) a systematic lack of understanding by the medical
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community of the experience of chronic pain. Rajagopal felt that this lack of recognition
came from the paucity of research on the experience of long-term, refractory pain in noncancerous, chronic pain conditions. The author concluded that narrative research on the
experiences of chronic pain patients might fill this gap.
Rivera et al. (2015) was a qualitative survey of 3,029 pain patients that focused on the
quality of their lives after three months of treatment. The study was limited to patients with
moderate to severe pain, with chronic pain duration of up to seven years. The survey
measured: (a) ability to self-care independently, (b) participation in usual activities, (c) levels
of pain and discomfort, and (d) levels of anxiety or depression. The authors concluded that
there was evidence of quality-of-life improvements in approximately half of the subjects
interviewed. The lack of progress in the other half showed evidence of undertreated pain.
Rivera concluded that the severity of pain and interference with usual activities significantly
impacted quality-of-life.
While many doctors expect cancer pain to resolve as the treatment progressed,
research showed that from 33% to 45% did not receive adequate cancer pain treatment
(Vuong et al., 2016). Other research showed that undertreatment existed at cancer treatment
centers even with multiple treatment modalities (Haumann et al., 2017; van den Beuken-van
Everdingen et al., 2016). Gatti et al. (2014) found that breakthrough pain was highest in
cancer patients who had undertreated baseline pain.
Undertreated, persistent pain also exists in acute pain populations. Undertreated pain
was reported: (a) in emergency rooms (Paydar et al., 2016; Platts-Mills et al., 2016); (b) after
motor vehicle accidents (Apkarian et al. 2016; Platts-Mills et al., 2016); (c) in hospitals
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(Trentin et al., 2001); (d) after major surgery (Singh et al., 2016; Sinatra, 2010); and (e) in
outpatient treatment centers (Emilson et al., 2017; Hayes & Hodson, 2011; Kehlet et al.,
2006). Undertreated, persistent pain had also been found: (a) in addicts both with and without
treatment for addiction (Nordmann et al., 2017); (b) in older adults, particularly in nursing
homes (Arnstein, & Herr, 2017; Björk et al., 2016); (c) in people with mental illnesses
(Abdallah & Geha, 2017); and (e) in children (Hiller & Suominen, 2017). These data
supported Siddall & Cousins (2004) contention that persistent pain caused a separate disease
state that could be more serious than the original pathology that caused chronic pain,
negatively affecting treatment decisions.
In summary, prior research has shown that the undertreatment of pain was evident in
all pain populations. It seemed particularly likely in moderate-to-severe pain, even when the
duration of the experienced pain was short. The literature indicated that the propensity to
undertreat pain might be due to: (a) fear of medication misuse, abuse, or addiction; (b) fear of
adverse side-effects; (c) lack of clear diagnostic criteria; (d) lack of training; (e) pressure
from government and professional organizations; (f) social stigmatization of pain patients;
and (g) systemic bias in the medical research and practice (Bell & Salmon, 2009; Bhamb et
al., 2006; Chapman et al., 2010; Gourlay et al., 2005; Peppin et al., 2015; Rajagopal, 2011).
As Wailoo (2104) stated, some of these factors were outside of the typical doctor-patient
relationship and were part of the broader social system.
Systemic Factors That Influence the Assessment and Treatment of Pain
A review of the literature revealed a lack of understanding on whether the
undertreatment of pain: (a) resulted in needless suffering, (b) was an unavoidable side-effect
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of good medical practice, or (c) was an interaction of the two that may depend on
circumstances or individual responses (e.g., Chapman, & Gavrin, 1999; Chapman et al.,
2010). Peppin et al. (2015) stated that these factors overwhelm busy primary care doctors,
mainly because of many factors out of their control. The authors said it was relevant to
examine the “macro-level” or systemic forces that influence how pain and pain patients are
perceived, assessed, and treated.
Fears of Addiction
The epidemiological trend documenting the rise in opiate addiction has further
increased the possibility of persistent pain undertreatment (Rajagopal, 2011). As previously
stated, the CDC reported that there were 1.9 million people who abused or became dependent
on opioids in 2013. From 1999 to 2014, opioid addiction increased and caused 160,000
deaths. Yet, opioid prescription use dropped 13% between 2012-2015, with no decrease in
opioid deaths. This result brings into question the causal role of opioid prescribers (Schuchat
et al., 2017).
Nonetheless, other studies continued to assert that the over-prescription of opioid
medications caused the opioid epidemic (Ballentine, 2010; Dowell et al., 2016). In an
epidemiological study, Compton and Volkow (2006) theorized that the increased use of
opioids to treat pain caused an increased availability of opioids, fueling an epidemic. While
focusing primarily on prescribing physicians, the authors suggested increased vigilance in the
use of opioid medications. Compton and Volkow (2006) also suggested increased research
on screening and the effects of opioids on brain development.
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Henry et al. (2015) studied the increase in opioid dosages for 246 patients treated
with opioid medications, termed drug escalation. The authors studied the increased likelihood
of addiction resulting from high-dose opioid use versus lower doses. Henry surveyed the
hospital records of people given opioids for pain who were naive to opioid medications. The
authors defined this as no documented opioid use for the past year. Henry also limited their
subjects to those with skeletomuscular pain but no other comorbid, pain-producing
conditions. The authors measured dosages in prescription-dose-days to account for
participants who took intermittent doses. Henry also measured office visits, emergency room
visits, nursing visits, telephone consultations, refill requests, and patient emails. The authors
used mixed-effects regression analysis to differentiate the groups who did not have dose
escalation from those who did. Once separated, Henry used a Wilcoxon two-sample test for
continuous variables and Fisher’s exact test for categorical and dichotomous variables. The
authors found that subjects identified as having dose escalation were more likely to be
substance abusers, had more frequent office visits, and was evident in the first year of opioid
use. Henry felt that early escalation of opioid doses in the first year might predict later
addiction, but further study was necessary. The authors mentioned, however, that
pseudoaddiction (i.e., undertreatment) could also explain those results.
Alternate Explanations for the Rise in Addictions
However, other researchers suggested that prescribers may not be the primary cause
of increased addiction. According to Sullivan and Levin (2016), more pain-producing
conditions might have resulted from an increased number of older baby boomers with
chronic pain. The authors stated that this population could also be more open to using
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medications for pain control. Also, there was little evidence that reducing addictive pain
medication prescriptions would lead to better long-term pain management (Finnerup et al.,
2015). Long-term pain management might require a personalized pain genotype, the
identification of which needed more progress in neurological research (Bruehl et al., 2015).
Exaggerated Fears of Addiction
Vowles et al. (2015), in a meta-analysis, documented the overlapping definitions in
pain research and the tendency to overestimate the prevalence and severity of increased
social problems with opioid use. According to the analysis, the author concluded that only
three terms used in the research were distinct and measured different pain medication
problems: (a) misuse, where the patient used medications in a way not prescribed by a doctor
(e.g., taking pain medication given to a spouse); (b) abuse, where the patient used a drug in a
medically unintended way (e.g., taking prescription medications for recreational purposes);
and (c) addiction where pain medications were repeatedly taken, or craved, despite apparent
harm and no medical benefit. Vowles et al. (2015) postulated that using non-overlapping
definitions would eventually bring consensus to the prevalence, treatment, and pain
management outcomes.
In a classic study, Heit (2001) stated that only two in ten patients (20%) on long-term
opioid medications became addicted when treated with opioids. Another 20% had sideeffects associated with the long-term use of opioids. The author called these secondary
conditions adverse drug events. The author stated that addiction prevalence data conflated
these secondary conditions with addiction. Opioids could be safe long-term for the remaining
60% in noncancerous, refractory pain. Not adequately controlling persistent pain would
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relegate these patients to needless suffering and unnecessarily lower their quality of life.
(Chapman et al., 2010; Gourlay et al., 2005; Kumar et al., 2015; Rajagopal, 2011; Vowles et
al., 2015).
Robins et al. (1974) in a classic study on addiction among veterans returning from the
Vietnam War found that heroin use, which was considered an epidemic among Vietnam
veterans in 1973, dropped from 60% to 10% one year after returning home. The authors
found that among those who continued to use heroin, they had a high probability of addictive
behaviors before being deployed. In a follow-up lecture, Robins (1993) stated that the data
from his previous study had withstood the test of time. No other factor explained the result
except that using heroin does not lead always lead to addiction. Treatment outcomes
involving the use of long-opioids for pain control backed up this conclusion (Kumar et al.,
2015; Passik, 2009; Rajagopal, 2011).
In summary, while the rise in addiction is undeniable, its true causes are in question.
Sanctioning doctors and prescription monitoring programs may result from an oversimplified understanding of the complex nature of pain and its treatment. Changing
population characteristics (aging), cultural changes in the acceptability of medication for
pain, and the promotion of opioids by pharmaceutical companies for use for conditions and
symptoms not appropriate for opioid use may all contribute to the current U.S. opioid
controversy. The rise of heroin and opioid addiction, particularly in older and Caucasian
demographics, may not be caused primarily by the over-prescription of pain medications. For
a more in-depth exploration of why the medical community needs a more comprehensive
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understanding of chronic pain and its confusion with other types of suffering, we must
consider other factors.
Effects of Bias on Pain Treatment Decisions
Chapman et al. (2013) defined explicit bias as a consciously expressed stereotype that
may be partially true for a group but does not predict the characteristics of any particular
member of that group (e.g., men like watching sports). The authors stated that bias could be
positive (e.g., rich men make good husbands) or negative (e.g., rich men make untrustworthy
sexual partners). Chapman defined implicit bias, on the other hand, as an unconscious belief
often denied by people who hold that belief. It was only evident through actions or decisions
(e.g., I believe women can be as good as men, but I have never met one I would hire). In
healthcare research, training controlled much of explicit bias. Yet, implicit bias has been
documented and may be prevalent (Zestcott et al., 2016).
Systemic Pain Bias
Berry and Dahl (2000) stated that one professional organization that addressed
persistent pain was the Joint Commission, formerly known as JCAHO. The authors stated
that, at the turn of this century, the goal of the Joint Commission was to address the prevalent
undertreatment of both acute and chronic pain in all clinical settings and includes: (a)
emergency rooms, (b) post-operative care, (c) burn centers, (d) cancer treatment, (e)
outpatient centers, (f) primary care offices, and even (g) at-home care. Berry and Dahl
concluded that these standards would address unrelieved pain costs and that appropriate pain
management was a right, not a privilege. Baker (2017) stated that, over the next 16 years, the
perception of undertreated pain versus addiction evolved into the current controversy. During
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that period, the author contended, the focus of the pain research shifted from undertreatment
and became: (a) moving away from narcotic pain medications, (b) improving quality of life
factors in pain management, (c) developing non-narcotic pain medications and nerve blocks,
and (d) developing psychosocial pain treatments.
Baker (2017) stated JCAHO remained concerned about the prevalence of
undertreatment. The author concluded that the accrediting commission kept four
recommendations: (a) engage all stakeholders, including the patients, in determining
standards; (b) anticipate, monitor for, and address unintended consequences; (c) ensure that
the survey algorithms of the JCAHO continually test against a focus on easily measurable
observations that negatively influence quality outcomes (e.g., the sole use of rating scales);
and (d) keep survey standards abreast of the most recent research. Baker showed that JCAHO
had yet to achieve its goal to treat pain relief as a right. So unnecessary pain may still occur if
physicians limit themselves solely to the biomedical model to treat pain.
Government Influence on Pain Bias
On the other hand, the federal government significantly influenced the perception of a
causal link between addiction and prescription pain medication abuse (Cole, 2011). Hari
(2016) stated the first federal agency charged with enforcing the laws against narcotic drugs
was the Federal Bureau of Narcotics. The author added that it replaced the agency designated
to enforce the prohibition of alcohol in the 1930s. Hari also said that, from its very inception,
this replacement agency deliberately promoted racist arguments. The current federal drug
enforcement agency, called the Drug Enforcement Agency (DEA), continued racial biases in
drug enforcement, with drug arrests and people imprisoned for drug offenses focused mainly
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on blacks and Hispanics (Bobo & Thompson, 2006). It helped create the school-to-prison
pipeline, incarcerating minorities, and low-income individuals, while being more lenient with
others who committed the same offenses (Ruiz, 2016).
In addition to the CDC issued guidelines against the long-term use of opioids, Tran et
al. (2017) posited that the Federal Drug Administration (FDA) had a role in creating rules
designed to prevent opioid abuse. The authors pointed out that the biggest, recent change in
regulations was the rescheduling of hydrocodone from Schedule III, a drug with limited
abuse potential, to Schedule II, one of high abuse potential but still medically useful. The
authors described other FDA inspired changes that so far have had only modest effects
included: (a) warning labels on medications with abuse potential; and (b) promoting
computerized risk management databases that monitored who was prescribing and who used
potentially addictive prescription drugs.
Windle (2016) said efforts to curb opioid use showed the government appeared to be
firmly on the side of controlling the opioid epidemic by restricting medical prescriptions. The
author openly questioned whether the federal government had tipped the scale on the
perception of persistent pain patients. Windle documented that various government agencies,
whose goal was to stigmatize, and sometimes criminalize, the use of painkillers, and how it
worked against agencies concerned with quality-of-life and pain relief (e.g., JCAHO). The
author further stated that this was difficult for nurses at the frontlines of pain control and
trained to be patient-centered. Windle concluded that advocating for pain relief often puts
nurses at odds with other hospital and governmental authorities.

59
Other Organizational Sources of Systematic Bias
Sismondo (2008), in a meta-analysis, contended that the pharmaceutical industry
created publication bias, often intentionally, because it resulted in higher profits. The author
stated that pharmaceutical companies accomplished this through ghost management, where
unacknowledged advisors designed studies, edited the reports, and then promoted the results.
Sismondo also stated that ghost management: (a) tended to attract more future funding; (b)
marginalized non-aligned academic researchers; (c) skewed the number of publications in the
direction of new, expensive drugs favored by the industry; (d) made it more likely to earn
FDA approval; and (e) tended to hide side effects, contravening research, or possible
alternate treatments. It supported and gave some context to the later assertion that pain
research was too focused on medication treatments (Peppin et al., 2015).
Eaves (2015) did a qualitative study on how people with chronic pain used OTC
analgesics to mitigate their chronic pain rather than more effective prescription medications
when in moderate-to-severe pain. The author found that advertising from drug companies
was a major contributing factor in the inappropriate use of OTC analgesics. Eaves (2015)
stated that advertising was also responsible for perceiving these drugs as harmless, further
stigmatizing opioids as a possible good alternative. As such, the author contended, their use
was often not discussed when seeking medical advice for pain, even when dosages were
critical to an accurate diagnosis and the possibility of drug interactions. Eaves stated that the
reasons for not using prescription medications include: (a) saving more effective medications
for more severe pain; (b) feeling that prescription medications masked the chronic pain and
made monitoring pain difficult; (c) concerns about tolerance; (d) fears that prescription
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medications would impair ability (e.g., thinking, driving, operating heavy machinery, etc.)
and (e) concerns about addiction. The author concluded that these were why people used
OTC medications in larger dosages than recommended, sometimes to the point where they
could harm.
Cooper (2013a) did a literature review on the abuse of OTC medications in general.
The author found that the problem was international in scope and little understood. A
qualitative study by the same author, done on people who believed they could become
addicted to OTC drugs, found: (a) while admitting their addiction, OTC drug abusers
differentiated themselves from addicts who used prescription drugs or illegal drugs; (b) those
who self-identified as addicts had formerly used prescription drugs for the same condition;
(c) codeine was the drug most often mentioned in OTC addiction, but Cooper indicated other
possibly addicting OTC drugs (e.g., pseudoephedrine, diphenhydramine; other cold remedies,
etc.); and (d) those self-identified with OTC drug addiction tended to avoid treatment
because they felt their addiction was more acceptable (Cooper, 2013b). Cooper (2018) later
asserted that OTC addiction was real, tended to be ignored, and was not completely
understood. Chhatre et al. (2017) said OTC drugs might be responsible for the general
increase in older adult addiction. Stone et al. (2017) also stated that misuse was in the older
populations, with drug interactions was the most common form of misuse. Other research
found that differing adverse effects of various analgesics might confuse the user. This
misunderstanding appeared to involve the method the FDA used to label the impact of
several types of OTC pain medications and their side-effects, particularly for older adults
(Ryan et al., 2016).
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Meier (2018) documented evidence that drug companies lied about the addictive
nature of their opioid medications. The author contended that drug companies knew their
medications were addictive as soon as 1996. Nonetheless, these companies promoted their
pills as less addictive to doctors until 2007. Meier found that early on, federal government
employees discovered this deception but were told by upper Bush administration officials in
the Department of Justice (DOJ) not to pursue an investigation. Instead, the author stated that
Perdue Pharma, convicted on one charge of misbranding, blamed the promotion on a few
rogue employees. The resulting fine was a fraction of the profit Perdue made over the years
of its legal challenges.
Sources of Pain Bias from Healthcare Providers
Staton et al. (2007) found that the increased costs for treating chronic pain may be
due to its ubiquity. The author further stated that this ubiquity could be based in
undertreatment. Using the 0-10 rating scale for pain, Staton independently asked patients to
rate their pain. The authors then asked the treating physician to rate the chronic pain of the
same patient. When there was a 2 point or greater difference, Staton labeled it as a
disagreement. The authors found that doctors consistently underestimated the intensity of
pain in their patients with chronic pain. The authors concluded that the factors that drove this
underestimation included: (a) lack of doctor training, (b) not appreciating the emotional
aspects that may exacerbate chronic pain, (c) fear of side effects or addiction, and (d) the
clinical judgment that complaints of pain were malingering. Staton found regular
disagreements between doctors and patients regardless of gender, ethnicity, or income level.
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The authors added that chronic pain perception differences often appeared when the patients
were from an ethnic minority.
Bell and Salmon (2009) looked at pseudoaddiction (another label for undertreatment)
and bias. In a meta-analysis, the authors also found a reluctance of doctors to prescribe
opioids. Bell and Salmon stated that three factors were behind this reluctance: (a) lack of
physician training; (b) prejudices against the use of opioids to treat pain (opiophobia); and (c)
government legal restrictions on the use of opioids even when clinically necessary to control
pain. The authors also found that pseudoaddiction was applied when treating white people
with opioids but less often used when treating minorities, particularly black patients, with
similar afflictions.
Althubaiti (2016) addressed the problem of confirmation bias in medicine. The author
stated that confirmation bias was when decisions were made according to the medical
provider’s presumptions, opinions, or predilections. Althubaiti went on to state that
confirmation bias was possible in any medical decision that required judgement. The author
stated that confirmation bias was best controlled by always acknowledging the possibility of
bias, being objective with evidence, accepting to advances in thinking, and taking into
account contradictory evidence.
Publication Bias in Pain Research
Calati et al. (2015) did a literature review of research on the relationship between
suicide and severe pain. The authors searched 159 studies in MEDLINE and PsychINFO
until 2015, with 31 articles meeting their search criteria. Calati reviewed studies on both
chronic and acute pain. The authors also researched various types of suicidal actions,

63
including ideations, suicidal plans, attempts, and completions. Calati commented that
underestimating chronic pain may affect suicide rates.
Calati et al. (2015) did not attempt to change their conclusions based on the
possibility of confirmation bias. The authors' primary judgment was that, as the severity of
the pain increased, the likelihood of suicidal behavior also increased. Calati suggested more
studies on why some people resisted severe chronic pain and others did not. A later review
indicated confirmation bias in suicide pain research, and the relationship between suicide and
chronic pain was more substantial than reported (Stubbs, 2016).
Some researchers discounted research that did not use quantitative, randomly
controlled studies (e.g., Vowles et al., 2020; Dowell et al., 2016). Others discounted pains
studies that had small effect sizes (Finnerup et al., 2015). This judgment tended to exclude all
research based on narrative and other qualitative methods. Yet, quantitative studies on pain
based their numbers on statements extracted from surveys and pain scales. (e.g., Wong et al.,
2015), which could be quantifying qualitative self-reports.
In summary, bias was a conscious or unconscious prejudgment based on stereotypes
instead of experience, observations, and facts. It had multiple sources, and it was complicated
to address. However, unaddressed, it could stigmatize people in persistent pain. Bias in pain
management research resulted from: (a) mutable definitions of pain, rating scales, and
surveys that do not fully reflect the experience of pain; (b) treatments that vary by the pain
model used; and (c) bias, whether implicit or explicit. Limiting information to evidencebased studies with the scientific patina of quantitative statistics did not seem to add anything
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to our understanding of pain. One area that could increase our awareness of chronic pain
would be to examine the feelings of stigma and the effects of bias on pain patients.
Role of Stigma
The study of stigma has a long history in social psychology, particularly on the
effects of social isolation (Cacioppo et al., 2015; Hawkley & Capitanio, 2015; Oliveira et al.,
2015). Major et al. (1998) defined stigma as a social identity spoiled by repeated negative
bias experiences. The authors contended that a negative social identity affected the reputation
and treatment of a person or group.
Jackson (2005) wrote a comprehensive essay on why chronic pain sufferers, despite
their ubiquity, posed a threat to a cultural definition of social order. In ordinary, face-to-face
encounters, the author stated that chronic pain sufferers learned to hide their affliction
because they might be disturbing and threatening to other people. Jackson postulated that
stigmatization was expected, even among chronic pain sufferers who negatively judged
others in chronic pain. The author further suggested this stigmatization resulted from the pain
sufferers' changing social roles that might put them in social limbo between their former and
current social classifications. Jackson concluded this uncertainty was threatening because the
sufferer's social role was no longer easily understood. The author labeled this social
displacement due to these uncertainties as liminality.
Monsivais (2013) studied 15 Mexican American women who experienced persistent,
chronic pain. The study focused on stigma in three forms: (a) social, (b) self, and (c)
systemic. The author also added perspectives on how their culture and gender roles
influenced Mexican American women. Monsivais postulated that chronic pain's invisibility
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made it more challenging to fulfill traditional roles expected of Mexican American women.
The author concluded that this lack of understanding in their support system created family,
work, and medical treatment problems. Monsivais added that Mexican American women
(and women in general) learned to hide their pain, avoid complaining, and overexert (at least
in terms of their disability). The author also contended that women avoided people who were
likely to judge them, including medical providers. Monsivais stated that the resulting
stigmatization potentially prolonged their healing process and prevented good outcomes. The
author concluded that to prevent stigma, treatments needed to involve the patient by
understanding how stigmatization causes harm. Monsivais also postulated that such an
understanding might give medical personnel the ability to ameliorate those causes instead of
unintentionally making them worse.
As stated above, in a telephone survey of over 46,000 subjects, including 15
European countries and Israel, 40% of the subjects reported undertreatment and stigma
(Breivik et al., 2006). In qualitative research that explored the role of exercise in treating
chronic lower back pain, subjects reported stigmatization in every focus group (Slade et al.,
2009). De C Williams (2016) did a topical review of stigma when treating pain in clinical
settings. The author stated that research showed subjects reported stigma due to
undertreatment and lack of proper assessment. De C Williams further noted that many other
studies on treating chronic pain showed stigma reports. The author also noted that little
research looked at the causes of stigma or how to alleviate stigma. The author also felt that
stigma was less likely if the patient complied with medical advice. De C Williams found that
questioning, or failure to follow, medical advice opened the patient to increased prejudice
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and stigma. The author also found bias in that pain should be short-term, based on an
observable physical disorder, and fixable. On the other hand, De C Williams concluded that
persistent pain was suspect and often stigmatized.
Werner et al. (2004) conducted a qualitative study on ten women with persistent,
chronic pain who recounted their feelings of self-shame and the experience of stigmatization.
The study documented their attempts to: (a) negotiate care; (b) deal with the prejudice of
family, friends, and acquaintances; and (c) deal with their self-shaming. The authors
concluded that these were characteristic results of stigma. Werner further found that the
woman tended to distance themselves from others experiencing pain and often said that
talking about chronic pain was boring. The authors theorized that this allowed them to avoid
any discussion regarding the psychological causes of pain and its social stigmatization.
Wilbers (2015) conducted a qualitative autoethnography of her experience supporting
her mother, who lived with persistent, chronic pain for 14 years due to a degenerative spinal
condition. The author stated that, as the disease progressed, opioid medications became the
only effective treatment. Wilbers described: (a) multiple episodes of stigmatization of her
mother; (b) difficulty getting effective treatment; (c) unfounded accusations that her mother
was an addict; (d) multiple instances of negative feedback from the author’s students, friends,
family, doctors, and even randomly encountered strangers when she discussed the situation
with others; and (e) multiple occasions where there was fear that the doctor might take away
her mother’s medications and leave her mother in despair. The author concluded that her
mother was stigmatized and presented with unneeded stress. The weakness of this study:
These experiences might have been an outlier case of chronic pain management.
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Waugh et al. (2014) studied 92 adults with persistent, chronic pain who answered a
questionnaire on their negative experiences with stigma. The authors differentiated between
social stigma, structural stigma, and internalized stigma. Waugh found that internalized
stigma, defined as expecting to experience stigma even in the absence of any environmental
triggers, was the predominant feeling expressed. The authors concluded that internalized
stigma was a factor in treating chronic pain and needed to be addressed concurrently with all
medical interventions.
Wong et al. (2015) conducted multiple surveys on 178 Chinese chronic pain patients'
quality of life, some suffering from persistent pain for up to 10 years. According to the
authors, Asian clinics differed culturally from western clinics. Asian patients tended to use
more passive coping methods, which means they were more likely to accept medical advice
without question. The subjects in Wong were also less likely to have the same doctor over
time, as their doctors often changed from visit to visit. The authors concluded that the
severity of pain and anxiety/depression were most likely to predict lower patient satisfaction
and quality of life. Depression and lower patient satisfaction, either caused or exacerbated by
stigma, had deleterious effects on medical treatment outcomes (e.g., Phelan et al., 2015)
In a review of the narrative literature on pain, Newton et al. (2013) studied the effects
of disbelief on stigma. The authors used the term delegitimation, defined as when medical
professionals did not believe reports of pain. Newton found five sources of this phenomenon:
(a) felt stigma even in the absence of anything said by the doctor; (b) biological explanations
used to disconfirm reports of pain; (c) challenges to the personal integrity of a patient; (d)
gender and ethnic stereotypes; and (e) accusation of psychological problems, particularly
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interpreting pain reports as psychologically-based complaints. Other research showed
disbelief was evident beyond the doctor/patient relationship. It appeared in different kinds of
relationships, including friends and family (Armentor, 2017). Research showed that even
when medical providers closely questioned their patients about their pain, stigma was still a
potential problem. In those instances, the goal appeared to persuade patients to follow given
medical advice even when it did not conform to patient beliefs (de C Williams, 2016;
Moseley & Butler, 2015; Zanini et al., 2016).
In summary, stigma was evident in various pain studies, some even when it was not
the focus of the research. The emotional impact of a chronic pain condition lowered the
ability to manage pain. The internalized effects of social stigma added to the adverse
consequences of chronic pain, even when there were no bias reports. Logically, if physicians
used a strictly biomedical model to treat pain, and they too often ignored emotional factors, it
may create an increased possibility of stigma and the undertreatment of unnecessary pain.
Theoretical Frameworks
The development of the methods and analyses in this study followed two theoretical
frameworks, social identity theory and attribution theory. These two theories explained the
changes in the self-concept of chronic pain suffered and possible sources of stigma.
Social Identity Theory
Social identity theory evolved in the early 1960s from Henri Tajfel, an experimental
social psychologist dedicated to making social psychology less reductionist (Dumont &
Louw, 2007). It postulated that social identities evolved from the need to develop and
preserve a positive self-image when interacting with a social group (Abrams & Hogg, 1988).
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The accentuation principle often defined social roles. Here individuals may take many forms
of social identity within a group, according to their immediate perceptions (Trepte, 2006).
Augoustinos et al. (2014) stated that no one theory defined all types of attributions. The
author went on to say current research on social identity theory was better able to explain
accentuation, bias, types of prejudice, and the formation of social identity.
Monsivais (2013) applied social identity theory to understanding how individuals
who live with chronic pain see themselves compared to others. The author stated that
individuals with chronic pain identify within a group according to how openly they express
their illness to others. The author also said moderate-to-severe chronic pain was difficult to
hide. Monsivais concluded that this could result from a change in social roles imposed due to
the pain condition.
Sturgeon and Zautra (2016), in a review of research on resilience to pain, stated that
both physical pain and social pain shared pathways of the brain pain network. The authors
labeled social pain as anxiety that came from social isolation and stigma. Sturgeon and
Zautra speculated that addressing social isolation and other adverse social effects common to
pain patients would increase resilience.
Sheedy et al. (2017), in a mixed design on the factors that promote resilience to pain,
found several negative experiences related to an inability to cope with chronic pain. The
authors stated these experiences included: (a) losses due to chronic pain (e.g., the failure to
resume previous activities; work/money losses; loss of ability to self-care, etc.); (b)
experiencing adverse social events due to pain (e.g., loss of friends; disbelief when they
express pain; loss of social activities, etc.); (c) loss of a sense of self (e.g., lowered self-
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esteem; lowered self-confidence; spoiled reputation, etc.); and (d) more negative mood
including increased anger and intolerance to minor stresses. The lowering of resilience to
pain and the effects of stigma and disbelief on chronic pain seemed to have similar
antecedents (e.g., de C Williams, 2016; Waugh et al., 2014).
Attribution Theory
Augoustinos et al. (2014) stated that attribution theory, a form of social identity
theory, dealt with how people created causal explanations in the absence of objective
evidence. Despite years of research, the author concluded that the literature revealed
competing theories about why people make causal explanations when the facts are not known
or even knowable. Augoustinos identified the problem as being within the research itself.
The authors stated that attribution researchers had trouble distinguishing the actual responses
from response bias, where the subjects hid their true feelings and gave a more socially
acceptable answer.
Since it is not possible to measure chronic pain except by self-report, attribution
theory was useful in understanding why patients and doctors disagreed on the severity and
causes of persistent pain (Katz & Rosenbloom, 2015; Newton et al., 2013). Being under
pressure by their professional organization and governmental agencies to reduce opioid
prescriptions, attribution bias could also explain why doctors sometimes chose treatments
that were self-serving (Coleman, 2011; Macciocchi & Eaton, 1995). These factors could be
added to stigma and bias concern advocates of the humanization of pain treatment have
regarding systemic undertreatment of chronic pain (Baker, 2017).
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Narrative research is also affected by another aspect of attribution theory, hindsight
bias (Groß et al., 2017). Roese and Olson (1996) defined hindsight bias as an after-the-fact
judgment of a past event, introducing new knowledge not available at the time of the
decision. More than just the recall of an event, it is a substitution of a new causal explanation
imposed without the narrator's conscious awareness. Sometimes this created a false memory
(Reyna et al., 2016). Hindsight bias might guide an interviewer in determining the difference
between a false memory, a truthful memory, and a fabrication (Volbert & Steller, 2014).
Douglass et al. (2013) stated false memories tended to affect eyewitness accounts of a crime.
The authors noted that these mistakes included: (a) using questions that lead the witness; (b)
frequent interruption of the account; (c) using closed instead of open questions; and (d) not
listening to facts that seem unrelated to the question asked. These issues were similar to those
raised by expert narrative researchers (Riessman, 2008; Saldaña, 2016).
Role of Narrative Medicine in Pain Relief
Jovchelovitch and Bauer (2000) stated that narrative research was a well-recognized
method for documenting shared cultural experiences, particularly illness and chronic pain
experiences. The authors felt that both the subject and the experimenter were active
participants in creating a credible account with a beginning, middle, and end. Maxwell
(2013) stated that surveys and case studies removed data from their original contextual
relationships and placed them in another context, thus changing their meaning. An excellent
way to maintain and fully understand the chronic pain experience was to put the data back
into its original contextual relationship through the use of narrative (Rajagopal, 2011).
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Tsao (2012) suggested that one of the reasons for the undertreatment of persistent
pain was that the patient's voice was missing from the treatment debate. The author stated
that the field currently needed a deeper understanding of: (a) the consequences of medical
decisions to restrict access to pain medications; (b) the reasons why doctors do not fully
understand persistent, chronic pain and tended to dislike treating it; and (c) the social effects
of long-term pain on treatment outcomes. Jurecic (2012) stated that misunderstanding a pain
patient's experience commonly occurred in the medical literature. The author felt that this
lack of understanding was because of the hermeneutics of suspicion. Jurecic defined
hermeneutics as the willingness to listen but a readiness to maintain doubt. The author stated
that illness narratives have a long history of being discounted. Also, advances in medical
technology often created a historic distance between patient and doctor (e.g., Newton et al.,
2013). Insurance companies and the profit motive discouraged comprehensive doctor/patient
contact and limited the ability to converse in depth (Larsen, 2016).
Jurecic (2012) stated that misunderstanding the experience of a pain patient usually
left patients at a loss, especially when they had a complicated medical condition. The author
said that unanswered questions about their prognosis, sometimes not fully understood by
anyone, created suspicion and distrust. Jurecic posited that if one could put illness narratives
back into their previously important role in the healing process, it could rehumanize pain
treatment. The author further asserted that narrative research gives satisfaction and complete
the meaning of the illness experience. Jurecic also stated that narratives were a check on
dehumanizing technological approaches to treatment. Finally, because they were accessible
to the average person, the author believed that personal stories could become an agent of
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social change both in the doctor/patient relationship and for social stigmatization as a whole.
Jurecic concluded that narrative research would add the voice of the patient and deepen our
understanding of how pain treatment might improve. When this voice is missing, doctors
might find themselves in the gatekeeper's role instead of their preferred role of healer
(Carlsen & Nyborg, 2017).
Summary and Transition
The study of pain and pain perception has varied throughout history, mainly due to
the lack of objective measures and the subjective nature of the experience. Nonetheless,
research also showed that persistent pain was undeniable. In response, various conceptual
models of pain promoted different treatments of pain, which led to controversies. According
to some researchers, this controversy led to the undertreatment of pain, fueled by fears of
addiction to pain medications, particularly opioids.
These controversies led to variations in how patients in pain were perceived and
treated by the medical community. Research also showed that the lack of an objective
measure of pain might create circumstances where medical decisions could be affected by
bias and stigma. The perceptions sometimes led to undertreatment, mainly due to a
reductionist approach to chronic pain that focused on the underlying causes instead of its
experiences.
The theoretical frameworks of social identity theory and attribution theory were used
to understand how bias, particularly implicit prejudice, and confirmation bias, can
unintentionally create stigma. This stigma might prolong suffering and sometimes caused
undertreatment, particularly in cases of complex pain. Also, the literature supported the idea
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that to re-humanize treatment, the field needs more research that included the voice of the
patient. Surveys and questionnaires were previous attempts to add the voice of the patient
into the treatment process. Without the context of their reports, however, what people in
chronic pain experienced was lost.
Chapter 3 presents the research design and rationale, including how the narrative
approach plays a role in the research questions. This chapter also presents my experience in
caring for a spouse with persistent pain, its effect on my role as a researcher, and other
trustworthiness issues. The methodology section includes the rationale for participant
selection and my data analysis plan. The chapter ends with my procedures for complying
with Institutional Review Board (IRB) requirements and my strategies addressing ethical
concerns.
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Chapter 3: Research Method
The purpose of this qualitative study was to explore the complex nature of pain
through the narratives of people who experienced persistent, chronic pain after treatment. In
this research, I collected stories of chronic pain, treatment-seeking, pain relief, and stigma.
The results were narratives told in the words of the participants. By looking for common
experiences, I attempted to develop a deeper understanding of how the participants, their
families, and their providers might better manage chronic pain.
Research Design and Rationale
What was missing from the literature was a deeper understanding of how individuals
with persistent, chronic pain experienced treatment, relief, and stigmatization. The research
needed more information about chronic pain experiences to illuminate better ways to
understand and treat the condition. In brief, chronic pain was considered a qualitative
experience (Penney et al., 2016; Webster & Harden, 2013). There was a growing interest in
using narrative analyses to rehumanize the understanding of chronic illness (Bury, 2001;
Thomas, 2010). The research suggested that a narrative approach might address the gap in
chronic pain understanding (Rajagopal, 2011; Tsao, 2012).
Eaves (2015) stated that narrative research was a well-recognized method for
documenting shared cultural experiences, particularly illness and chronic pain experiences.
The author said that both the subject and the researcher were active participants in creating a
credible account with a beginning, middle, and end. Eaves concluded that an excellent way to
maintain and fully understand the chronic pain experience was to collect the data as it occurs
in its actual contextual relationship using narrative research.
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Riessman (2008) stated that the stories people told themselves created social
identities that were often fluid. The author noted that narrative research was the study of
information that created a given outcome, meaning, or social identity. Riessman suggested
that a narrative researcher intended to learn about an experience in all its details. The author
added that a sequenced narration was the best approach to analyze this experience. Riessman
believed that examining themes over multiple, independent stories makes it possible to
identify common experiences of participants.
Riessman (2008) further stated that a narrative method looked at the whole story and
its themes, not just the common details broken into fragments. The author believed a
grounded theory analysis, with coded narrative fragments, sometimes left out the context.
Riessman added narratively organized ethnographic studies only focused on the
interpretations of the researcher. They missed the experience of the participants and their
surrounding culture. The author also believed that other qualitative research forms, such as
hermeneutics, semiotics, discourse, and conversation analysis, offered some narrative
research elements. Yet, Riessman suggested the narrative approach was more
crossdisciplinary and gave a broader picture of the lived experience. Narrative research also
tended to offer a more comprehensive understanding of the social identity of pain patients
and the consequences of such an identity (Bury, 2001; Frank, 2015).
Research Questions
This study addressed the following research questions and subquestions to draw
closure on the identified gap in the literature:
RQ1: What are the narratives of chronic pain management in patients?
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SQ1a: How do these participants describe their experience of access to treatment?
SQ1b: How do these participants describe their experience with the pain management
process?
RQ2: What is the meaning of stigma for participants who use or believe they need
opioids?
SQ2a: How is stigma experienced in the treatment process?
SQ2b: How is stigma experienced with family and other social supports?
Role of the Researcher
Riessman (2008) recommended that a qualitative researcher's primary goal was to
find recurring patterns in independent narrations without creating a bias. The author stated
that the participants might simply give information the researcher appeared to expect in a
poorly designed study. As a result, even though interviewers were the cocreators of the
narrative, Riessman believed that their influence over the story content should be minimal.
Therefore, in this study, the pain stories were in the first person and used words chosen by
the participant. My role as the researcher was to mostly listen, clarify when necessary,
prompt if the narrative faded prematurely, and allow for tangents. Such an approach allowed
for analysis of the style of the story as well as its content.
Putting an illness into a narrative may also have a beneficial effect on the participant's
ability to cope with their pain by giving their experience more profound meaning and
supporting a positive social identity (Thomas, 2010). Creating an empathetic narrative during
the 4 years of caring for my spouse with refractory pain gave us both an experience of this
beneficial effect. It increased our ability to cope with my wife's pain and allowed her to
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manage her pain, using more biopsychosocial strategies. As her pain management strategies
progressed, she started a garden, did regular exercises, became more involved in church and
community activities, incorporated meditation into her daily routine, and tried to increase her
circle of friends. Friends and medical providers often commented on her improved ability to
manage her pain over the years.
For the first 2 years of my wife’s pain experience, however, I felt multiple doctors
were dismissive of the amount of pain she suffered and often left her pain undertreated.
There were several confrontations with various doctors who described my wife as: (a) being
an addict, (b) exaggerating her chronic pain due to mental illness, or (c) as intentionally
malingering. Two years later, my wife’s underlying medical conditions progressed to where
medical tests confirmed her reported pain. Also, due to my review of the pain research, I was
better able to understand why some physicians decided to undertreat. In these discussions, I
was able to offer research-based alternative points-of-view. After my wife received regular
opioid medications, my conversations with prescribing doctors became less contentious,
particularly with her primary physician. Nonetheless, it still appeared that my wife's pain
continued to be ineffectively managed, intermittently, during numerous hospitalizations.
In a typical hospital admission, an emergency room doctor ordered an opioid pain
medication that adequately treated my spouse’s pain. Once admitted into a hospital bed,
however, my spouse often called and said that the hospital physician discontinued her
previously prescribed opioid medication with no explanation. Instead, the hospital substituted
Tylenol and ice packs. After multiple calls and complaints, sometimes a third doctor would
reinstate the opioid, though by now, my spouse was in agony for hours. Even then, her
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prescribed opioid was only at half of its regular dose. Still later, sometimes days later, and
after further complaints to the hospital, the dosage would be increased to an adequate level—
but not always. The problem with this dosing approach, and its negative consequences,
existed in research on unnecessary pain during cancer treatment (Melzack, 1990).
Despite our best efforts, these undertreatment experiences during hospital admissions
happened so often that my wife loathed going into a hospital. Yet, her frequent kidney
infections, the danger of sepsis, and her numerous vertebrae compression fractures remained
a concern. I worried that avoiding the hospital was a risky choice. The ordeal of my wife, the
lack of definitive answers, and the conversations I had with doctors over the years, was the
inspiration for this study.
These experiences might raise questions about the trustworthiness of this study. The
extensive and sometimes contentious history of caring for my wife might have created a bias
for reaching conclusions. Roulston and Shelton (2015) gave six suggestions for managing
bias in qualitative analysis: (a) acknowledge interests of the researcher and how it might
influence data analysis, (b) reflect on how closely the data stays within the range of the
research questions, (c) examine how the data elicited differences from researcher
expectations, (d) reveal what data surprised the researcher, and (e) explain how the
conceptualizations of the researcher changed the throughout the study. I used all these
guidelines in my data analysis.
I used six suggested steps to minimize other trustworthiness threats: (a) become
involved in the phenomenon on a long-term basis; (b) develop rich, detailed data; (c) solicit
feedback from people within the phenomenon; (d) use a variety of participants under
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different circumstances; (e) look for negative examples (e.g., where there was no use of
addictive medications, yet participants managed their pain effectively); and (f) use numbers
appropriately in qualitative research (Maxwell, 2015). Another strategy I used to minimize
possible threats to trustworthiness was recognizing how personal experiences with the topic
can be an attribute for qualitative researchers (Patton, 2002). Finally, in the selection of
narrative themes, it was essential to examine multiple perspectives. These perspectives
included: (a) participants who refused or severely limited pain medications, and (b) attempts
to balance, complete, and fairly represent multiple points-of-view (Shenton, 2004).
I did not use triangulation, where data collection entails different methods (Shenton,
2004). Data came solely from the narrations of the participants, with me as the sole data
collector. This data was available, though, both in raw and coded form, for any committee
member to examine. To increase trustworthiness, I used member checking (Varpio, 2017).
Feedback also was continuously solicited from doctors, other treatment professionals,
individuals with chronic pain not in the study, and other acquaintances who showed interest.
After I stated that I was not a medical professional during these discussions, I freely gave any
helpful information I could offer.
Finally, I recognized that my experiences with pain management were both an asset
and a drawback. It was an asset because I was already deeply involved in the phenomenon. It
was a drawback because it opened the possibility of bias. Because of trustworthiness issues, I
addressed: (a) implementing what research suggested would minimize bias, (b) following
suggestions from expert qualitative researchers, and (c) bringing in different points-of-view
in the selection of participants when it was possible.
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Methodology
Target Group
Participants had to meet the following criteria: (a) be 18-years-old or older, (b) be
able to express the details of their condition, (c) be able to consent to the study, (d) respond
to a formal invitation to participate from a referral source or approach me and volunteer, (e)
had experienced their pain for 3 months or longer, and (f) experienced persistent, chronic
pain daily or regularly. These criteria gave the participant adequate experience with current
medical treatments, chronic pain limitations, and increased participant selection
trustworthiness.
Sampling Strategy and Criteria
Participants came from a convenience sample those who responded positively to the
distribution of an invitation from a “referral source” or who approached me and volunteered
after hearing I was doing a study on chronic pain. Possible sources of referrals included: (a)
local health vendors (e.g., health food stores); (b) sponsors of local health management
classes; (c) acquaintances of mine who encountered people with chronic daily pain; (d)
people with whom I had an established relationship and who knew others in chronic pain;
and (e) snowball sampling where people I had interviewed referred others in chronic pain.
Referral sources did not choose participants. They only forwarded invitations to their
contacts without further influencing the choice to participate. The invitee contacted me a selfaddressed, stamped envelope (SASE) included in the referral packet. They were also able to
contact me by phone or email to find out more about the study and to decide to participate.
See Appendix A for a sample of the referral packet.
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There was no attempt to limit participants who were unhappy with either their doctor
or their treatment regimen. Neither were those participants excluded. There was a purposeful
attempt to solicit participants from minority groups. Monsivais (2013) stated that bias was
evident in chronic pain management. The author questioned whether minorities had increased
difficulty seeking treatment for chronic pain.
Sample Size and Saturation
The number of participants was planned to be 10-15 individuals. Previous narrative
research stated that this was where saturation tended to occur (Boddy, 2016; Francis et al.,
2010; Mason, 2010). The final sample size was 17 individuals. Saturation had two
considerations: (a) theme saturation, where new interviews reported no new themes; and (b)
meaning saturation, where up to nine of the most frequent themes were assessed for
consistency of meaning (O’Reilly & Parker, 2013). If either of these criteria had shown a
lack of saturation, I would have increased the number of participants. Since there appeared to
be saturation, the search for participants ended. All participants received a written report
summarizing the results.
Instrumentation
The semi-structured interview questions attempted to encourage the participants to
tell their pain experiences in their own words (See Appendix B for the interview script).
Several books influenced the selection of interview questions. These books focused on
helping people with refractory pain organize their thoughts, understand possible treatment
options, and consider alternative approaches to dealing with pain (Caudill, 2016; LeFort et
al., 2015; Nagel, 2016).

83
During data collection, I informally interacted with other people in chronic pain and
who showed interest in sharing their experiences with me. These informal interactions
provided shared experiences like the formal participants, despite different diagnoses and
circumstances. Finally, this instrument initially evolved from an attempt to meet the
requirements of an advanced course on qualitative analysis techniques. The early version of
this instrument produced hours of recorded data from three individuals who voluntarily
allowed me to interview them regarding their chronic pain as part of my course assignments.
This study did not use any of those data.
During the interviews for this study, I inquired as to: (a) their gender, (b) age range,
(c) reasons for chronic pain, (d) region of the country, (e) medications used, and (f) length of
time in chronic pain. I did not ask these questions directly. Instead, I hoped the data would
occur naturally during the narration. If they did not, these queries followed what appeared to
be the natural end of the narrative.
The semi-structured interview introduced enough flexibility to answer the research
questions but kept the narrative in the subject's words. I was a skilled interviewer and
ensured that all participants had the same interview questions. Such consistency allowed for
better comparisons of narrations. The semi-structured interview questions did not change as
the data taking progressed. Nonetheless, I sometimes rephrased the questions to deal with
any context or culture-specific issues that arose during the interview. To add to the
trustworthiness of this study, I informally interviewed doctors who treat pain. I looked for:
(a) their opinions on how they dispensed pain medications, (b) any questions they had about
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the experience of chronic pain, and (c) if they would be interested in being a possible referral
source for other participants.
I obtained certification to teach courses on the self-management of chronic illnesses.
These courses were through a local hospital and its patient education program (Nathan
Littauer Hospital, 2012). Self-Management Resource Center (2018) developed the program.
Teaching these courses gave me further experience in the field of treating chronic pain.
Procedures for Data Collection
The primary interviews occurred by phone through a computer conferencing website.
Before beginning the interviews, all participants gave written consent, sent to me by the
included SASE. The interviews took between 20 to 60 minutes. An audio recorder provided
by the website recorded all questions and responses. This recording was then transcribed into
a word processing file by computer through a transcribing website. I later checked the
accuracy of the transcriptions using the tools provided by the transcription website. No one
else had any access to the data.
Since the interview was online, the participants chose the location for the interviews
that provided for confidentiality and comfort. The time of the interview was by mutual
agreement. After 17 interviews, the study reached saturation criteria, and the interviews
ended. All participants received a summary of their narration sent for member checking.
Data Analysis Plan
The overall approach to data analysis followed the guidelines given in Saldaña
(2016): (a) similarity, themes that seemed congruent with logical expectations of the research
questions; (b) difference, themes that were not able to be predicted from the research
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questions; (c) frequency, how often either kind of themes occurred; (d) sequence, the order in
which particular recurring themes tended to occur; (e) correspondence, how often the themes
tended to occur with other kinds of everyday life events; and (f) causation, where the
emergence of one theme seemed to cause another. As data emerged, they were both handcoded and coded by a computer program. The themes of the second and third analyses
answer the research questions. Also included were results from discrepant cases. The
CAQDAS software chosen for this analysis was MAXQDA (Saillard, 2011). Data analysis
was reviewable, both in its raw and coded form, by any committee member.
Issues of Trustworthiness
This study addressed trustworthiness by following the recommendations of Saldaña
(2016): (a) increased credibility using prolonged contact, saturation, reflexivity, and peer
review; (b) increased transferability with detailed, thick descriptions and using a variety of
referral sources to distribute invitations to enhance variation in participant selection; (c)
while not using triangulation, I used member checking; (d) a detailed process of the study
allowed future researchers to repeat the study; and (e) increased confirmability by using the
words of the informants when identifying themes and making conclusions. As stated above,
the data, both raw and coded, were saved and were available for any committee member
review.
Ethical Procedures
All data were kept confidential. Identifying information was stripped from the
narrative. I was not in a power relationship with any possible participant because I was
retired from full-time employment. Some of the participants who responded to the invitation
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came from family, friends, and acquaintances. All these participants experienced persistent
pain and responded to a request from a referral source or approached me and volunteered to
be part of the study once they heard about it. I kept confidentiality from other acquaintances
and family members unless I had written permission to share the interview information. As
stated above, I stripped all identifying information from the narrative and gave each narrative
an identifying number. I kept all confidential information on my computer with restricted
access, and I kept paper records in a locked box file in my home office. These data will be
stored safely for the next five years.
There were no external organizations that needed IRB approval to interview
participants. Written consent was reviewed and signed before the interview began. After they
signed, each participant received a copy of the consent agreement. If any participant was
reluctant after giving initial consent or expressed a reluctance to continue, I took the first no
as an answer. The results reflected the number of participants not completing the application.
Any information gathered to that point was eliminated from the final analysis.
Participants experiencing persistent, chronic pain were from a vulnerable population.
Interviews certainly involved sensitive topics. High priorities included earning the subject's
trust, assuring confidentiality, and developing a nonjudgmental, empathic connection. The
approach helped participants develop a deeper understanding of their situation and learn
better-coping skills (Charon, 2001). If an interview produced distress in any subject, I would
have referred the participant to a trained clinician or other support sources. This resource was
not requested or appeared to be needed.

87
Summary and Transition
This study explored the complex nature of pain through the narratives of people who
experienced chronic pain after treatment. I addressed my experiences with caring for a
spouse in chronic pain and its possible effects on the study's results. The target group was
adults who experience persistent, chronic pain daily, or almost daily, for three months or
longer. An online audio recorder website recorded the entire interview and protected
confidentiality. A second online service transcribed all audio recordings into word processing
files. Using the tools of this second website, I checked those files against the audio recording.
The number of participants was 17 individuals. I obtained written consent for other ethical
concerns, kept all data confidential, stripped identifying information from the narrative.
In the following chapter, I describe the participant pool and the procedures for
analyzing the data. The results are presented and organized by research question. Discrepant
cases and findings are discussed, and the efforts to maintain trustworthiness are evaluated.
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Chapter 4: Results
The purpose of this qualitative study was to explore the complex nature of pain
through the narratives of participants who experienced chronic pain and received varied
treatments for it. This exploration collected participant stories of chronic pain, treatmentseeking, pain relief, and the experience of stigma. There was a growing interest in using
narrative analysis to rehumanize the understanding of chronic illness (Bury, 2001; Thomas,
2010). Prior research revealed that patients' voices were missing from the literature, and
narrative research was an excellent way to gain access to these to better understand chronic
pain (Eaves, 2015; Rajagopal, 2011; Tsao, 2012).
This study addressed the following research questions and subquestions:
RQ1: What are the narratives of chronic pain management in patients?
SQ1a: How do these participants describe their experience of access to treatment?
SQ1b: How do these participants describe their experience with the pain management
process?
RQ2: What is the meaning of stigma for participants who use or believe they need
opioids?
SQ2a: How is stigma experienced in the treatment process?
SQ2b: How is stigma experienced with family and other social supports?
For the study I used two different methods to analyze the results. One was a structural
analysis that grouped participants according to the strategies they used to manage pain. The
second analysis examined how the results addressed the research questions and themes that
all participants shared. This chapter covers the setting and demographics of participants. It
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details how I collected and analyzed the data. Finally, how I systematically explored the
themes that resulted from those analyses.
Settings
The primary interviews were by phone through a computer conferencing website. I
used website tools to record and transcribe all interviews. As promised, no one besides me
had any access to the raw data. The participants chose the location for the interviews based
on their sense of confidentiality and comfort. The time of the interview was by mutual
agreement. After 17 interviews, the study reached saturation and the interviews ended.
Because the last four interviews produced no new themes or experiences, this met the
requirement for saturation (O’Reilly & Parker, 2013).
There were a few problems with the member check. The member check plan was to
summarize the interviews and write the synopsis in the third person. All identifying details
were eliminated or changed, as planned. However, the COVID-19 pandemic posed a few
problems with sending the summaries to the participants. The first attempt was to email a
password-word protected file to each participant. Most participants could not open this file
even after they received the password. The modified member check plan sent each
participant a printed file created using pandemic-safe protocols of a mask, gloves, and tape to
seal the envelope. This modification delayed the final data analysis, but participants who
responded to the member check requested only minor changes. Three participants did not
respond.
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Demographics
Of the 17 participants, 10 were women, and seven were men. Because the interviews
were by phone, there were no restrictions on location, a possible concern before the study
began. All participants were American citizens. All were Caucasian, but three were born in
Lebanon. Eleven participants lived in my local area, Gloversville, NY. There were two
participants from the Northeast. Finally, there were four participants from the Southeast and
one participant from the Southwest. As described in Chapter 3, my intent was to recruit
participants from my geographic area. Yet, in the final sample, six participants were
nonlocal. Table 1 displays the age range, diagnosis, and primary means of managing pain for
each participant. A pseudonym identified all participants.
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Table 1
Demographic Characteristics of the Sample
Pain group Participant

Gender

Age Range

Diagnosis

Pain gone
Ralph

male

65-74 years

Herniated disc back/neck

Peter

male

25-34 years

Torn ACL

Justin

male

18-24 years

Back pain

Bill

male

45-34 years

Back/knee pain

Ada

female

25-34 years

degenerative spine

Sally

female

65-74 years

Cyst at the base of the spine

Vito

male

25-34 years

Ehlers-Danlos syndrome/arthritis

Mada

female

25-34 years

Kidney Transplant

Rita

female

65-74 years

Neck/leg pain

Dina

female

55-64 years

Shoulder dislocated

Jean

male

65-74 years

Rachael

female

74-85 years

Spinal stenosis bone spurs/bulging
disk
Arthritis

Caity

female

65-74 years

Stenosis in the spine

Nija

female

65-74 years

Arthritis

Ben

male

45-54 years

Degenerative bone disorder

George

male

35-44 years

Kidney transplant/arthritis

Mary

female

65-74 years

Ruptured a disk in back

Nonopioid

Used opioids
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Data Collection
The target group was adults who were: (a) 18-years-old or older, (b) could express the
details of their condition, (c) were able to consent to the study, (d) had experienced their pain
for 3 months or longer, and (e) experienced persistent, chronic pain daily or regularly. These
criteria gave participants adequate experience with current medical treatments, and chronic
pain limitations and insured trustworthiness in participant selection.
As previously stated, most participants came from a purposeful sampling of adults
who responded positively to the distribution of an invitation from a referral source. Also,
some participants came from people who volunteered after hearing about the study.
Furthermore, a few participants came from snowball sampling of those interviewed. All
participants then contacted me to answer any questions, signed the necessary consents, and
made an interview appointment.
The original data collection protocol was modified when people who heard me speak
about this study approached me and asked if they could participate. The original data
collection plan did not anticipate such a qualification for participation. The modified data
collection protocol added this qualification after IRB approval (Walden University IRB
approval number 04-19-19-0116261). Once individuals qualified, the interview protocol
went as planned. Eleven people handed out invitations and were not participants. These
referral agents distributed over 75 invitations. Of the people who received invitations, 15
people responded positively, and five others approached me after hearing about the study. Of
those interviewed, five participants agreed to contact other people they knew who were in
chronic pain, and these snowball referrals had three positive responses.
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In every referral packet, there was a letter describing the study, Of the 20 people who
filled out the necessary paperwork, 17 set up an interview appointment, and three did not.
While I had not anticipated that some participants would be pain-free at the time of
their interview, it did not disqualify them from the study if they were previously in pain for 3
months or more. Two participants reported they were pain-free. Concerns of a study
limitation due to limited medical services in my surrounding community were unfounded.
Participants included individuals from other parts of the country (see Table 1). Some
received advanced treatments specialized for their diagnosis and were provided pain
management treatments not available in my local community.
The semistructured interview protocol did not vary for any participant. After
expressing interest and signing the consent, every participant received a phone contact that
answered any questions and set a time for the interview. A computer conferencing agency
recorded phone conversations. Afterward, an online service transcribed the data using
computer algorithms into a word processing file. I then used the tools at the transcription site
to check the transcriptions against the audio. As a result, I was the only person who had
access to any form of raw interview data.
Structural and Thematic Analysis
I used two different approaches to analyze these data. I used a structural analysis to
explore the difference between three groups: (a) participants who were pain-free at the time
of the interview, (b) participants who had chronic pain but did not use addictive medications,
and (c) participants who used potentially addictive drugs to manage their chronic pain. The
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thematic analysis answered the research questions by exploring common themes discovered
through computer-assisted qualitative data analysis software.
Structural Analysis
I first analyzed all transcripts through a structural analysis by hand from the
transcribed interview data. The resulting documents were chronological pain stories for each
participant. The results of the structural analysis revealed the narrative organization of all
pain stories. Each had a beginning, middle, and end. This analysis revealed that, while there
were numerous similarities among narratives, the experience of chronic pain was
idiosyncratic but was able to be grouped by the way the participant chose to manage their
pain:


Pain free. Participants who experienced chronic pain for 3 months or more, but
the pain had resolved.



Nonopioid pain management. Participants who did not use opioids or addictive
pain medications regularly.



Used opioids or other addictive medications. Participants who used opioids or an
addictive medication as their primary pain management strategy.

The resulting structural differences are in Table 2. Later, these documents were the
source of a synopsis that was sent to each participant as a member check.
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Table 2
Participant Differences in Their Primary Pain Management Strategy

Pain free

Did not use opioids

Used opioids
regularly

Access to
treatment

Had little trouble
accessing treatment.

Had some trouble
accessing treatment.

Managing the
ebb and flow of
chronic pain

Typical ebb and flow
pain management

Ebb and flow of pain
difficult on some
days

Discussions
about addiction

Did not have a
discussion about
addiction with a
doctor
Avoided opioids and
other addictive drugs

Had minor
discussions about
addiction with a
doctor
Avoided opioids and
other addictive drugs

Felt they had to prove
they were not an
addict when with a
doctor
Embraced opioids and
other addictive drugs

Beliefs about
opioids and
addiction

Believed opioids
always led to
addiction

Believed opioids
always led to
addiction

Believed opioids
sometimes led to
addiction

Experience of
stigma from
medical
professionals

Experienced little
stigma after being
pain-free.

Experienced some
stigma from medical
professional

Experienced major
stigma from medical
professional

Experience of
stigma from
others

Experienced little
stigma from others
after being pain-free.

Experienced some
stigma from family
and friends

Experienced major
stigma from family
and friends

Use of opioids

Remained worried
about access to
treatment
Ebb and flow of pain
difficult daily
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The results of this analysis also revealed fundamental structures that affected: (a)
access to treatment, (b) daily planning to manage pain, (c) how often they experienced stigma
from doctors, and (d) how often discussions about addiction arose during medical
appointments. The most dramatic differences were in the group who used opioids or another
potentially addictive medication to control pain. These differences are described below and
supported with text from participant transcripts.
Access to Treatment
Access to treatment for chronic pain varied according to the primary way participants
managed their chronic pain:
Pain-Free
The following participants who had resolved their chronic pain seemed to have little
difficulty accessing medical treatment. Peter said,
I did go to doctors and orthopedists. I went … several times to orthopedists. I … got a
prescription every time for physical therapy. I also … brought up Active Release….
My doctor … said she had heard of it. And that was really helpful.
Ralph said, “I go see my family practitioner. He checks up on me…. I got blood pressure
and cholesterol problems.”
Non-Opioid Pain Management.
Some participants who used OTC medications and other strategies to manage pain
had little difficulty seeking treatment but sometimes felt medical interventions did not help.
Rita stated,
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Because I was terribly under impressed [with my treatment]. It was not helpful. I
thought it might have been sciatica. They said it wasn't. They didn't really tell me
what it was. They didn't seem to know what it was. I went to the pain clinic, initially,
I saw one doctor. Then they had made up a follow-up appointment. And he, all of a
sudden, had quit and I saw somebody else. And then that person left. They did
recommend physical therapy. So … I went back. I went to PT. And they did various
exercises for probably a couple of months, maybe … two to three months. And it
didn't do one single thing … it didn't seem to have any rhyme or reason to it. And I
would do the PT and it wouldn't have any kind of an impact, whether I did it or not.
So, after a couple months … I just told them it's not making a difference. It's not
doing anything. It doesn't seem to make one bit of impact … So, I stopped going.
Sally said,
And people thought it was sciatica, but it was not sciatica. So, I was going to
physicians to try to get a diagnosis. I went to an orthopedic [doctor] and I went to a
chiropractor to try to deal with it. And I finally ended up at a neurosurgeon's office.
And he was the physician who was able to help me the most, at least, in diagnosing
what I had. Through all the tests, through the years, I had MRIs. And they showed a
huge cyst in the base of my spine. It was, I think, 3 centimeters long, or something
like that, in size. And what the neurosurgeon said, because he did a contrast MRI …
[was] that [the] cyst is leaning on nerves in the base of my spine. And it's developed a
kind of place where it sits in my pelvic area.
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Used Opioids or Other Addictive Medications
Participants who used opioids regularly were apprehensive that their next doctor visit
might result in losing their most effective pain medications. Mary said,
She’s a PA and when I asked for a refill of the Soma [Carisoprodol], the head doctor
in the practice put a note in my chart, “Get her off of this…. She should not be taking
that all the time.” And I panicked and I said … what am I going to do? I do not take it
for pain management, I take it for my bladder. So, she [my PA] advocated for me.
George commented,
I mean, they did do the tests, but when things were coming back negative, they sent
me to a rheumatologist. But my blood tests were coming back almost negative. I
didn't have … arthritis. But they said it wasn't what was causing my issues. But again,
they didn't know really what to do because pain management as a thing wasn't really
popular. And every time we mentioned it, [the] docs … [said] “No, no, no. You got to
go see a specialist.” But never point me in the right direction.
Managing the Ebb and Flow of Chronic Pain
All participants had to manage both mild pain days and days that were more difficult.
However, the intensity and frequency of these experiences varied according to the primary
strategy used to manage chronic pain.
Pain Free
For the pain-free participants, managing pain was mostly just a problematic memory.
Peter said,
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I have like soreness after working out, but it's within normal limits. So, right now my
pain is no worse than it was before my injury because I have a flat foot on my left
foot. And that's always had some soreness to it. But it hasn't really been a problem
ever. It was pain within normal limits for what I was used too.
Ralph stated, “The first episode of pain, with all those pills, was gone by … September 25th,
1998. I'll never forget it…. That's 21 years ago…. And four years after that … I was
[ultimately] without pain.”
Non-Opioid Pain Management:
For participants who use OTC medications as their primary medical intervention,
there were difficult days and some more easily managed. Rita said,
It hurts every day. But sometimes it tends to be worse. Sometimes when I'm sitting at
the computer working … I … take an Excedrin…. Or I might have to lay down if my
back is in spasm for a little while … or to put heat on it. [Yet] I do the same things,
whether I'm in pain or not. And it doesn't stop me from doing any activities. But …
sometimes I just have to sit and rest. And … occasionally go out and do things. But
what really starts to bother me is … in the evening, when I'm watching my
granddaughters.
Rachel stated,
I know when I start hurting that I just have to take more breaks. I have to sit down in
between while I'm doing outdoor work or whatever I'm doing and kind of relax. And
put more stuff on [OTC topical medications]. And then wait a while and then I go
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back to try to finish the job if I can. Whether it's mowing or trimming or painting or
whatever I'm doing or washing floors or whatever.
Mada said,
The only medication I can take is Tylenol. Well, no matter what happens, even if I
got sick, like now, I'm not allowed to get out of the house a lot because my immune
system is very weak…. So maybe the pain is less [since my liver transplant] it's like
80% less. But the pain in my kidney now, sometimes it's crazy because it starts from
that from the lower back all the way to the shoulder…. So, it's going to be a bumpy
road. But I'm going to be strong enough for it. I passed through a lot of pain. I'm
learning to pass through more if I actually get to a point where I'm going to be
painless, completely painless.
Used Opioids or Other Addictive Medications
For participants who used opioids or other addictive medications, difficult days
appeared to be more likely and more frequent. George said,
So, when I wake up in the morning, that's usually when it's at its peak. Because I've
been lying down and sleeping. And I wake up and everything is just hitting me at
once. Just getting out of bed is like a job…. Sometimes … it's not worth it…. I'm just
going to call in…. As soon as I get up and move, and I start moving the joints a little
bit, I have to get hot water on me immediately…. I am almost in tears sometimes
because it's so bad. I run my hands … [under] hot water so those things start
moving…. I get in the shower … [and] let all the heat do what it's got to do. And then
… as I am moving, it feels like everything is just like punching me and stabbing me at
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once. I'll take some medicine in the morning. I'll finally get to work…. then once my
pills start kicking in … it takes the edge off just enough so I can function. It's not that
the pain disappears. It gets to the point where I could actually do my job without
really showing them I'm [in] a little bit in pain.
Ben stated,
In a lot of pain? Well, it's pretty much every day that I come home from work … I
come home … my hips are sore. It's hard to fall asleep because I can't sleep on my
back. I don't sleep on my stomach. So, I kind of jump from side-to-side and my hips
are always sore. Feels like I got hit with a baseball bat, sometimes. And this is very
uncomfortable.
Discussion About Addiction with Doctors
While addiction was a concern for all participants, it most often became an issue
during a medical appointment if the participants were using an addictive medication to
manage their pain.
Pain-Free
Doctors sometimes offered addictive medications to participants during their time
with chronic pain. One participant used them, but neither participant felt they were useful. In
response to a question if he had ever had a conversation with any doctor about addiction,
Peter said, “I don't think so. No, I haven't really had any problems with substances.” Ralph
stated,
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The last doctor I saw [while I was in pain] … told me there was nothing he could do
for me except for keep giving me pain pills. I said they're not working. They just said,
well, there's nothing we can do.
Non-Opioid Pain Management
Even when participants refused addictive medications, they still had to deal with the
possibility that they were secretly harboring a desire for an addictive drug. Dina said,
Yes, they dismiss what I'm actually telling them because they think I'm only there
looking for them to give me a pill--until I got really upset. Like I didn't even ask for a
pill. And in prior years, in another instance, I went to a neurosurgeon and he said to
me, “We don't write pain pill prescriptions.” And it was the first time meeting him.
And truly, what he said to me was very offensive. Because I never asked him for a
pain pill, never implied I wanted one. And he directly looked at me and told me that.
Like he thought that's what I was there for.
In response to a question as to whether he ever had a conversation with any of his doctors
about addiction, Justin stated, “Yes. Usually, depending on like the medications that they
prescribed. Just … [be] careful on how much you take or whatever … because certain
medicines can be very addicting compared to others.” When it was suggested that he did not
take them, he replied, “That was the hydros [hydrocodone].”
Used Opioids or Other Addictive Medications
When participants used additive medications to control their pain, they often had to
prove that they are not an addict, or they might lose their pain prescriptions. Ben stated,
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So now I am to get this young doctor. Now I've got to sit here and tell my whole story
again and they don't like giving medicine … because everybody's acting like …
there's a bigger epidemic or something. You know, they don't want to give anybody
any pain medicine anymore. And it's like you've got to be kidding me. You don't
know my story. The only thing you see is that there's a chart saying, hey, he's been on
this medicine a long time. Why is he on this medicine?
George said,
But every time I got a new doctor and they saw [Dilaudid] it raised red flags on their
end ... they immediately … say, “Let's get you off of this.” And I'm … looking at
them saying, that's not going to work. We've done this before…. And doctors are very
scared to write a prescription for that type of med. And I mean, I understand, but
when you get a person that's on it for a reason, there's a difference.
Believed More Medical Intervention Would Help
Even when participants had a bad experience with doctors when managing their
chronic pain, a strong faith in medical interventions remained, for the most part. With
participants who used addictive medications, however, their faith usually contained a dose of
skepticism.
Pain Free
Pain-free participants had positive things to say about medical intervention. Peter
said,
[My doctor] was pretty validating. I felt like she was letting me know that she was
listening. She had an excellent bedside manner. And she also was she was really well
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trained. Her background was in sports medicine. And she knew a lot of people who
got surgery and people who didn't get surgery.
Nonopioid Pain Management
Despite having some difficult experiences with chronic pain and doctors, participants
in this group maintained their faith in medical interventions. Sally said, “I go to the doctor for
my annual physical…. And so, I'm sure that he would order pain medication for me, but I
have not asked for it.” Caity stated, “I go to a fabulous [doctor] group…. So, I went there and
… when I walked in, he said, ‘Well, I can tell you right away what you have.’ My experience
with that doctor was just phenomenal.” Vito said, “My doctor was a really good doctor, and
she worked at the [nearby clinic] ... I buy … [OTC medicines] at the store. Bill stated, “I
haven't had a bad experience with a doctor. Other people have had bad experiences with
doctors. But I've always been fortunate. My family has also been very fortunate not to have
really negative experiences.” Ada said,
But I really think I am lucky, and I'm blessed that at least for the conditions I have are
treatable. Worst case scenario was the surgery. Of course, it gets irritating here and
there. Like, the days when the pain is really bad. But I'm so thankful because I really
think it could be worse. And I remain motivated to do my part, to do what I can to
prolong whatever it is that's degenerating my spine. We'll find that out soon,
hopefully. And I'll do my part, as much as I can, like I said, and the doctors will do…
theirs. I've seen a lot of doctors, in different states and different countries, try[ing] to
get as many opinions as I can. And, recently, I kind of realize that they all have the
same thoughts each time. The same advice on what to do next.
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Used Opioids or Other Addictive Medications
Participants in this group liked their doctors but seemed worried about the future
treatment of their chronic pain or a change in provider. Ben stated,
I'll be meeting my new doctor and I don't know how keen they are to giving me pain
medicine … he did run bunch of tests and, [made] sure that I'm taking my medicine
and … not abusing them … and I tested out fine…. And it's kind of scary, at the same
token … because what I [was] used too … [was] a great doctor. He even told me
things like, “I'm an old school doctor…. I know what it's like to be a laborer.” He
knows how many surgeries I've been through.
Mary said,
I had to have the battery replaced [in my spinal column stimulator] but … things
didn’t work right, so they ended up doing the whole thing over. So, that one lasted
until the battery ran out in May of 2009. Then it was replaced, and it’s been a miracle
until last year when I felt my whole back of my shoulder and my ribs was burning
and on fire ... they told me I had a broken rib, they told me I had shingles … and
finally, last December, I convinced them to do a myelogram … and it showed that the
implant had shifted…. So, I had to wait to get that approved. In February, they
replaced … [and] they revised it … and I begged them, please, the battery has already
outlasted its lifetime, it’s going to die. And they said, no we are not going to do it.
Well, two days after I got home, the battery died. So, I had to go back May 2nd and
have the battery replaced. So … they think they know everything about it, and they
don’t know a thing.
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George stated,
I was hoping a different doctor would say or do something different. And the general
practice doctors, of course, [said] they don't know, but they pointed me in a direction.
Usually starts as rheumatology first … but when I get there, I talk to the
rheumatologist and they say, no, you need to see a pain specialist. Well, the military
works in mysterious ways. It takes months … to get into the doctor. And when you
finally do get there, it starts all over again. The pain doctors even went, “Well, let's
try to see if it's a rheumatology thing.” But they don't listen to you. So, it's like a giant
circle. That tells me either they don't know about it or they didn't care.
Believed Addictive Medications Always Led to Addiction
Participants who were not using addictive medications did not state that they felt the
need for those medications. Some reported that they would refuse if offered. Participants
using addictive medications, however, felt that their medications were essential.
Pain Free
Pain-free participants believed that potentially addictive pain medications should be
avoided and usually led to addiction. Peter said, “I've never smoked marijuana in my life. I
know I get stomach trouble when I drink alcohol. So, I think I was fine with meditation
because that's the healthy way to get a buzz for me, not for everyone.” Ralph said,
There were times that I thought maybe I would double dose, but I wasn't that type of
person. Even though I was in pain, they told me I had to take one tablet every six
hours and that's what I took. I would just have to suffer if it didn't work because I
knew of addictions, and I didn't want it. I might become addicted. I guess even with
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these new drugs that they got out there, it doesn't take long to get an addiction to
them. And then you go through some major side effects. And I didn't want to do that.
Nonopioid Pain Management
It was a similar reaction with participants who used OTC medications to manage
pain. Rachael said,
[Interviewer asked, “And do they [doctors] ever talk about other meds you could
take?”] No. Not really. Just the basic ones as you need them. That's all. Nothing
strong. [Interviewer, “They don't talk about any stronger meds?”] No. No. And that's
okay because I to go the natural way. Or, like now, the biggest thing is the CBD, the
rub. I have the rub, and I have the drops. I have to take them every day.
Dina said,
And I opted to not take them [Percocet] because I didn't want to cause another issue
for myself. So, I didn't take … [as much] from the second day after the surgery. I
didn't take them regularly … And then I would only take one a day, or one in the
evening when I tried to sleep. Or when I really couldn't stand it, I would take one.
Probably not even every day, but just at the point from not being able to stand the
pain.
Sally said,
He was the one that offered me pain medication. He said it's just … going to be there.
If you want and I'll give you pain medications. I said, no, I don't want it … He offered
me gabapentin … Not any of the opioids or anything like that. [Interviewer asked, “If
he had offered you the opioids, would have taken them?”] No.
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Used Opioids or Other Addictive Medications
Participants using opioids and other addictive medication believed the drugs were
essential to their pain management. There was also no indication of abuse. Mary said,
After the head doctor said to stop prescribing addictive medication, my PA talked to
him and said, “Listen, this girl needs this. She’s not taking it for pain management.
She is taking it for her bladder because she is allergic to everything.” So, she
advocated for me. And I was afraid [I’d] have [to] switch doctors because the doctor I
was going to left. And…[once] they put me in [another] practice [and they] said, “I’m
not giving you this Altram. You’re a drug addict and you need to … take pain
management and get off of it.” I switched doctors.
George said,
And so, they said they put in my records for a pain management-type thing, that
[Dilaudid] is the only thing that would work. But like I said, it's not that I got
suggested to a pain management specialist. It was, “Let's try things to see what
works.” And that was like [the] E.R. doctors … every time I got brought into the
emergency room for something. It just became a routine. I had like, they call it a
cocktail. It's just like different types of little meds. And then they give me the big
juice med, that's what I call it … And sometimes it was a full … juice-wise, which is
straight in [intravenous injection]. So, it immediately it takes effect, all the way up to
2 milligrams … I did not take Dilaudid today. Like I said, on good days, I'm able to
take … Tylenol, about a thousand milligrams…. It's not that I don't. They were
expecting me to come in every month or so and get refills. What it ended up being
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every six to eight months I got refills. And, you know, it got down to the point where
I was taking only so many meds or so many times, they knew I was not one of those
[addicts].
Stigma from Doctors and Medical Professionals
Stigma during medical treatments was common, but the experience varied by the
strategy the participant used to manage chronic pain. Twelve participants experienced stigma
during medical treatments. As will be seen, even when stigma was not experienced during
medical appointments, all participants in chronic pain experienced stigma from some source.
Pain Free
Participants who were pain-free experienced stigma as a problematic memory. Peter
said,
Yeah, my orthopedist said that I should be running. This was the first one I saw in
2016. And he said I should be running after I got like the boot. And … he said …
Your leg is strong. You should be running in like three months.” And I think that was
a very unhelpful comment. Even though I respect his expertise, he definitely was
helpful in a lot of ways. But this … was unhelpful. And, when I thought I should be
running in the summer later, I injured myself. So, it was not solution focused.
Nonopioid Pain Management:
Stigma occurred even when a participant would refuse addictive medications. Dina
said,
[One doctor] basically dismissed my pain when I was telling them what I felt and the
pain that I was in. He just kind of laughed it off and said, "Oh, I've had five shoulder
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dislocations like whew, that's nothing. What are you worried about?” And I assured
him that if I was not in pain I wouldn't be there.
Caity said,
[The doctor said,] “You know maybe I'll send it to [another doctor] and let him
evaluate.” And then he said, “Why aren't you fat?” And I said, “I beg your pardon?”
He said, “Ninety-nine percent of the people who come in here with knee problems are
fat.” And I said, “Well, I suppose I'm not fat because I eat right and exercise. But, you
know, injuries are caused by all sorts of things.”
Mada said,
And [the case manager] said, “We know that there's something wrong with you. But
it's not to that [much of an] extent. There's a lot of people more sick than you.” And
… and she did not put herself in my shoes. And I actually told the doctor …. Even if I
wasn't in pain, she should take it into consideration. [My test] results were scary. My
liver started forming very bad cells. They were scared of cancer…. And I used to go
nuts [when anyone mentioned I was not sick enough].
Used Opioids or Other Addictive Medications
Participants who used addictive medications were most likely to experience stigma
during medical appointments and had the most to lose. Mary said,
I have been called a doctor hopper because I kept trying to find someone to help me.
And it is just, there very few doctors that I trust. I feel better now than I have in a
long, long, long time but it is never going to all stop hurting.
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Ben said,
I did have a doctor visit with an on-call doctor, the one who was covering for my
doctor. I had a different procedure done and he started giving me the business about
me being on my medicine for so long. He's like, "Oh, you shouldn't be on it…. You
know you should go see an orthopedic doctor.” And I'm like, “Dude you don't know
anything about me…. you know, I don't drink. I don't do anything. I pretty much just
take my meds and that's it. You know I'm a laborer. I've worked hard all my life. I
still have one leg longer than the other. And I'm in constant pain.” And he just wasn't
even trying to hear me … and I'm like, well I'm glad he's not my permanent doctor.
Stigma From Family and Friends
Even when stigma was not reported from medical professions, all participants
reported experiencing stigma from other sources. These sources included family, friends, and
casual acquaintances.
Pain-Free
Again, when pain-free, stigma from friends and family were often just a bad memory.
Peter said,
In terms of my friends, a lot of them didn't necessarily wait up when I was trying to
come along with them to class. And I didn't really complain about pain with friends
so much. But I did complain about pain when I was with family. And they wanted to
do something, and I wanted to rest. Like my parents don't take themselves too
seriously but they do like to hurry a lot…. I don't exactly remember what he said. I
remember the attitude of feeling rushed. I think it was the essence of it was that he
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was feeling burdened … And one of the issues was that I was taking breaks when I
was doing well. Whenever I walked somewhere … I would sit for like maybe 30 to
60 seconds.
Non-Opioid Pain Management
In this group, stigma from friends and family could be avoided by merely hiding pain
or refusing to discuss it. Bill said,
But it's very aggravating … because as soon as I take Tylenol, one of my coworkers
at work … [begin] joking about it, because I was having a lot of pain. And we’re
allowed to sleep at work when we don't have any calls because … the ambulance
service … and the trucks are all taken care of…. So, I'm like, “Yes, this will take
about 15-30 minutes and then I might try and fall asleep.” So [a coworker] had to
joke it … "Oh, yeah … here's Bill. He'll take some of this Tylenol in 30 mins and
fake snoring sounds.” Pretending like, as soon as the medicine gets in my mouth, I'm
out like a light.
Caity said,
When I was 24-years-old, I had been married for six months, [and] we were crosscountry skiing with a group. And I was staying with this horrible husband that I
divorced way too late, and I should have done it sooner. And my feet just went out.
And I put my hand down and catch myself. And when I got up, I said I thought … I
broke my arm. And he [husband] said, “You can't have broken your arm. You just put
it down in soft snow.” I said, “Honestly, I think I broke my arm….” My husband was
an alcoholic…. And he said, “Well, let's just get a beer and maybe it'll feel better.
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And then if not, we'll go home.” So, he had a beer and I said, “You know … honest to
God, I broke my arm.” And he said, “You can't [have]. But if you're gonna be a
booboo, we'll go home.” So, I went home and I cooked … and served dinner and
washed the dishes and complained about my arm. And [he said] “So … since you're
complaining all the time, I will take you to the hospital….”. So, we got to the
hospital. They said, “You did indeed break your arm. But it's more complicated than
that. You need to see an orthopedic surgeon….” Of course, the orthopedic surgeon
was closed on Monday. So, I saw him on Tuesday. And he went apoplectic because I
had a bone tumor and it had eaten my bone away … And, because I broke it, it
pierced the tumor. If the tumor was malignant, I was in deep … trouble. Especially
since it had been now a day and a half…. And I saw a specialist in these sorts of
tumors…. And he said he couldn't believe I had no pain leading up to it…. Well,
everybody has advice. Everybody has a doctor. Everybody has, “You know, what I
did?” Everybody has an authority of some sort. And some of that's comforting. And
some of that's just like eye-rolling….
Used Opioids or Other Addictive Medications
In this group, attempts to protect their most effective pain medication was to deal
with the appearance of an addict and sometimes hide their pain. Yet hiding their chronic pain
was often difficult. George said,
Sometimes my friends here at work think it's fake, that I'm trying to get out of
stuff…. I've had … people pulling me aside, saying … that I'm a shammer and I just
want to get out of work. Because … like a lazy person and I just want to get out and

114
go home. So, we call them shammers. [Interviewer … how did that make you feel?]
Well, mainly angry because of my history with the military. I've never been that
person…. But also freaked out that I'd be labeled [with] higher-ups with military
promotions, awards, things like that. Because … you do so much in your career, all
of a sudden, you're labeled as a shammer.
Ben said,
My friends understood it [but] my family maybe not so much. Everybody had the
attitude that well you had the surgery you should be fixed you shouldn't have any
pain. And … that's not true … they don't live with it. They don't understand …
you're constantly walking crooked…. My family just didn't get it. They didn't
understand…. “Why are you in pain?” And I'm like, “Well … I don't know. Maybe
because I was cut open so many times….” I had to work for a living and
unfortunately hard labor is hard labor…. And then having a disability definitely
didn't help.
Discrepant Cases and Findings
Despite the many underlying similarities, confirmability was evident because there
were also striking counterexamples not anticipated by the research questions. These included
faith healing and chronic pain unexpectedly vanishing and then returning. Ralph said,
I believe in Jesus and my brother Phil. He was a born-again Christian who was a
Baptist minister he laid his hands on me and asked Jesus to take away my pain and
heal me. And I stopped taking all my narcotics except for Celebrex…. And I was able
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to do things I wasn't able to do before…. [Now] I come home and I sit down, eat
dinner, and sit and watch TV and I'm normal. I've been normal now for 10 years.
Rita said,
And then at some point, it [the pain] kind of just disappeared. Now, once in a while, it
will recur, but it's much more mild … actually this winter, it kind of recurred, but it's
much more mild and it doesn't really bother me very much.
Thematic Analysis
A thematic analysis was employed to explore common experiences across interviews.
This thematic analysis used both a hand analysis and MAXQDA (Saillard, 2011). The
themes discovered through this second analysis answered the research questions. These
themes are summarized in Table 3.
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Table 3
Summary of Themes for Research Questions
Theme
Research Question 1
Good pain days.
Difficult pain days.
RQ 1, Subquestion 1a
Multiple Doctors and
Uneven Outcomes
RQ 1, Subquestion 1b
Very Severe Pain

Anxiety and Pain
Biomedical Treatment
with Biopsychosocial
Elements
Research Question 2
Social Identity and
Liminality
Evidence of Resilience

RQ2 Subquestion 2a
Stigma from Medical
Professionals
RQ 2 Subquestion 2b
Stigma from Family
and Friends
Self-stigma

Example Quote
A good day would be I wake up and it feels good and… I'm very motivated…
(Dina)
So, I did go through to the hospital. I was hospitalized for two weeks because I
have jaundice and chronic hepatitis…. (Mada)
But I just feel like they've always said there really was nothing that… they
could do. So, I don't even bother with it anymore. I don't even bother discussing
it. I just figured, what are they going to tell me? Ice and take pills… and I
already know that. (Jean)
It's [when] I have to take something for the pain. I would have to put … cold
and hot compression on my neck. It depends on how bad the pain is. But at
times it's so bad, I mean, I cannot even hear anything. That's how bad the pain
gets. And other times … I just have to do breathing and stretching. And I try to
do a lot of mind over matter. (Ada)
I was a constant, stressed-out mess. And I have subsequently learned that
complicates every physical thing I have .… And I was sad about that … but my
pain has always been worse when I'm discouraged. (Caity)
I was having a lot of pain. I was still trying to … do things that help me like
remain satisfied with my life. Like I was meditating daily and that seemed to
help. I was still doing pretty well in school. I think I actually was very involved
with school because it was a good distraction from my anxiety about like
reinjury and pain. (Peter)
But a lot of times they just said it was not a real thing. It's in my head. Or I was
a hypochondriac. Or, you know, we can't find any physical thing that caused
this pain. So, it's not a real thing …. (Geroge)
One time, a couple of years ago, when I was having that hip issue and I was
going to go horseback riding. And my one relatives … who tends to be
negative, said, “Don't go. Maybe you shouldn't go.” And I said, “No way. I'm
going to go. I don't care. It hurts anyway. I might as well go and have fun.”
Which I did…. I had a blast and it was fine. (Rita)
“Are you visiting your psychiatrist recently?” Because I have a psychiatrist.
“No … I'm just telling you that I'm in pain, and you guys have to do something
about it….” Because I felt like they were taking it in such an easy way. (Mada)
Of course, that hurts because everyone keeps teasing me about I need to go in
bubble wrap and stuff. They don’t understand…. I haven’t done any of this stuff
on purpose. I didn’t have plans to hurt my back in nursing [school]…. (Mary)
I do whatever I have to do for whatever work … because I need to work. And,
like I said…. I'm too young to be treated like an invalid. And I don't want that.
So, I just kind of pretend I'm okay most of the time. (Jean)
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Research Question 1: The Experience of Chronic Pain
The most common theme was managing days when chronic pain was less intense and
days when the chronic pain was more severe. The goal was to find a balance where the
chronic pain was still present, but participants could still function. Participants used various
idiopathic strategies to achieve this goal.
Good Pain Days
These days were sometimes the result of adequate pain management strategies. Other
times, relief appeared to be a matter of luck. Dina said,
A good day would be I wake up and it feels good and … I'm very motivated…. you
just have an outlook where you're ready to go. You're not exhausted…. you just feel
light. In the mornings, [if] you wake up and there's that pain or that constant nagging
discomfort, then you're almost defeated before you start….
Ada said,
A typical day now is studying in the morning. My first few hours in the morning are
always spent studying. I do gym after that. I finish any errands I have after that.
Either I come back to studying or I've been looking for work recently. I started
volunteering teaching, right now, teaching adults.
Rita said,
I'm sitting at the computer working, which I was this morning. So, I took an
Excedrin. I take an Excedrin every day. There's … never a day when I don't take an
Excedrin. Because it does help take the edge off. But when it's really bad, I might
have to take two. Or I might have to lay down if my back is in spasm for a little
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while. And that helps, or to put heat on it. And I put heat on sometimes. Other than
that, there's nothing different. I do the same things, whether I'm in pain or not.
Difficult Pain Days
Sometimes, difficult days resulted from anxiousness, over-doing a task, or meeting
otherwise everyday demands of life. Other times, there was no predicting or explaining days
with more pain. Mada said,
So, I did go through to the hospital. I was hospitalized for two weeks because I have
jaundice and chronic hepatitis…. So, I got out of the hospital and everything was fine.
I lived my life normally again. And then in 2013 … the pain started. And … I had to
go through … six years until 2020, when I had my liver transplant.
Ada said,
When somebody is in pain, it can be difficult … to get doctors that understand you….
[And] then I didn't want to go. I told my mom, I give up on going to doctors…. So …
[it’s] the same way a woman meets the man of her dreams. It was the doctor of my
dreams. He understood exactly what I was talking about.
Research Question 1, Subquestion 1a: Access to Treatment
While the experience of going to the doctor varied by the primary pain strategy used,
many participants spoke of hiding pain from doctors. Also, regardless of pain strategy, pain
management often had multiple doctors, and it sometimes did not improve treatment.
Multiple Doctors and Uneven Outcomes
Even when a participant could find a doctor who would treat their chronic pain, this
often led to numerous referrals and uncertain outcomes. Sally said,

119
It's a local physician. And so, I'm sure that he would order pain medication for me, but
I have not asked for it. He knows what I have. He's gotten all the reports from all the
physicians…. He's a GP, so he's not going to know anything to do with it.
Bill said,
I am probably supposed to get a yearly checkup, at least for the fire department's sake
and haven't gotten one yet. It's a whole time issue. And I'm kind of afraid of what
they will say about my knees. And that [I] might not be able to work anymore. And I
know that I'm very capable of working. I'd just go out and do it. So, I'm a little
concerned what they might say [something] about my knees. I really never got up to
getting a physical done.
Justin said,
[Interviewer, “And how do you feel when you leave the office of a typical doctor
visit? Do you feel like something has happened or you've been helped?”] Not really,
because … they tend to just tell me … [to] take pain meds [OTC] and stuff like that
… Not too much physical activity. And because that's something that I already know
and already do.
Jean said,
I'm not a complainer. You know, I may go in and speak of this or that. But I just feel
like they've always said there really was nothing that … they could do. So, I don't
even bother with it anymore. I don't even bother discussing it. I just figured, what are
they going to tell me? Ice and take pills … and I already know that. So why waste
their time and mine? It's a kind of forgotten thing.
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George said,
So, I went from being seen and cared for very meticulously prior to my transplant and
after my transplant. And then I was put on to a transplant kidney specialist that's not
part of the surgical team…. And I see him for literally five minutes…. “Your blood
test looks great… your meds look fine. Let's get you set up for a rheumatologist.”
Well, I've seen rheumatologists for the last couple of years. And I keep getting the
blood tests. It's not that. So. he can't figure it out because if it's not the kidney
problem, it's not the meds I'm on from the kidneys. He doesn't know what to do for
me. And only knows what to do is point me towards a rheumatologist. [Finally, the
doctor says] “Do you have any questions?” [I replied] “I have joint pain, or I have
this pain … I need to take care of it to see what it is.” And he kind of scratches the
head… “I don't know what to do for you, it's a pain thing. I'm not the pain guy….”
Research Question 1, Subquestion 1b: Experience with Pain Management.
The success of a given management strategy also depended on idiosyncratic factors
plus the severity of the pain. If the chronic pain was too severe, most pain management
strategies failed. All participants reported incidents where there might have been an
improvement in the managing of chronic pain. This outcome might indicate possible
undertreatment, though no participant used that term. The next chapter will address
undertreatment in more detail.
As participants experienced more anxiety, they seemed to experience more pain. All
doctors appeared to use the biomedical model. On their initiative, some participants found
other treatment strategies useful as supplements.
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Very Severe Pain
Severe pain days were often commented upon by all participants. If the pain was too
severe, participants tended to stay home when they could. Dina said,
A bad day? [I] just get my coffee. Sit down. Turn on the news. Maybe just … take
some Tylenol and putter around my house. I feel like doing something, but I don't feel
like doing something. My mind says I do, but my body says no … I'll just sit back
down … and watch … TV … [then] get up and … pace in the house. Like I'm
uneasy or antsy. I'm bored. But you don't know what to do with yourself.
Peter said,
If it were like eight out of ten, it would probably mean that I'm going to have
difficulty getting to the kitchen. I would stay in bed longer. I would probably be just
worrying, at that point, and not really able to … do much about my pain.
Ada said,
Poor pain days is when I tried to go to the gym, and I can't. And if I push myself, I
can only do very, very basics. Maybe just a little bit of walking. It's [when] I have to
take something for the pain. I would have to put … cold and hot compression on my
neck. It depends on how bad the pain is. But at times it's so bad, I mean, I cannot even
hear anything. That's how bad the pain gets. And other times… I just have to do
breathing and stretching. And I try to do a lot of mind over matter.
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Anxiety and Pain
Anxiety reportedly increased pain. For some, decreasing anxiety was a psychological
intervention in pain management. The next chapter will discuss anxiety management and its
implications for pain treatment. Caity said,
I was a constant, stressed-out mess. And I have subsequently learned that complicates
every physical thing I have.… And I was sad about that … but my pain has always
been worse when I'm discouraged. If I feel like somebody is listening to me, and that
there is light, not necessarily at the end of the tunnel, but there's something I can do.
There is some responsibility I can take to make this better … then I can endure it.
Peter said,
Oh … my physical therapist told me. It was a mixture of the nerves, the physical
nerves firing a whole lot when stimulated. And that my pain was also making me
more anxious. And anxiety adds to the perception of my pain. So, it's more like I was
used to feeling pain for so long that like even resting my leg at an angle was enough
to stimulate a pain response…. I was concerned about my anxiety.
Nija said, “But … the one thing I have noticed that stress a lot adds [to] the pain. So that's
one thing I'm sure of. And I was kind of surprised when the doctor told me that.”
Biomedical Treatment with Biopsychosocial Elements
Participants who received medical treatments for chronic pain had doctors who used
the biomedical model. Yet, some participants found elements of the biopsychosocial model
to manage pain. Ada said,
Yesterday, I was in a yoga class and I try to incorporate yoga as much as I can. I try
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to do as much meditation as I can at the house, while I'm at home or outside. Once in
a while, I go on a retreat for a couple of days, just to … regenerate your inner drive,
the mind, the body and all of that. All those have helped.
Peter said,
I was having a lot of pain. I was still trying to … do things that help me like remain
satisfied with my life. Like I was meditating daily and that seemed to help. I was still
doing pretty well in school. I think I actually was very involved with school because
it was a good distraction from my anxiety about like reinjury and pain.
Caity said,
I really am very happy. And so now I'm back hiking and doing yoga and kayaking
when the weather is conducive. And … [I] got rid of the boyfriend that didn't like a
handicapped woman in his life. And I also attribute a lot to counseling because I was
just buckling under the stress. And that was a big help. I did that for maybe two and a
half years in the middle of the back saga.
Research Question 2: Meaning of Stigma
The experience of stigma was also idiosyncratic but had many similarities.
Social Identity and Liminality
Whenever possible, participants avoided talking about their pain with people who
might not understand or judge them. Other times, trusted people provided social supports that
enhanced the ability of the participant to manage pain. Dina said,
[Interviewer: So how do you feel about the fact you have to hide your pain from
people?] I don't know. I guess I never really thought about that. I just don't want to be
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Debbie Downer. So … in the moments that I'm with people … not particularly my
family or sisters, but say my friends, just … being around them and hearing their
goings-on and feeling a part of that … is actually uplifting for me. So … I don't talk
about my pain. If they ask me … I'm just very vague about it. Most of the time … I
want the positive effect of their company.
Bill said,
Frustrating. I grew up in a house where my dad was in the army. My mom was a nurse
and they made light of everything like, “Oh, it's not really that bad….” I've had several
injuries as a kid. So, I … [just] shrug it off …. So, yeah, it's frustrating.
Sally said,
They didn't notice [my pain] and I don't complain about it … I mentioned it a couple
times to some friends, and [now] I just don't bring it up…. It's not a topic of
conversation. Some people occasionally … know I have … pain. They'll ask me
about it. But, normally, it doesn't come up … sometimes my family, like my older
sister, may ask me. “How is it?” And I’ll say, “Well, it's just there. I mean, it's not any
worse, any better.” You just handle it.
Rita said,
I don't think they realize I'm in pain. I said something to my son a couple of weeks
ago. I don't think they realize I'm in pain because I don't talk about it or complain
about it … when it gets really bad, I'll [sometimes] complain about it….
George said,
I'm saying … [that] they're very afraid to do [any medical intervention] … because
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they're not pain specialists…. But a lot of times they just said it was not a real thing.
It's in my head. Or I was a hypochondriac. Or, you know, we can't find any physical
thing that caused this pain. So, it's not a real thing….
Jean said,
Well, just very old, very helpless, very useless, very not contributing. When I was on
disability and then I wasn't working, I felt horrible. Because … I wasn't bringing any
money in…. when I stopped doing the work that I was used to, and wasn't making as
much, I just felt … just so limited. What can I do now? You know, I used to be able
to do anything. And now my options are, I've got to pick and choose whatever. And
I'm not good at that kind of work. The work I'm good at, I can't do now. So, what am
I gonna do? So, kind of scared.
Evidence of Resilience
There was also evidence of resilience in most participants. Resilience was apparent
when participants reframed their pain as an experience where they had functional or
psychological control. This evidence was more noticeable when participants faced with
everyday stressors or unexpected events or changes. Rita said,
One time, a couple of years ago, when I was having that hip issue and I was going to
go horseback riding. And my one relatives … who tends to be negative, said, “Don't
go. Maybe you shouldn't go.” And I said, “No way. I'm going to go. I don't care. It
hurts anyway. I might as well go and have fun.” Which I did…. I had a blast and it
was fine. As a matter of fact, for some reason … doing that horseback riding that day
actually helped. My hip felt better for a couple of days. I don't know if it was just the
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fact of sitting in the saddle.
Mada said,
I'm a person that never actually talks about pain. They [my family] used to feel that
without me saying [it] … And they used to know whenever I'm in pain, [when] I need
to be alone. [Or] I need to speak. They were not [the] kind of people that [say], “Oh,
my God, why are you calling us? Why aren't you answering, blah, blah, blah?” No,
they always were there. They never left my side … And my mother played a very big
role, and all my family did. But my mom was number one.
Sally said,
I've taken ibuprofen. I've taken Excedrin. Those are the two main pain medications.
They don't really affect it. But I think that's more psychological, for me to be able to
take something. But sitting for long periods of time and driving really was the worst.
And I was on the road a lot for the last three years. So that was really the worst time.
And now that I'm back in the office [and] sitting is really doing it to me. I have no
pain at night … sometimes I don't notice it as much as other times. Sometimes it's
really difficult to handle. But … there's nothing you can do about it. So, I just handle
it.
Research Question 2 Subquestion 2a: Stigma Experienced During the Treatment
Process
Stigma from Medical Professionals
All participants reported the experience of stigma in a variety of ways, though not
always from medical professionals. Mada said,
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“Are you visiting your psychiatrist recently?” Because I have a psychiatrist. “No …
I'm just telling you that I'm in pain, and you guys have to do something about it….”
Because I felt like they were taking it in such an easy way.
Justin said, “There is one doctor that I went to and he had, jokingly …said, ‘You might just
be faking it ....’ But … I came there in real pain. I don't need you to joke about it….”
Research Question 2 Subquestion 2b: Stigma From Family, Social Supports, and SelfStigma.
Many participants also expressed being shamed by others, mostly from people they
knew. Even when participants attempted to hide their pain from strangers and other
acquaintances, stigma from family and friends was evident. Sometimes, though, it appeared
unintentional.
Stigma from Family and Friends
Peter said,
I was upset and frustrated with how [my father] expressed his emotions. But he wasn't
making me or forcing me to carry things. I am grateful he stopped when I told them
how I was not comfortable with helping out. He didn't force me to do things. He just
wanted me to do [more] things.
Caity said,
And I have never, ever forgiven my friends, that I hike with. Because they all trooped
off [when I was injured and could not walk]. And there were just … two frail people
[left] who felt sorry for me and just cheered me up. But all my friends just marched
off and then it started to rain. So that was an incredible two hours.
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Mary said, “Of course, that hurts because everyone keeps teasing me about I need to go in
bubble wrap and stuff. They don’t understand…. I haven’t done any of this stuff on purpose.
I didn’t have plans to hurt my back in nursing [school]….” Justin said, “There have been
times during physical activity where I have to take a break because my back hurts. And, you
know, people are rag on me. But nothing serious because they know that I do have back
issues.”
Self-stigma
When describing their chronic pain experience, self-shaming was common. It often
took the form of not wanting to be a burden or be labeled as a complainer. Often these
participants hid their pain whenever possible. Racheal said, “[You are depressed] but you just
push yourself because … there's no one else to do anything. And you just have to take care of
him [her husband] and that's all.”
George said,
Mentally, not good. Yeah, physically, obviously still hurting, but mentally it was very
frustrating. I caused a few ruckuses every now and then. Like I'd go up the chain [of
command]. But I felt, I don't want to use the word helplessness and bad, but it was
helpless…. I can't do anything about it. I just got to trudge on and just deal with it.
But it was to the point where mentally I felt drained. I felt lonely about it. You know,
my wife, she couldn't do anything. She just said, well, let's go see a doc cause she's
not a pain person. She just knows what I was doing every morning. But it felt like this
can't be it. Someone's got to know about this stuff. Because I wasn't the only one….
There's a lot of military men and women and spouses that are going through
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something like this with no answers.
Jean said,
Well ... one day … they'll say, oh, your back's bothering you today, isn't it? And … I
just brush it off. I don't want people feeling sorry for me. And I don't want to be
treated any differently. Especially at my work. I'm not a complainer or anything. I do
whatever I have to do for whatever work … because I need to work. And, like I said
… I'm too young to be treated like an invalid. And I don't want that. So, I just kind of
pretend I'm okay most of the time.
Evidence of Trustworthiness
Credibility
The recommendations of Saldaña (2016) guided the establishment of credibility.
There was prolonged contact with the data. I did four separate analyses: a) the review of the
computer-generated transcripts against their audio recording, b) a structural analysis of the
transcripts to organize the pain stories into chronological narratives, c) a computer analysis of
the transcripts to identify experiences in common; d) a member check using a synopsis of
each pain story to insure accuracy and record any developments, and (e) identification of
counterexamples not anticipated by the research questions.
By including two extra participants in the study than planned, I found evidence of
saturation. The last four interviews reported no new experiences. Also, participants were able
to be grouped according to their primary pain management strategy. Despite any differences,
however, the sequala of the pain processes management of most participants was similar.
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For the member check, each pain story was re-written in the third person. I password
protected member check files and then emailed to each participant with 2-step certification
over the phone to unlock the file. Most participants, however, were unable to open this file.
In a second attempt, I sent printed synopses to each participant prepared using COVID-19
safe protocols. The responses to these synopses included only minor changes that did not
change any themes. Three participants did not respond to the second member check, but the
other 14 members usually stated that the synopses accurately described their chronic pain
experience.
Transferability
The commonality of the experiences of the participants despite having different
diagnoses, ages, pain management strategies, and circumstances was evidence of
transferability. For instance, most participants had to start each day while still in bed. During
this time, they planned how to approach the expected demands of the day, plus how they
might pace themselves to manage their pain and still achieve their daily goals.
Dependability
In my proposal, there were concerns that the contentious history of caring for my wife
might have created biases for reaching conclusions. I followed Roulston and Shelton (2015)
six suggestions for managing bias in a qualitative analysis, which included: (a)
acknowledging interests of the researcher and how it might influence data analysis, (b)
reflecting on how closely the data stayed within the range of the research questions, (c)
examining how the data elicited differences from researcher expectations, (d) revealing what
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data surprised the researcher, and (e) explaining how the conceptualizations of the researcher
changed the throughout the study.
All participants met the following criteria: (a) were 18-years-old or more; (b) were
able to express the details of their condition; (c) were able to consent to the study; (d)
responded to a formal invitation to participate from a referral source or who approached me
and volunteered; (e) had experienced their pain for three months or longer; and (f)
experienced persistent, chronic pain daily or regularly. These criteria ensured that the
participant had adequate experience with current medical treatments. It also confirmed that
the participants had experiences with ongoing pain limitations.
Participants were not limited to those unhappy with either their doctor or their
treatment regimen. Neither were those participants excluded. There was a purposeful attempt
to solicit participants from minority groups. Monsivais (2013) stated that bias was evident in
chronic pain management. He questioned whether minorities had increased difficulty seeking
treatment for chronic pain.
Confirmability
The reflexivity evident in the multiple exchanges between the researcher and all
participants indicated confirmability. In these exchanges, participants sometimes reflected on
how their participation in the study changed their lives. As Rita put it,
[K]nowing I was going to be doing this interview about pain, made me realize … I
get cranky because … I'm so tired. All I want to do is lay down because my neck is
hurting, or my back is hurting. And … if the kids … need things … I want to be able
to be there for them without getting cranky about it.
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Evidence of Ethical Procedures
All data were kept confidential. Identifying information was stripped from all
narratives. I was not in a power relationship with any possible participant because I was
retired from full-time employment. Some of the participants who responded to the invitation
came from family, friends, and acquaintances in persistent pain. All participants responded to
a referral source request or approached me and volunteered. I kept interview data
confidential, even from other acquaintances and family members, unless I had written
permission. Each narrative had an identifying number and a pseudonym. I stored the personal
information on my home computer or in a locked box file for paper records.
Summary and Transition
This study interviewed 17 participants regarding their experience of chronic pain. All
participants interviewed were able to describe their experience with pain and their access to
treatment. The most common themes revolved around managing pain with different
strategies daily to retain/aspire to a quality of life worth living. Most participants experienced
stigma in various forms. Stigma came from people they knew, mostly medical professionals,
family, and friends.
For participants not using addictive drugs, a brief discussion on addiction
occasionally occurred during medical meetings. For participants who used opioids, however,
these meetings were challenging and often produced anxiety. These challenges remained
ongoing.
Common themes were identified through the structure of the interviews and how
participants answered the research questions. The evidence for these themes came from exact
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quotations. The themes showed that pain management was idiosyncratic to the individual,
though there were many similar pain experiences. The data demonstrated trustworthiness.
There were both common themes and unexpected experiences that were not anticipated by
the research questions. The data achieved saturation because the last four participants
interviewed added no new experiences to the data. Reflexivity was evident because of the
multiple exchanges between the researcher and all participants. Finally, there was evidence
of transferability because all participants had no difficulty answering the questions and
creating a narrative with a beginning, middle, and end.
Chapter 5 presents how the study’s results compare to existing research and how the
results might point to a possible synthesis in pain conceptualization. I describe how these
results point to the need for psychological interventions to help people in pain, regardless of
severity or diagnosis. This chapter also discusses other implications of the findings, and the
need for future research. The conclusion discusses study’s potential to impact social change.
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Chapter 5: Discussion, Conclusions, and Recommendations
In this qualitative study I explored the complex nature of chronic pain through the
narratives of adults who experienced it for 3 months or more. The primary focus was to
investigate whether exploring the voice of pain sufferers would deepen the understanding of
the experience of chronic pain and improve treatment (see Eaves, 2015; Rajagopal, 2011;
Tsao, 2012).
Key Findings
I conducted a narrative analysis, and 17 participants were interviewed. The results
were generated from both structural and thematic analyses. The structural analysis revealed
distinct groups (pain-free; nonopioids to manage pain; opioids to manage pain), and the
thematic analysis identified 12 themes to describe the nature of their pain experience and
how they experienced stigma both in treatment and in their social interactions with family,
friends, and community. These findings supported the need for a biopsychosocial approach to
chronic pain treatment. The results also seem to align with the approach that chronic pain
treatment is better addressed as a separate disease rather than a symptom of an underlying
problem. Finally, the results showed that insights can arise from the narratives of people
experiencing chronic pain.


There were dramatic experiential differences among participants who used
opioids or other potentially addictive medications to manage their pain. Yet, there
were also striking similarities in the experiences of all participants with chronic
pain.
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All participants discussed needing to balance the ebb and flow of chronic pain.
Their goal was to find a balance where their chronic pain was still present, but the
participants could function. Participants sometimes received medical help in
developing their pain management strategies. More often, the participants
developed unique pain management strategies with only occasional guidance
from medical professionals. The resulting pain strategies were often idiosyncratic.



All participants responded affirmatively to the questions about good days and bad
days, but the reasons behind their comments varied considerably.



Most participants reported that anxiety increased their pain.



Most participants had a story of experiencing stigma when doctors dismissed their
pain or experienced stigma from medical professionals. Other sources of stigma
included family, friends, and casually encountered strangers. Participants also
reported feeling self-ashamed about their pain and their attempts to participate in
everyday life.



There were instances of discrepant cases, where two of the 17 participants were
pain-free at the time of the interview. In one case, this was due to extensive
physical therapy. In the second example, pain relief came through faith healing.
Interpretation of the Findings

The results reflected many findings in the research on chronic pain. Overall, the wide
variety of treatments may reflect the lack of consensus on the definition of chronic pain and
treatment found in the pain research (Bourke, 2014; Wailoo, 2004). A comprehensive listing
of how participant reports matched those found in existing research is in Appendix E.
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Some of the experiences of participants seemed to fit into three categories: (a) painfree participants, (b) those who did not use addictive medications to manage pain, and (c)
participants who used potentially addictive medicines regularly. Yet, all groups had
numerous experiences in common. For example, reaching out to their physicians and medical
professionals often resulted in recommendations for medications, surgery, or physical
therapy (Peppin et al., 2015). As described earlier in Chapter 2, the biomedical model has a
minimal repertoire for treating chronic pain. Participants reported feeling frustrated and
sometimes despondent (Jurecic, 2012). For example, when an on-call doctor suggested Ben
reduce his medication because he had been on it too long, Ben responded, “You know I'm a
laborer. I've worked hard all my life. I still have one leg longer than the other. And I'm in
constant pain.” Nonetheless, the doctor continued to dismiss his pain.
Most participants had little more than a casual discussion with doctors regarding
addiction. The interaction was more confrontational if participants took a potentially
addictive drug, or their doctor concluded they wanted one. Commonly it was opioids, but it
was also benzodiazepines or other kinds of anxiolytics. Such participants felt they had to
prove a negative (i.e., demonstrate that they were not abusing medications). After they found
a doctor willing to prescribe their medications, there were ongoing concerns that a new
doctor would refuse to prescribe the potentially addictive drug. Yet, no participant who used
potentially addictive medicines to control pain appeared to be abusing those medications.
George reported, “But a lot of times they [the doctors] just said it was not a real thing … I
was a hypochondriac. Or, you know, we can't find any physical thing that caused this pain.”
These findings were consistent with published literature showing that using addictive drugs
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did not always lead to addiction, and opioids can be useful in managing long-term pain
(Chapman et al., 2010; Gourlay et al., 2005; Heit, 2001; Kumar et al., 2015; Ljungvall et al.,
2020; Rajagopal, 2011; Vowles et al., 2015; Wilbers, 2015)
Balancing the Ebb and Flow of Chronic Pain
While every participant reported experiencing an ebb and flow of chronic pain, they
reported various approaches to finding a balance. The data showed that nearly all 17
participants felt that their daily activities influenced their chronic pain (see Appendix E).
OTC treatments were popular supplemental pain management approaches and were often
used in combination with other therapies. Also, OTC medications were preferred and used
more frequently than prescribed medicines (Eaves, 2015). This preference could be because
opioids were not available to most participants. Yet, 14 of the 17 participants felt that using
opioids would lead to addiction and said they would refuse those medications if offered
(Bruehl et al., 2015).
Biopsychosocial strategies (Engel, 1980) were used as supplemental pain
management strategies and included: (a) limiting or modifying daily tasks (Jensen and Turk,
2014); (b) regular exercise (Slade et al., 2009); and (c) cognitive-behavioral techniques
including mindfulness, meditation, or psychological counseling (Sheedy et al., 2017;
Sturgeon & Zautra, 2016). Often, the participants developed their own pain management
strategies with only occasional guidance from medical professionals. Most participants
believed that their daily activities influenced their pain experience (Rivera et al., 2015).
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Anxiety and Pain
Increased pain seemed most significant when anxiety negatively affected social
identity (Major et al., 1998). It was particularly evident when participants reported
embarrassment at not maintaining their previous level of functioning. As they lost friends,
jobs, and spouses, their self-esteem suffered. When perceptions became internalized,
participants often seemed to blame themselves for their predicament (Monsivais, 2013). So,
from a psychological point of view, finding a way to prevent self-shaming and reduce
anxiety, in general, seemed to be a point of possible psychological intervention to improve
pain management.
Over time, anxiety had a cumulative effect on pain (Ljungvall et al., 2020; Palmeri,
2016; Wong et al., 2015). As this cycle progressed, chronic pain sometimes increased beyond
what medical professionals would expect (Kaufman & Baucom, 2014). Anxiety was often
evident in the reports of pain by participants. These reports could explain the findings that
doctors often felt that patients exaggerate their chronic pain feelings (Staton et al., 2007).
Figure 2 shows the escalating nature of anxiety and pain over time, as expressed in the
participants’ narratives.
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Figure 2
The Relationship between Anxiety and Pain Severity

Note. This figure graphically illustrates the cumulative effect of anxiety, pain and suffering.
As chronic pain continues, it creates anxiety, and this increased overall suffering. If left
unattended, anxiety can increase overall suffering, leading to further interventions for
adequate pain management.
Undertreatment Was Evident
All participants struggled with pain management. In the literature, this is identified as
undertreatment, and it was a frequent topic in the peer-reviewed literature on pain (Abdallah
& Geha, 2017; Arnstein & Herr, 2017; Björk et al., 2016; Breivik et al., 2006; Clauw et al.,
2019; de C Williams, 2016; Hiller & Suominen, 2017; Kehlet et al., 2006; Nordmann et al.,
2017; Paydar et al., 2016; Platts-Mills et al., 2016; Peppin et al., 2015; Rajagopal, 2011;
Trentin et al., 2001; Wailoo, 2014). Ten participants in this study explored biopsychosocial
techniques for pain management (e.g., yoga, exercise, meditation, diet), yet they reported
little support from their treating professionals other than agreeing with the effort. Other
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participants did not report the need for biopsychosocial strategies (see Gourlay & Heit,
2009). Nonetheless, their regular reports of severe pain suggested whether a more
comprehensive, physician-directed approach might improve treatment outcomes. This
study’s findings concurred with the literature in that many of those participants would refuse
stronger, potentially addictive medications even if offered (Bruehl et al., 2015). However,
three participants found opioids and other addictive drugs essential to their functioning (see
Ljungvall et al., 2020; Rajagopal, 2011).
Often, when pain could not be relieved, the participant stated they would "push
through the pain." The success of this strategy depended on pain severity. If the pain was too
severe, this strategy usually failed. However, almost as often, many participants responded
with resilience and an openness to better pain management. In this study they reported: (a)
ignoring the pain and continuing with a planned activity, (b) intentionally lowering their
anxiety through reframing; (c) seeking counseling; (d) reaching out to family and friends for
support; (e) changing their physical environment; (f) testing whether they could expand their
exercise regime even when it might increase their pain; (g) warning supervisors of their
limitations and asking for an accommodation; (h) challenging any pain medication to see if
they needed it; (i) getting training and taking college courses to find employment more
compatible with their limitations; (j) taking time to engage in favorite activities; (k)
increasing exercise even if it risked short term pain; (l) confronting medical professionals
when they exhibited bias or stigma; (m) fighting for the right to continue employment after
their chronic pain became an issue; and (n) exploring cognitive-behavioral therapy and
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mindfulness strategies (see Ambrose & Golightly, 2015; McCracken,1998; Rupp et al., 2004;
Sheedy et al., 2017; Sturgeon & Zautra, 2016; Wong et al., 2015).
Four participants hoped their next medical intervention would stop their pain forever.
The rest of the participants accepted that they might be in pain for the rest of their lives.
Those participants seemed less hopeful about their future and more resigned to their fate.
The Experience of Stigma
Most participants had a story where a doctor dismissed their pain (Coleman, 2011;
Katz & Rosenbloom, 2015; Macciocchi & Eaton, 1995; Newton et al., 2013; Roese & Olson,
1996; Waugh et al., 2014). While seeking medical treatment, the reports of stigma did not
seem to be limited by gender, age group, or geographic location. Other than stigma from
medical professionals, many participants expressed being shamed by others, mostly from
people they knew, including self-shaming (Abdallah & Geha, 2017; Armentor, 2017; Hiller
& Suominen, 2017; Monsivais, 2013; Waugh et al., 2014; Werner et al., 2004; Wilber, 2015).
Despite these experiences, 8 of the 17 participants expressed faith in their doctor to manage
their pain. The other nine participants felt that their doctor was no longer helpful or was
never beneficial in their pain management. Yet, these participants still sought medical
intervention for other medical problems.
Theoretical Analysis of Findings
The methods and analysis were guided by social identity theory, attribution theory,
and the construct of stigma. The results of the study also revealed the relevance of barriers to
treatment, and the idiosyncratic use of biopsychosocial approaches to managing pain.
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In social identity theory, the experience of liminality (as described in Chapter 2), was
defined as the consequences associated with changes in a person’s social role that resulted in
feelings of being in limbo. Expressions of hopelessness (e.g., regret at losing a vital
employment role or internalizing experienced stigma), were examples of liminality (Jackson,
2005). In addition, hiding their real feeling of pain to protect a former social role could be
considered a part of the liminality experience (Monsivais, 2013). Other statements included:
a) feelings of helpless; b) being frustrated with the limitations of pain; c) feeling left out of
recreational and routine activities; d) hiding feelings of pain from friends to prevent pity; e)
being fearful of the future because of their chronic pain; f) saying few people understood or
empathized with their pain complaints; g) being worried about limited employment
opportunities; and h) expressing fears of being labeled an addict (Cacioppo et al., 2015;
Carlsen & Nyborg, 2017; Hawkley & Capitanio, 2015; Major et al., 1998; Monsivais, 2013;
Oliveira et al., 2015; Sturgeon & Zautra. 2016) The uncertainty produced by stigma and
chronic pain exemplifies how people move through the liminal state in negotiating their
social identity and seeking help (Dauphin et al., 2020).
Attribution theory was useful in understanding why patients and doctors disagreed on
the severity and causes of persistent pain (Carlsen & Nyborg, 2017; Katz & Rosenbloom,
2015; Newton et al., 2013). As described in Chapter 2, attribution theory is useful for
understanding the circumstances under which people attribute a cause to self or something
else. In this research, patients described how doctors refused to attribute their pain experience
to a condition or symptom when the sources of the pain could not be detected by biomedical
means. Doctors were more inclined to attribute the reports of pain to exaggeration, personal
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weakness, or seeking addictive drugs. Attribution theory also explains why participants hid
their pain from doctors and medical professionals (Jackson, 2005; Monsivais, 2013; Waugh
et al., 2014; Werner et al., 2004; Wilbers, 2015).
The construct of stigma was explored from multiple perspectives. The sources of
stigma were varied and reflected the sources of stigma found in the research (Bell & Salmon,
2009). Participants report the experience of stigma from: (a) doctors (e.g., that they were
complainers or seeking more drugs); (b) from family and friends (being ostracized from
family and friends for “not keeping up” or being limited from activities by pain); and (c) selfstigma (feelings of being punished, feeling hopeless and unworthy of support, feeling
responsible for their pain). These examples of stigma are consistent with other studies
(Dauphin et al., 2020; Jackson, 2005; Major et al., 1998; Werner et al., 2004).
Emergent Ecological Model of the Barriers to Pain Relief
A surprising and consistent set of experiences that were described by participants
were the barriers encountered while accessing treatment and support. These barriers
included: (a) governmental and legal barriers to pain relief such as laws that prevent doctors
from making an independent decision on pain treatment; (b) institutional and administrative
policies that interfered with doctors and patients relationships, including a lack of insurance
reimbursement when pain relief programs were available; (c) interpersonal barriers including
biases encountered during the ordinary course of social interactions with friends and families;
and (d) internal barriers including personal values, self-shaming, and the inability to accept
the limitations imposed on the participants by their chronic pain (Littlejohn & Guymer,
2019). This emergent model is conceptualized in Figure 3.

144
Figure 3
The Levels of Bias that Create Stigma and Other Barriers to Pain Relief

Note. Adapted from “Five Mind-Blowing Realities About Race (That White People May Not
Know).” By M. Lietz, 2018, August 27, Emmanuel Gospel Center,
https://www.egc.org/blog-2/2018/5/23/3u8bsicsasybnnco5bea7vculw6m9s
The Need for a Biopsychosocial Approach to Pain Management
On the biomedical side, Carlsen and Nyborg (2017) said that these barriers often
force doctors into restricting access and treatment, information, and alternative services
outside of the biomedical model. The authors also noted that the gatekeeper's role often
conflicted with the ability to be a healer and sometimes left their patients angry and confused.
Furthermore, Carlsen and Nyborg suggested that these barriers seemed to be more a matter of
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biomedical tradition than evidenced-based practices more consistent with a biopsychosocial
model. It was noted that in this study, while all participants received standard biomedical
treatment when they sought help, many tried to improve on that treatment by searching out
biopsychosocial therapies on their own. The result was a panoply of different outcomes and
idiosyncratic solutions to the management of their chronic pain.
Limitations of the Study
This study provided a snapshot of the experience of chronic pain for participants who
were in chronic pain for three months or more. Credibility was established using two kinds of
data analyses, member checks, and identification of discrepant cases. There was also
evidence of saturation because the last four interviews did not contain any reports of new
experiences.
Efforts to enhance transferability allowed readers and future researchers to understand
and use the results to do further research (Shenton, 2004). Methodological details of data
collection and analysis followed well respected qualitative procedures (Riesman, 2009).
Dependability was evident because my interests and potential biases were stated. The
data stayed within the range of the research questions. Participants met all selection criteria.
These criteria ensured that the participant had adequate experience with current medical
treatments and experiences with ongoing pain limitations. Participants were not limited to
those unhappy with either their doctor or their treatment regimen. There was no attempt to
determine what would happen to these individuals over time.
Confirmability was evident in the reflexivity due to the multiple exchanges between
the researcher and all participants. In these exchanges, participants sometimes reflected on
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how their participation in the study changed their lives. My analysis did not differentiate the
person who is abusing an addictive medication from those who require addictive medicines
to control their pain.
Recommendations
Evaluating the sequelae and effectiveness of non-pharmacological chronic pain
treatments presents several problems (Clauw, 2019). Such future studies would be especially
complicated if they relied solely on evidence from randomized controlled trials. Shadish
(2011) stated the concerns with RCT studies when evaluating observational data include: (a)
ethical considerations of waitlists and no-treatment controls, (b) the divergent outcomes of
subjects who have varying diagnoses and differing levels of pain severity, (c) the lack of
consistency in the treatment strategies used with observational data, (d) the lack of consensus
on desired outcomes and the inability to measure those outcomes objectively, and (f) the
difficulty of controlling research bias.
There is also limited value to relying on solely qualitative studies on the chronic pain
experience to compare any pain management method of effectiveness. Noyes et al. (2017)
proposed qualitative evidence synthesis as a supplement to deciding the comparative value of
any pain management intervention. However, the authors further suggested that this method
may not be adequate to make such a decision without using a quantitative approach.
Instead of relying on RCT studies and the limitations of qualitative meta-analysis for
evidence of chronic pain effectiveness, future researchers could use propensity scores. Guo
and Fraser (2014) stated that propensity scores are a second-best choice when RCT trials are
neither ethical nor feasible. This lack of feasibility is often the case with observational data.
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Due to the lack of objective measures in determining pain, the idiosyncratic nature of chronic
pain strategies, the varying diagnoses of pain sources, and the likelihood of bias from
multiple sources, propensity scores may prove a better research strategy (Devilly &
McFarlane, 2009). There is considerable research on chronic pain using this kind of analysis
(e.g., Teh et al., 2010).
As previously mentioned, this study was a snapshot of the experience of chronic pain
to date. Of the participants interviewed, 15 still needed to manage their pain daily. What
happens to these individuals over time? How effective is their treatment? What are the
sequelae of the experience of pain management?
As previously mentioned, one way to study the sequelae of chronic pain management
is to use propensity scores. It statistically divides subjects into groups and is considered the
best second choice when RTC designs are not feasible. Such a method can use data readily
available from anonymous quantitative medical records or other sources. It can also employ
Quality of Life measures and other accepted measures of pain's known comorbid measures.
Such scales may result in a more useful measure of pain severity. While any given scale may
not be a fully effective method of measuring pain, multiple measures might be more helpful.
Future researchers can use a mixed methods design to combine a qualitative evidence
synthesis with quantitative data. Such research might provide us with insight into the
usefulness of non-medical strategies for improved pain management, including online
education, support groups, and cognitive-behavioral therapy or other kinds of
psychoanalysis.
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Implications
In addition to more research, effective change requires further training not usually
provided to medical professionals. Medical policymakers and legislators are encouraged to
investigate how the War on Drugs harmed the doctor/patient relationships without effectively
addressing the opioid epidemic. If protocols to treat pain and addiction become more humane
and used addictive medications when necessary, it may provide a better alternative to
refusing medicines in chronic pain patients. The problem of drug addiction has increased
despite laws trying to control the medical use of these medications. The four decades of
failure using the criminal justice system and subverting the doctor/patient relationship
requires exploring other approaches that may have better results. (Maté, 2008)
Another policy recommendation is to explore how harm management strategies might
help treat both conditions when people are in chronic pain and abusing addictive medications
(Gourlay et al., 2005). When addictive pain medications are necessary to manage persistent
pain, harm reduction programs are another option to treat drug misuse and addiction (Ivsins,
2019; Maté, 2008).
There is ample evidence in the data that cognitive behavior therapy, particularly
contextual behavior therapy, helps to manage pain (Sturgeon & Zautra, 2016; Sheedy et al.,
2017). Sirois and Wood (2017).stated that positive psychology health improved physical pain
management. The authors also stated that these capabilities are underutilized in the treatment
of chronic pain. Treede et al. (2019) recommended changes on improving chronic pain
diagnosis. The author speculated that utilizing new ICD codes might encourage
reimbursement for psychological therapy.
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While the efforts to provide new diagnostic codes for chronic pain are welcome, they
are not necessary for insurance reimbursement, and are not widely accepted. As a possible
alternative, the DSM-5 (2013) has redefined Somatic Symptom Disorders. It now includes
Psychological Factors Affecting Other Medical Conditions (316, F54). This diagnosis would
allow insurance reimbursement for the mental health treatment of the psychological effects of
chronic pain. Helping people cope with the impact of psychological suffering is the primary
focus of psychologists and other mental health therapists.
Conclusion
This study supports the research that inadequate pain treatment springs from several
sources and include: (a) lack of physician training; particularly in the psychological effects of
pain; (b) treatment models that focused on procedures and symptoms rather than other
comorbid factors (i.e., the biomedical model); (c) lack of reimbursement from insurance
companies for biopsychosocial treatments of pain; and (d) fears of addiction from pain
medications whose proper use is not fully understood. Outside of the doctor/patient
relationships, other factors that influence the adequate treatment of pain were biases that
include: (a) pressures from government regulations and professional organizations; (b) social
stigmatization of pain patients; (c) systemic bias in the medical research and practice; and (d)
prejudices that are internalized and promote hopelessness in patients with chronic pain.
This study also shows that when medical professionals confine their treatment to the
biomedical model, people who suffer from chronic pain will seek out biopsychosocial pain
treatments on their own, resulting in idiopathic therapies and outcomes. The study also
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supported using opioids and other addictive medications long-term as safe for some people,
as some research suggested.
Finally, this study suggests that the regular inclusion of psychological and other
adjunctive therapies for treating chronic pain might address the lack of consensus on chronic
pain treatment. The tools for such inclusion, including how one might obtain insurance
reimbursement, already exist. However, further study on the sequela of chronic pain
treatment may be necessary to win wider acceptance. These results support the Joint
Commission's goal to address the prevalent undertreatment of chronic pain in all clinical
settings.
Too often, doctors who want to be healers must take the role of gatekeeper. They
must defend a system where their treatment decisions are restricted. They must maintain
patient trust and still explain why their patients must endure pain that too often is
unnecessary. They must face chronic pain management's complexity and overcome the
psychological effects of stigma in their patients and their own implicit biases. In the primary
care office, where most long-term treatment of chronic pain occurs, they must perform this
difficult task in the time allotted by their practice requirements. A biopsychosocial model's
necessary treatment may be asking too much of the current medical system as it exists. More
research will be needed to win acceptance of the benefits of biopsychosocial treatment. These
benefits include reducing the costs of unrelieved pain, encouraging doctors to be healers
instead of gatekeepers, and encouraging more patient-centered pain treatments. The medical
community and greater society can rehumanize pain management and promote the right to
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better pain management as fundamental to the care and well-being of those who suffer from
chronic pain.
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Appendix A: Referral Packet
Hello,
Thank you for considering participation in my study on chronic pain. You were
given this invitation because one of the people who agreed to help me find participants felt
that you might be a good person to interview. What I hope to hear is your pain story, from
beginning to present, in your own words. After that, I will compare what you said to what
others told me. I expect to interview 15 people and to look for similarities or differences.
Anything said to me will be kept confidential, even from the person who gave you the
invitation.
The reason this invitation did not come directly from me is because my thesis
committee felt that my experience with caring from my wife’s chronic pain might negatively
influence my choice of participants. By putting another person between me and my
participant recruitment, they believe it would add trustworthiness to the study. This is also
why we will conduct this interview by telephone, by appointment, through United
Conferencing, a computer conferencing organization. This organization will record the call,
transcribe what was said, and send the results to me. This organization agreed to keep your
confidentiality. The results will be stored in locked file on my computer. All recordings will
be given a number and any identifying information will be stripped from the narration.
If you wish to participate, contact me in any of ways listed below. Also, read the
consent form and, if you agree and understand it, sign it. Then send if back in the pre-paid
envelope provided. Alternatively, if you have a email signature, I will send you a computer
version.
Thank you for considering participation.
Matthew Vittucci, MS, ABD
PhD Candidate Walden University
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CONSENT FORM
You are invited to take part in a research study on what it is like to be in chronic pain. This is
because you identified yourself as a person in chronic pain for 3 months or more. This form is part of
a process called “informed consent” to allow you to understand this study before deciding whether to
take part.
This study is being conducted by Mathew Vittucci, a doctoral student in the clinical
psychology program at Walden University. You might already know the researcher in another role,
but this study is separate from that role.
Background Information:
The purpose of this study is to compare the experiences of different people in chronic pain without
judgement. It is hoped that the study will reveal experiences people with pain have in common. I am
looking for how people describe their pain, what they tried to relieve their pain, and how chronic pain
affected their well-being. It has been reported in research that people in chronic pain feel that telling
their pain story without judgement has helped them better cope with their pain.
Procedures:
If you agree to be in this study:
 You will be asked to tell your pain story, in a face-to-face interview, from its start until now.
 Your words will be recorded by an audio recorder and transcribed into a word processing file.
All identifying information will be stripped from this file and it will be given a unique
number.
 This interview should take 60-90 minutes and will be done in an area that is private and
where you feel comfortable.
 In a second face-to-face interview, you will be able to see the transcript of your story. You
can make corrections, add more information, or even decide the you no longer want to be part
of the study. You can also talk about any feelings resulting from being in the study. I may
also ask for any background information that will be kept out of the transcript and used for
anonymous participant profiles (gender, age group, ethnicity, social relations, etc.). Again,
identifying information will be kept strictly confidential.
 If necessary, a third session may be needed to add any new information, make changes you
feel are necessary, or add to any further experiences that occurred after participating in the
first two sessions. This information may be done by phone, computer, or in a third face-toface interview, depending on your preference.
Here are some possible sample questions. They will only be used as prompts. Your pain story
may be told as you see fit:
 In your own words, tell me your pain story. When did it begin?
 Describe for me a typical day with your chronic pain?
 Did it affect your employment or your employment goals?
 How did your friends and family respond to your pain?
 Let’s discuss your relationships with doctors.
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Voluntary Nature of the Study:
This study is voluntary. You are free to accept or turn down the invitation. No one will treat you
differently if you decide not to be in the study. If you decide to be in the study now, you can still
change your mind later. You may stop at any time.
Risks and Benefits of Being in the Study:
This type of study involves some risk due to minor discomforts because the feelings discussed are
emotional and private. If you choose to share a sensitive topic (i.e., that could trigger emotional
distress, depression, etc.), and need more help, I provide contact information for further support.
Being in this study should not pose a risk to your safety or wellbeing. It is not intended to be a
replacement for regular counseling or doctor visits. Yet, as stated above, may people find that telling
their pain story without judgement, in their own words, helps them understand their experience more
completely. Often, they are better able to describe it to doctors, family, friends, and acquaintances. In
addition, it sometimes helps them identify ways to better cope with their pain.
Payment:
There is no payment for participation. You may keep, however, a copy of your pain story as
transcribed. A summary of the results will also be mailed to you if you complete the study
successfully.
Privacy:
Reports coming out of this study will not share your identifying information. I will not use your
personal information for any purpose outside of this research project. Your transcribed story will be
kept secure by an identifying number in separate files. Identifying information will be kept in another
file with a security code to prevent unauthorized access. Data will be kept for a period of at least 5
years, as required by the university.
Contacts and Questions:
You may ask any questions you have now. Or, if you have questions later, you may contact me via
email.. If you want to talk privately about your rights as a participant, you can call the Research
Participant Advocate at my university at 612-312-1210. Walden University’s approval number for
this study is 2019.04.19 and it expires on 07-2034-5.
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Obtaining Your Consent
If you feel you understand the study well enough to decide about it, please indicate your consent by
signing below.
Printed Name of Participant
Date of consent
Participant’s Signature
Researcher’s Signature
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Contact Information
In the course of this study, I may have to contact you for several possible reason.
This information will be kept in a place that is separate from your Pain Story. It will be
destroyed after the study is completed and you have been informed of the results. A phone
number or email is preferred. Please fill this out and send it in with your Consent Form.
Name_______________________________________
Address_______________________________________
Phone __________________________________(optional)
Email ___________________________________(optional)
Best way to contact _________________________________
Best time to contact ____________________________________
Thank you.
Matt Vittucci

Just fill out this form and sign the consent form. Then send
this page and the last page of the consent form in the SASE.
Keep the numbers for the Conference Center handy for the
interview. If you have any questions, feel free to call me at
607-287-2084.
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Appendix B: Script for the Interview
As we already discussed, the purpose of this study is to explore, in your own words,
your pain story. As a reminder, everything you tell me will be kept confidential unless you
tell me something that would be an imminent danger to you or others. I am recording this
with an audio recorder to make sure I do not miss anything you said. This recording will be
kept confidential, and your real name will not be associated with this recording or any other
document except your informed consent form. Do you understand what I just said? Do you
agree?
1. In your own words, tell me your pain story. When did it begin?
2. What was your life like before your chronic pain began? Can you describe for me
a typical, ordinary day?
3. Describe for me a typical day with your chronic pain?
4. Tell me about your course of treatment. When did you first go to a doctor? What
was suggested? How did you feel about those suggestions?
5. Then what happened? Was there a turning point, getting much better or much
worse, in the management of your pain? Or has your pain been consistent since it
began.
a. Were there activities you did more frequently or less frequently?
b. How did it affect your employment or your employment goals?
c. How did your friends and family respond to your pain?
d.

What was said?
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e. How did that make you feel?
6. What is your day like when the pain is well managed? Describe a typical day of
good pain management?
7. What is your day like when the pain is poorly managed? Describe a typical day of
poor pain management?
8. Let’s discuss your relationships with doctors. Tell me about your relationship the
current doctor who prescribes (or would prescribe) your pain medications.
9. What happens now during a typical doctor visit?
10. How do you feel when you left that office?
11. How does that doctor assess your pain?
12. How does that doctor manage your meds?
13. What was said?
14. How did that make you feel?
15. Describe for me what happened during your worst doctor visit.
16. How did you feel when you left that office?
17. How did that doctor assess your pain?
18. How did that doctor manage your medications?
19. What was said?
20. How did that make you feel?
21. What happened during your best doctor visit? How did you feel when you left that
office?
22. How did you feel when you left that office?

199
23. How did that doctor assess your pain?
24. How did that doctor manage your meds?
25. What was said?
26. How did that make you feel?
27. Have you ever had a conversation with any of your doctors about addiction?
28. What was said?
29. How did you feel about the conversation?
30. How did it affect your treatment?
31. Is there anything else you’d like to tell me about your pain story or your
experience of pain in general?
32. Do you know anyone else who might be interested in telling me their pain story?
33. Demographics: Gender _______ Age range______
Diagnosis of pain condition: _____________________________________
Medications used: ______________________________________________
City/Region: _____________
Length of time in chronic pain: ______________
Referral: _______________________________________________
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Appendix C: Coding Scheme
No notes were taken during the interview. Instead, raw data was captured solely by
use of an audio recorder. The recording was transcribed into a Word file only by me. These
transcriptions were checked for accuracy and stripped of any identifying information
unintentionally recorded. The first analysis was a structural analysis and was done by hand
coding. The second and subsequent coding reviews were done with the help of MAXQDA, a
qualitative computer program (Saillard, (2011). As stated above, the coding scheme looked
for: a) similarities; (b) differences; (c) frequency; (e) correspondence; and (f) causation
(Saldaña, 2016). The resulting data from the second and third analyses related to the research
questions in the form of themes. Since there were discrepant and unexpected results, and the
last four interviews contained no new experiences, saturation was reached, and no additional
participants were added.
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Appendix D: Permission to Reprint
The clinical application of the biopsychosocial model
Author: Engel, George L.
Publication: Journal of Medicine and Philosophy
Publisher: Oxford University Press
Date: 1981-01-01
Copyright © 1981, Oxford University Press
Order Completed
Thank you for your order.
This Agreement between Matthew Vittucci ("You") and Oxford University Press ("Oxford
University Press") consists of your license details and the terms and conditions provided by
Oxford University Press and Copyright Clearance Center.
License Number 5098891207854 Printable Details
License date Jun 30, 2021
Licensed Content
Licensed Content
Publisher: Oxford University Press
Licensed Content Publication: Journal of Medicine and Philosophy
Licensed Content
Title: The Clinical Application of then Biopsychosocial Model
Licensed Content
Author: Engel, George L.
Licensed Content
Date: Jan 1, 1981
Licensed Content: Volume 6
Licensed Content: Issue 2
Order Details
Type of Use Thesis/Dissertation
Requestor type: Author of this OUP content
Format: Print and electronic
Portion Figure/table
Number of figures/tables: 1
About Your Work
Title: Narratives of chronic pain after treatment in adult patients
Institution name: Walden University
Expected presentation date: Jul 2021
Additional Data Portions: Figure 1, Hierarchy of Natural: Systems page 537
6/30/2021 Rightslink® by Copyright Clearance Center

202

Ra
lp h
Pe
ter

Appendix E: Participant Topics Found in Research
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Research
Question
1

Under treatment/
pseudoaddiction

Citations
Abdallah & Geha, 2017; Arnstein & Herr, 2017; Apkarian
et al. 2016; Björk et al. 2016; Emilson et al., 2017; De C
Williams, 2016; Hiller & Suominen, 2017; Kehlet et al.,
2006; Nordmann et al., 2017; Paydar et al., 2016; PlattsMills et al., 2016; Peppin et al., 2015; Wailoo, 2014;
Rajagopal, 2011; Breivik et al., 2006; ; Trentin, et al.,
2001

Pain Influenced by
Rivera et al., 2015
Activities
Role of narrative in pain Jurecic. 2012; Maxwell, 2013; Newton et al., 2001;
Rajagopal, 2011; Tsao, 2012
relief
Sheedy, et al., 2017, Sturgeon & Zautra, 2016, Wong et
al., 2015
Research
Breivik et al., 2006 Jackson, 2005; Werner et al., 2004;
Stigma and self-shaming
Wilber, 2015; Waugh et al., 2014
Question

Resilience and Anxiety

1-1

Role of exercise

Breivik et al., 2006; Slade et al., 2009

Used Psychobiosocial

Engel, 1980

Liminality and chronic
Research pain
Question
2
Stigma from Doctors

Stigma Other
Opioids lead to addiction

Cacioppo et al., 2015; Hawkley & Capitanio, 2015;
Jackson, 2005; Major et al., 1998; Monsivais, 2013;
Oliveira et al., 2015; Sturgeon & Zautra. 2016
Augoustinos et al., 2014; de C Williams, 2016; Jackson,
2005; Moseley & Butler, 2015; Monsivais, 2013; Newton
et al., 2013; Phelan et al., 2015; Waugh et al., 2014;
Zanini et al., 2016
Abdallah & Geha, 2017; Armentor, 2017; Hiller &
Suominen, 2017; Monsivais, 2013;
Bruehl et al., 2015
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1995; Newton et al., 2013; Phelan et al., 2015; Roese &
Question pain
Olson, 1996; Wilbers, 2015; Waugh et al., 2014
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Complying with Medical
advice reduces stigma
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Pain a separate disease Siddall & Cousins, 2004
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